data_2m9n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m9n _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 166' ' ' ILE . 33.2 m . . . . . 0 C--O 1.228 -0.062 0 CA-C-O 120.462 0.172 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -49.55 -21.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.641 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -83.45 2.6 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.336 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.498 ' CD1' ' CD1' ' A' ' 210' ' ' PHE . 5.8 mt -66.59 130.16 94.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.32 128.99 16.27 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.648 1.566 . . . . 0.0 110.684 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.87 -51.57 0.77 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.0 t -49.57 -49.73 18.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.207 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 88.19 83.0 1.24 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.55 -19.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.6 t -69.74 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.051 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 170' ' ' GLY . 22.6 tttm -85.96 -19.19 30.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.476 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.448 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -35.39 -58.54 0.78 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.534 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 41.1 Cg_endo -71.02 -29.11 18.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.534 2.156 . . . . 0.0 111.847 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 173' ' ' LYS . 31.8 tp -70.55 -57.48 4.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.552 0.691 . . . . 0.0 110.306 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.496 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 5.1 tt -67.68 -21.98 65.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.541 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.611 ' O ' ' O ' ' A' ' 181' ' ' PHE . 0.6 OUTLIER -68.56 -42.34 78.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.928 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.465 ' N ' HD21 ' A' ' 178' ' ' LEU . 9.5 mm-40 -42.37 -28.32 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.097 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 178' ' ' LEU . 17.8 mttt -100.34 -15.77 17.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.136 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 178' ' ' LEU . 18.7 m-85 -128.74 152.77 79.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.019 0.437 . . . . 0.0 111.035 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . 0.537 ' C ' ' HG ' ' A' ' 183' ' ' SER . 82.6 Cg_exo -38.88 -77.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.884 2.389 . . . . 0.0 112.523 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 69.2 m -162.45 166.26 25.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.3 -16.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.776 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 16.3 tt0 -72.24 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -87.51 -35.35 18.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.74 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.594 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -48.78 -52.28 24.71 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.284 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 184' ' ' ILE . 3.4 p -61.36 -13.0 16.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.717 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.532 ' O ' ' OD1' ' A' ' 189' ' ' ASN . 24.2 t-20 -109.08 10.13 26.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.425 ' CB ' ' CE2' ' A' ' 181' ' ' PHE . . . -56.8 150.25 16.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.57 ' CB ' ' OE1' ' A' ' 194' ' ' GLU . 0.8 OUTLIER -44.89 136.67 4.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 204' ' ' ALA . 31.0 mm -52.13 -52.03 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.2 3.41 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.57 ' OE1' ' CB ' ' A' ' 191' ' ' SER . 8.2 mt-10 -81.82 -61.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.292 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 mt -53.44 -32.84 51.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.63 ' C ' ' H ' ' A' ' 198' ' ' VAL . 8.8 tt0 -71.71 -61.2 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.417 HE21 ' HA ' ' A' ' 197' ' ' GLN . 0.9 OUTLIER -66.48 7.27 0.35 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.63 ' H ' ' C ' ' A' ' 196' ' ' GLU . 5.1 t -108.89 -36.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.58 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.458 HG11 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -143.89 -38.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.457 -179.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.458 ' N ' HG11 ' A' ' 199' ' ' VAL . . . -178.49 139.11 3.93 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.882 -1.152 . . . . 0.0 112.402 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -61.69 -46.1 91.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -70.62 -42.49 70.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 40.0 t -53.54 -61.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.277 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 192' ' ' ILE . . . -53.65 -29.21 37.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.928 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -24.64 48.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.997 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.8 mt-30 -81.35 -53.75 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.438 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.439 ' H ' HG13 ' A' ' 207' ' ' ILE . 16.9 mt -55.64 -28.9 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.66 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.67 -43.0 66.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.12 -18.76 29.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.498 ' CD1' ' CD1' ' A' ' 166' ' ' ILE . 27.2 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.228 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 166' ' ' ILE . 1.4 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.678 0.275 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.79 -18.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.223 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 163' ' ' VAL . 7.1 mt-30 -84.46 10.89 9.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.124 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 163' ' ' VAL . 7.4 mt -75.51 130.41 79.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.81 129.71 12.79 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.033 1.822 . . . . 0.0 111.082 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.32 -49.85 0.83 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.6 t -49.7 -44.35 19.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 79.8 80.91 0.78 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.6 pttt -43.13 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 170' ' ' GLY . 40.8 t -67.88 -48.68 74.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.116 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.651 ' O ' ' N ' ' A' ' 176' ' ' LEU . 4.3 tttp -77.96 -34.85 50.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.796 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 173' ' ' LYS . . . -29.12 -59.98 0.24 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.41 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 18.8 Cg_endo -60.99 -32.47 92.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.36 2.04 . . . . 0.0 111.645 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 173' ' ' LYS . 12.7 tp -70.42 -56.81 5.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.458 0.647 . . . . 0.0 109.829 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 181' ' ' PHE . 0.8 OUTLIER -70.53 -18.34 62.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.204 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.623 ' CD1' ' O ' ' A' ' 182' ' ' PRO . 5.8 tp -55.85 -43.55 77.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.256 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -56.39 -20.64 20.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.382 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -99.17 -17.57 18.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' A' ' 178' ' ' LEU . 68.0 m-85 -136.79 150.4 69.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . 0.623 ' O ' ' CD1' ' A' ' 178' ' ' LEU . 88.1 Cg_exo -37.34 -79.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.044 2.496 . . . . 0.0 112.814 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.3 OUTLIER -163.29 171.58 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.672 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.489 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -38.91 -17.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.899 0.38 . . . . 0.0 110.103 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.671 ' N ' ' O ' ' A' ' 183' ' ' SER . 1.5 tm0? -67.35 -62.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.484 HE21 HD21 ' A' ' 189' ' ' ASN . 21.5 tp60 -88.22 -34.85 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.24 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.611 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -45.36 -56.96 4.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.474 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 38.9 m -59.88 -4.72 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.484 HD21 HE21 ' A' ' 186' ' ' GLN . 25.9 t30 -113.95 2.03 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.465 ' HB2' ' CE2' ' A' ' 181' ' ' PHE . . . -47.57 154.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.539 ' H ' ' HG ' ' A' ' 191' ' ' SER . 0.8 OUTLIER -46.81 154.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.43 HG21 HD12 ' A' ' 192' ' ' ILE . 29.4 mm -65.49 -50.83 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.557 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -48.96 -47.23 32.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.559 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 2.8 mm-40 -64.29 -62.9 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.859 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.3 mt -57.1 -21.7 34.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' A' ' 198' ' ' VAL . 9.0 tt0 -79.5 -61.59 1.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.043 0.449 . . . . 0.0 110.823 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -67.76 7.52 0.5 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.611 ' H ' ' C ' ' A' ' 196' ' ' GLU . 14.7 t -106.64 -37.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.131 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -144.19 -38.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.33 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.15 138.39 3.71 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.36 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -66.55 -38.76 87.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -78.34 -28.55 47.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 206' ' ' GLN . 13.6 t -70.01 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -48.81 -39.35 25.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.57 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -70.37 -25.4 63.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.663 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.503 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.13 -36.37 22.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.525 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.469 ' N ' ' HG3' ' A' ' 206' ' ' GLN . 66.4 mt -65.79 -43.16 93.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.966 0.412 . . . . 0.0 110.203 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -63.68 -42.26 98.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.039 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.8 -18.4 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.814 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.526 ' CD1' ' CD1' ' A' ' 166' ' ' ILE . 42.6 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.873 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.691 0.282 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 165' ' ' GLN . 1.5 pp0? -54.83 -21.44 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.47 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.404 ' N ' ' HG3' ' A' ' 164' ' ' GLN . 19.0 mt-30 -83.14 0.35 45.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.4 mt -59.56 131.42 88.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.473 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.61 129.12 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.907 1.738 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.64 -50.77 0.8 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.7 t -49.51 -59.48 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.123 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 93.56 84.81 1.59 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 170' ' ' GLY . 28.7 pttt -42.75 -18.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 170' ' ' GLY . 26.1 t -68.17 -43.28 85.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.3 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 170' ' ' GLY . 18.5 tttt -91.9 -7.79 48.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.654 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.475 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -45.79 -59.73 4.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.62 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 33.3 Cg_endo -66.64 -32.6 37.98 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.581 2.187 . . . . 0.0 111.836 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.5 tp -66.84 -57.85 6.2 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.608 0.718 . . . . 0.0 110.71 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 5.6 tt -67.27 -30.11 69.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' A' ' 181' ' ' PHE . 2.1 tt -57.83 -42.37 84.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.969 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.46 ' N ' HD22 ' A' ' 178' ' ' LEU . 10.5 pt20 -38.75 -32.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.157 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 178' ' ' LEU . 7.4 mtpt -92.85 -34.92 13.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.203 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.608 ' O ' ' O ' ' A' ' 178' ' ' LEU . 8.2 m-85 -112.76 149.21 40.85 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 110.892 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -35.3 -77.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.866 2.377 . . . . 0.0 112.496 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 57.0 p -162.71 173.5 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.813 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.477 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.73 -14.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.917 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 9.5 tt0 -69.53 -62.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 189' ' ' ASN . 20.4 tt0 -87.89 -34.46 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.955 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -45.32 -56.56 4.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.376 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.442 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 3.8 m -59.27 -13.09 6.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.012 0.434 . . . . 0.0 110.256 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.676 ' ND2' ' O ' ' A' ' 189' ' ' ASN . 1.1 t-20 -103.97 2.65 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.651 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.488 ' HB2' ' CE2' ' A' ' 181' ' ' PHE . . . -51.01 157.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.408 ' OG ' ' OE1' ' A' ' 194' ' ' GLU . 0.7 OUTLIER -47.53 135.78 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.664 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.47 HD13 HG21 ' A' ' 192' ' ' ILE . 48.0 mm -54.54 -47.3 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.364 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.19 -46.56 62.57 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.52 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 4.3 mt-10 -63.9 -65.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.193 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 1.8 mt -50.05 -23.42 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.013 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 198' ' ' VAL . 10.8 tt0 -79.37 -61.11 2.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.717 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.24 4.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.597 ' H ' ' C ' ' A' ' 196' ' ' GLU . 71.4 t -108.99 -35.03 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.34 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.424 HG11 ' N ' ' A' ' 200' ' ' GLY . 1.0 OUTLIER -144.14 -39.24 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.942 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.424 ' N ' HG11 ' A' ' 199' ' ' VAL . . . -179.57 138.5 3.48 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -67.07 -42.09 85.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.13 -21.38 54.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.457 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 206' ' ' GLN . 41.3 t -78.4 -60.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.057 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -47.47 -31.5 4.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.685 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -81.13 -27.5 35.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -81.48 -23.42 37.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.441 HG21 HD13 ' A' ' 207' ' ' ILE . 65.0 mt -78.38 -36.02 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.51 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -80.69 -32.13 36.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.215 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.58 -18.78 30.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.7 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.242 -179.512 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.754 0.311 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.54 ' C ' ' H ' ' A' ' 166' ' ' ILE . 8.3 pt20 -49.33 -31.69 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.04 12.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.097 0.475 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.54 ' H ' ' C ' ' A' ' 164' ' ' GLN . 4.5 mt -76.4 132.39 72.93 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.13 128.95 14.47 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.033 1.822 . . . . 0.0 110.856 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.49 -50.41 0.81 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 37.2 t -48.56 -49.64 13.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.103 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 173' ' ' LYS . . . 84.73 82.6 1.03 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' GLY . 25.1 pttt -42.96 -19.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 170' ' ' GLY . 65.8 t -70.46 -42.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.845 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 19.0 tttm -86.91 -12.62 47.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.475 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -43.97 -60.02 3.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.293 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 29.0 Cg_endo -65.66 -29.68 51.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.507 2.138 . . . . 0.0 111.788 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.9 tp -70.92 -57.92 4.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.587 0.708 . . . . 0.0 110.37 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.7 tt -67.69 -31.6 71.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.131 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -55.61 -21.35 17.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.675 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -26.89 68.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -97.53 -18.03 19.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 178' ' ' LEU . 35.2 m-85 -132.88 150.92 77.01 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -38.56 -74.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.213 2.609 . . . . 0.0 112.944 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 1.3 t -160.51 169.33 23.2 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.066 0.46 . . . . 0.0 111.298 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.65 -15.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.731 -179.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 5.6 tt0 -66.53 -63.59 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -89.41 -31.26 17.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.173 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.603 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -48.09 -55.22 10.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.631 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.477 ' O ' ' CG2' ' A' ' 207' ' ' ILE . 1.0 OUTLIER -62.58 -17.67 60.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.721 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -101.39 8.09 42.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.511 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.402 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -49.77 154.51 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -45.2 146.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.568 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 30.7 mm -59.49 -43.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -57.88 -50.41 66.03 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.581 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 39.3 mt-10 -62.28 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.727 0.299 . . . . 0.0 110.598 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 3.4 mt -53.0 -21.42 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.56 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.554 ' C ' ' H ' ' A' ' 198' ' ' VAL . 11.5 tt0 -77.84 -61.23 2.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.446 ' NE2' HG21 ' A' ' 198' ' ' VAL . 3.7 pp0? -68.14 5.22 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.581 ' CG2' ' O ' ' A' ' 194' ' ' GLU . 71.9 t -108.59 -36.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.365 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.7 OUTLIER -143.34 -39.09 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.705 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.456 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.84 136.7 2.96 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.472 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -47.75 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -72.77 -36.92 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.439 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.37 -61.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -50.92 -34.01 26.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.79 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -69.94 -27.14 64.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.76 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 1.0 OUTLIER -84.23 -55.98 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.422 . . . . 0.0 110.545 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 188' ' ' SER . 26.8 mt -48.52 -28.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.906 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -80.69 -32.6 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.88 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.45 -22.49 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.589 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.474 ' CD1' HD13 ' A' ' 166' ' ' ILE . 32.4 t80 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.825 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 166' ' ' ILE . 1.8 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.761 0.315 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -18.97 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.708 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -83.27 2.36 36.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.653 ' CD1' ' CD1' ' A' ' 210' ' ' PHE . 6.1 mt -67.11 131.2 93.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.433 ' O ' ' NE2' ' A' ' 206' ' ' GLN . 30.5 Cg_endo -68.14 128.66 17.94 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.52 1.48 . . . . 0.0 110.351 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.89 -49.97 0.84 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.0 t -49.29 -57.58 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.812 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 99.94 87.28 1.94 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.2 pttt -43.2 -19.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.9 t -72.27 -45.12 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.2 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.2 tttm -87.24 -17.53 32.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 173' ' ' LYS . . . -35.53 -58.77 0.78 Allowed Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.307 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 53.5 Cg_endo -72.5 -36.26 5.36 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.686 2.258 . . . . 0.0 111.451 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.7 -57.61 11.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.247 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.473 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 3.0 tt -65.69 -31.63 72.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -51.53 -14.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.167 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -79.05 -35.24 42.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.063 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -85.13 -6.93 59.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.652 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.598 ' O ' ' O ' ' A' ' 178' ' ' LEU . 38.6 m-85 -147.29 153.56 44.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.664 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -38.27 -73.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.097 2.531 . . . . 0.0 112.836 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -160.79 168.93 23.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -39.13 -26.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 183' ' ' SER . 7.6 tt0 -63.19 -56.34 17.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.5 tp60 -87.39 -38.81 15.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.999 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.575 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.36 -50.67 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.142 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.474 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 22.9 p -64.16 -17.84 63.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.526 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.512 ' O ' ' OD1' ' A' ' 189' ' ' ASN . 48.7 t-20 -106.12 1.2 26.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.24 159.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.415 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.1 p -52.29 137.76 28.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.534 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.477 HD12 HG23 ' A' ' 192' ' ' ILE . 44.2 mm -54.92 -43.59 69.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.681 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.0 -33.87 45.14 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.579 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 67.5 mm-40 -81.78 -65.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.645 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.4 mt -47.86 -29.53 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.595 ' C ' ' H ' ' A' ' 198' ' ' VAL . 2.5 tm-20 -72.54 -61.01 1.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.897 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.511 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 7.1 pt20 -67.76 6.76 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.595 ' H ' ' C ' ' A' ' 196' ' ' GLU . 72.7 t -106.24 -38.94 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.79 -39.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.361 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 199' ' ' VAL . . . -178.57 139.25 3.98 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.266 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.429 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 37.7 tt0 -65.27 -44.72 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.69 -31.2 64.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.465 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 206' ' ' GLN . 18.6 t -68.31 -61.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.884 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -46.96 -33.48 4.69 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -81.4 -23.47 37.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.992 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 203' ' ' VAL . 4.1 pt20 -83.23 -31.56 26.94 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.557 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.37 -50.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.102 0.477 . . . . 0.0 110.007 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.21 -35.72 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.5 -20.68 27.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.653 ' CD1' ' CD1' ' A' ' 166' ' ' ILE . 27.0 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.654 0.264 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -53.05 -22.58 6.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.827 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -80.61 13.51 2.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 5.8 mt -78.15 130.44 72.32 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.869 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.74 129.2 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.897 1.732 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.65 -51.45 0.78 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.477 HG23 ' HG ' ' A' ' 188' ' ' SER . 63.6 t -49.39 -45.66 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.945 0.402 . . . . 0.0 110.112 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 82.21 81.1 0.92 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.37 -19.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 170' ' ' GLY . 46.4 t -66.91 -44.68 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.069 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 176' ' ' LEU . 2.7 ttmm -84.06 -32.49 24.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.549 ' C ' ' O ' ' A' ' 173' ' ' LYS . . . -28.27 -62.69 0.19 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.425 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.505 ' CD ' ' CB ' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -55.51 -36.4 94.23 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.245 1.963 . . . . 0.0 111.115 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.679 ' N ' ' O ' ' A' ' 173' ' ' LYS . 19.5 tp -77.74 -57.01 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.555 0.693 . . . . 0.0 109.54 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 173' ' ' LYS . 23.6 tp -59.98 -18.59 46.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.095 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.604 ' CD2' ' C ' ' A' ' 178' ' ' LEU . 1.0 OUTLIER -73.58 -38.24 65.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.16 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.438 ' N ' HD23 ' A' ' 178' ' ' LEU . 22.5 mt-30 -47.02 -20.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.326 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.405 ' N ' ' C ' ' A' ' 178' ' ' LEU . 6.2 mmtt -101.38 -26.5 13.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 178' ' ' LEU . 21.6 m-85 -126.23 148.53 63.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -36.79 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.199 2.6 . . . . 0.0 113.31 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.7 OUTLIER -157.17 168.18 28.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.021 -179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -39.52 -16.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 183' ' ' SER . 1.9 tp-100 -66.33 -62.95 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -88.09 -32.3 18.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.034 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -49.89 -54.03 22.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.632 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.477 ' HG ' HG23 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -68.94 -12.61 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 110.417 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -107.72 6.51 27.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.645 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.87 163.26 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.557 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.1 t -43.98 159.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.698 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 50.3 mm -76.33 -42.96 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.625 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.8 -37.16 92.06 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.529 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 16.4 mt-10 -69.34 -65.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.771 0.32 . . . . 0.0 110.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.52 -22.62 45.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 198' ' ' VAL . 3.8 tm-20 -74.11 -60.39 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.494 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -66.77 2.9 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.565 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 194' ' ' GLU . 45.3 t -96.94 -48.9 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.07 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 200' ' ' GLY . 0.4 OUTLIER -134.62 -39.62 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.679 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.487 ' N ' HG13 ' A' ' 199' ' ' VAL . . . -178.79 143.27 5.77 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.947 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 205' ' ' GLN . 12.6 tt0 -65.66 -36.36 83.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -71.56 -43.34 66.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.563 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.44 -61.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.531 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -50.27 -27.3 5.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.644 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.431 ' CG ' ' O ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -80.0 -25.32 40.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.291 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.9 mt-30 -84.48 -43.09 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.412 ' CG2' ' O ' ' A' ' 188' ' ' SER . 17.3 mt -63.19 -48.99 85.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.877 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -58.9 -37.03 75.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -81.82 -27.2 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 14.1 t80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.523 -179.88 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.637 ' C ' ' H ' ' A' ' 165' ' ' GLN . 14.5 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.636 0.255 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.674 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 0.1 OUTLIER -47.89 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.74 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.674 ' N ' ' OE1' ' A' ' 164' ' ' GLN . 20.5 mt-30 -94.29 3.93 54.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.43 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.594 ' CD1' ' CD2' ' A' ' 210' ' ' PHE . 5.3 mt -71.81 131.14 86.1 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.86 129.12 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.794 1.663 . . . . 0.0 110.899 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 -49.64 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.6 t -53.79 -37.55 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.999 0.428 . . . . 0.0 110.205 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 75.35 82.65 0.45 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -42.83 -19.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 170' ' ' GLY . 49.9 t -68.14 -51.6 46.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.091 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 174' ' ' ALA . 21.7 tttm -75.67 -29.27 59.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.785 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.529 ' CB ' ' CD ' ' A' ' 175' ' ' PRO . . . -29.3 -64.68 0.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.669 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.529 ' CD ' ' CB ' ' A' ' 174' ' ' ALA . 18.5 Cg_endo -61.28 -36.33 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.542 2.161 . . . . 0.0 111.657 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 173' ' ' LYS . 43.3 tp -64.12 -57.32 9.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.424 HD23 ' CD1' ' A' ' 181' ' ' PHE . 1.4 tt -68.84 -28.25 66.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.592 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.603 ' CD2' ' C ' ' A' ' 178' ' ' LEU . 0.8 OUTLIER -55.17 -39.03 69.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.909 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.443 ' N ' HD22 ' A' ' 178' ' ' LEU . 76.4 mt-30 -45.04 -30.29 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.993 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -100.24 -17.9 17.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.261 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' A' ' 178' ' ' LEU . 62.6 m-85 -124.73 149.05 61.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 111.006 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -37.57 -78.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.677 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.56 167.03 23.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.905 0.383 . . . . 0.0 111.079 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.591 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.58 -13.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.811 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.677 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.0 OUTLIER -72.1 -60.96 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 189' ' ' ASN . 46.8 tt0 -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.026 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.591 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.84 -50.17 14.53 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.397 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.507 ' H ' ' HG ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -62.45 -10.79 12.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 186' ' ' GLN . 40.6 t30 -111.63 4.69 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.711 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.45 158.11 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.372 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.82 131.37 15.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.41 HG22 HD12 ' A' ' 192' ' ' ILE . 30.9 mm -47.88 -50.61 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -45.63 -42.86 10.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.02 -62.05 1.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.873 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.8 mt -53.84 -25.41 19.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.907 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.64 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 2.6 tm-20 -78.21 -60.75 2.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 110.836 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.64 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 1.6 pt20 -67.1 3.52 1.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 196' ' ' GLU . 3.4 t -103.74 -37.67 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.094 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.7 OUTLIER -144.07 -38.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.749 -178.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.48 138.25 3.59 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.578 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.442 ' NE2' ' HG3' ' A' ' 196' ' ' GLU . 3.9 tp-100 -58.79 -52.53 65.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.11 84.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.736 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 21.0 t -53.87 -60.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.276 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.14 -29.17 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.799 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.89 -27.61 43.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.401 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 210' ' ' PHE . 1.2 mt-30 -80.49 -51.37 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.111 0.482 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.416 ' CG2' ' HB3' ' A' ' 188' ' ' SER . 25.3 mt -52.75 -34.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.669 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -71.56 -40.92 69.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -84.17 -18.47 36.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.594 ' CD2' ' CD1' ' A' ' 166' ' ' ILE . 69.6 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.202 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 166' ' ' ILE . 3.4 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 165' ' ' GLN . 9.3 pt20 -46.58 -27.55 1.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.428 ' N ' ' HG3' ' A' ' 164' ' ' GLN . 10.5 mt-30 -76.37 8.5 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.424 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 210' ' ' PHE . 5.1 mt -69.43 131.54 90.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.589 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.98 129.53 14.37 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.876 1.717 . . . . 0.0 110.822 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.91 -49.71 0.85 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.6 t -54.79 -45.97 74.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 109.96 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 85.68 83.89 1.06 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.5 OUTLIER -43.03 -19.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 170' ' ' GLY . 63.9 t -71.22 -55.7 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.917 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 174' ' ' ALA . 0.3 OUTLIER -71.71 -29.0 64.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.439 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.558 ' CB ' ' CD ' ' A' ' 175' ' ' PRO . . . -29.32 -64.83 0.18 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 174' ' ' ALA . 11.0 Cg_endo -57.13 -45.38 35.96 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.703 2.269 . . . . 0.0 111.495 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 173' ' ' LYS . 21.3 tp -54.27 -57.24 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.507 0.67 . . . . 0.0 110.399 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.8 tt -72.35 -17.68 61.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.679 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -59.47 -30.74 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -62.28 -21.79 65.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -96.86 -22.29 16.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.122 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 178' ' ' LEU . 48.1 m-85 -132.32 150.21 75.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -36.77 -76.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.997 2.464 . . . . 0.0 112.65 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.678 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.59 171.26 17.22 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.015 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.474 HD11 HG21 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.38 -15.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 -179.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.678 ' N ' ' O ' ' A' ' 183' ' ' SER . 24.0 tt0 -70.78 -60.21 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 189' ' ' ASN . 1.3 tt0 -87.99 -34.46 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.025 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.595 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.33 -51.02 11.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.25 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.454 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 54.5 m -61.68 -15.02 36.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.301 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 186' ' ' GLN . 5.3 t-20 -105.51 12.22 31.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.083 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.466 ' HB3' ' CE2' ' A' ' 181' ' ' PHE . . . -53.71 149.55 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.31 128.7 4.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.653 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.2 mm -48.26 -49.17 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -50.72 -35.94 31.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.405 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 18.4 mt-10 -77.8 -64.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.7 mt -51.4 -23.91 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.606 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.629 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 3.2 tm-20 -79.73 -60.98 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.629 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 0.8 OUTLIER -66.44 3.67 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.598 ' H ' ' C ' ' A' ' 196' ' ' GLU . 13.4 t -104.06 -37.54 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.131 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 200' ' ' GLY . 0.7 OUTLIER -143.67 -39.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.436 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.46 ' N ' HG13 ' A' ' 199' ' ' VAL . . . -178.89 139.08 3.83 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.413 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.423 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 6.5 tp-100 -63.71 -40.63 97.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.35 68.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.872 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.83 -61.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.209 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.37 18.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.734 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -78.46 -26.37 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.927 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.498 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.69 -36.18 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.649 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.462 ' N ' ' HG3' ' A' ' 206' ' ' GLN . 72.3 mt -65.34 -43.35 94.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.088 0.47 . . . . 0.0 109.959 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -66.99 -35.41 79.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.703 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.2 -18.42 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.533 ' CD2' ' CD1' ' A' ' 166' ' ' ILE . 45.1 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.491 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 166' ' ' ILE . 2.9 t . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.64 0.257 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.56 -22.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.628 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -84.94 10.32 12.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.299 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 163' ' ' VAL . 4.5 mt -70.21 132.01 88.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.04 129.17 16.85 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.021 1.814 . . . . 0.0 111.247 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.64 -47.86 1.0 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.9 t -50.64 -46.31 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.232 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 81.2 82.12 0.82 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.522 ' CB ' ' NZ ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -42.75 -18.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 43.8 t -66.9 -42.04 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.013 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.8 tttt -87.6 -22.25 24.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.672 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.488 ' CB ' ' CD ' ' A' ' 175' ' ' PRO . . . -33.93 -61.83 0.39 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.597 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 174' ' ' ALA . 24.4 Cg_endo -63.69 -37.42 46.48 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.603 2.202 . . . . 0.0 111.707 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 22.0 tp -59.26 -56.68 19.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.562 0.696 . . . . 0.0 110.562 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 tt -74.47 -28.2 60.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.722 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.8 tt -50.32 -17.87 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.847 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 179' ' ' GLN . 9.2 mm100 -78.04 -36.55 48.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.826 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -82.39 -18.62 41.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 178' ' ' LEU . 20.9 m-85 -131.82 154.34 81.74 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.194 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -36.62 -76.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.841 2.361 . . . . 0.0 112.462 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 68.8 m -162.8 169.4 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.789 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.567 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.54 -14.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.481 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.1 OUTLIER -73.26 -60.91 2.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -87.7 -26.66 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.088 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.58 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -55.11 -53.93 49.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.51 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.455 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 1.4 t -64.32 -19.99 65.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.086 0.469 . . . . 0.0 110.13 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.571 ' O ' ' OD1' ' A' ' 189' ' ' ASN . 22.8 t-20 -104.05 11.09 35.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.927 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' A' ' 181' ' ' PHE . . . -57.87 163.59 2.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.635 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.1 p -51.25 131.86 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.703 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 192' ' ' ILE . 41.4 mm -49.46 -49.82 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.791 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -47.48 -46.93 23.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.561 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 64.1 mm-40 -66.68 -66.12 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.647 0.261 . . . . 0.0 110.56 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.7 mt -49.4 -25.53 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.686 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.556 ' C ' ' H ' ' A' ' 198' ' ' VAL . 4.3 tt0 -73.29 -60.93 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -69.03 6.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 194' ' ' GLU . 89.7 t -108.71 -36.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.505 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.82 -38.98 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.606 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.463 ' N ' HG11 ' A' ' 199' ' ' VAL . . . -178.53 137.48 3.29 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.263 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.73 -45.89 87.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.29 59.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.58 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 206' ' ' GLN . 19.7 t -68.08 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.094 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -47.68 -31.05 4.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.852 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.62 -26.48 41.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -84.76 -32.98 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.449 ' N ' ' HG3' ' A' ' 206' ' ' GLN . 63.3 mt -68.46 -34.02 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -71.99 -41.58 67.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.137 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -76.11 -29.71 57.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.547 ' C ' ' CD1' ' A' ' 210' ' ' PHE . 9.2 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' A' ' 165' ' ' GLN . 2.7 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.833 0.349 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.48 -12.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 163' ' ' VAL . 4.2 mt-30 -96.12 4.39 52.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.522 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.583 ' CD1' ' CD1' ' A' ' 210' ' ' PHE . 3.6 mt -56.52 115.76 10.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.556 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.28 129.57 29.36 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.788 1.658 . . . . 0.0 111.288 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.72 -46.26 1.2 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -48.86 -55.2 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.333 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 83.83 82.33 0.98 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 172' ' ' VAL . 0.0 OUTLIER -42.83 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 170' ' ' GLY . 48.6 t -64.14 -41.81 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.945 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -85.86 -31.12 22.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.888 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.528 ' CB ' ' CD ' ' A' ' 175' ' ' PRO . . . -29.07 -65.13 0.17 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 174' ' ' ALA . 18.7 Cg_endo -60.77 -33.42 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.561 2.174 . . . . 0.0 111.691 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 173' ' ' LYS . 53.9 tp -67.9 -56.47 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.605 0.717 . . . . 0.0 109.734 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.47 -17.06 61.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.233 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.624 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.7 tt -52.59 -54.16 36.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.449 ' N ' HD22 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -48.48 -23.91 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.533 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.419 ' N ' ' HG3' ' A' ' 179' ' ' GLN . 49.2 mttp -88.91 -16.15 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.869 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.624 ' O ' ' O ' ' A' ' 178' ' ' LEU . 95.3 m-85 -148.6 145.73 20.75 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 121.003 0.43 . . . . 0.0 110.922 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 181' ' ' PHE . 80.8 Cg_exo -31.82 -78.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.17 2.58 . . . . 0.0 112.87 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.2 OUTLIER -163.11 175.8 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.857 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.481 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.78 -14.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.516 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.685 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.5 OUTLIER -69.29 -62.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.1 tt0 -88.37 -33.26 18.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.033 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.576 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -46.06 -52.07 12.61 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.234 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.46 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 0.4 OUTLIER -65.63 -3.69 5.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.51 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 186' ' ' GLN . 49.1 t-20 -121.98 3.98 9.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.474 ' HB1' ' CE2' ' A' ' 181' ' ' PHE . . . -48.71 161.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.487 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.43 140.7 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -62.51 -47.54 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.528 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -52.41 -28.53 28.41 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 4.2 mm-40 -81.87 -64.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.782 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.58 -30.21 29.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.807 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.563 ' C ' ' H ' ' A' ' 198' ' ' VAL . 15.1 tt0 -72.39 -61.09 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.49 4.25 1.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.563 ' H ' ' C ' ' A' ' 196' ' ' GLU . 25.4 t -108.78 -35.58 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 200' ' ' GLY . 0.8 OUTLIER -143.01 -39.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.551 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.463 ' N ' HG11 ' A' ' 199' ' ' VAL . . . -179.69 138.03 3.29 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.445 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -63.79 -43.5 96.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.97 -32.88 69.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.545 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.459 HG11 HE21 ' A' ' 206' ' ' GLN . 48.6 t -66.3 -61.68 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.446 ' HB2' ' N ' ' A' ' 196' ' ' GLU . . . -50.69 -29.97 12.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.491 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -81.09 -28.01 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.813 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 210' ' ' PHE . 3.4 pt20 -84.44 -42.77 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.599 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.461 ' N ' ' CG ' ' A' ' 206' ' ' GLN . 65.4 mt -58.62 -42.5 85.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -66.72 -42.63 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.0 -18.57 32.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.038 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 206' ' ' GLN . 6.5 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.035 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.799 0.333 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.89 150.26 36.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.685 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.541 ' O ' ' CD2' ' A' ' 160' ' ' LEU . 39.3 Cg_endo -70.93 122.17 8.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.747 2.298 . . . . 0.0 111.944 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.586 ' O ' ' N ' ' A' ' 162' ' ' THR . 50.8 p -80.33 -20.67 43.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.88 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.537 ' O ' ' CG1' ' A' ' 163' ' ' VAL . 6.3 tp -38.03 -28.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.087 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 157' ' ' PRO . 0.9 OUTLIER -83.52 -41.75 17.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 109.988 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 158' ' ' SER . 13.6 ttm180 -79.16 -15.86 57.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.586 ' N ' ' O ' ' A' ' 158' ' ' SER . 18.6 m -85.57 -47.24 10.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.496 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 159' ' ' LEU . 33.2 m -66.04 -45.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.829 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -49.55 -21.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.641 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -83.45 2.6 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.336 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.498 ' CD1' ' CD1' ' A' ' 210' ' ' PHE . 5.8 mt -66.59 130.16 94.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.32 128.99 16.27 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.648 1.566 . . . . 0.0 110.684 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.87 -51.57 0.77 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.0 t -49.57 -49.73 18.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.207 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 88.19 83.0 1.24 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.55 -19.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.6 t -69.74 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.051 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 170' ' ' GLY . 22.6 tttm -85.96 -19.19 30.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.476 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.448 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -35.39 -58.54 0.78 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.534 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 41.1 Cg_endo -71.02 -29.11 18.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.534 2.156 . . . . 0.0 111.847 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 173' ' ' LYS . 31.8 tp -70.55 -57.48 4.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.552 0.691 . . . . 0.0 110.306 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.496 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 5.1 tt -67.68 -21.98 65.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.541 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.611 ' O ' ' O ' ' A' ' 181' ' ' PHE . 0.6 OUTLIER -68.56 -42.34 78.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.928 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.465 ' N ' HD21 ' A' ' 178' ' ' LEU . 9.5 mm-40 -42.37 -28.32 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.097 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 178' ' ' LEU . 17.8 mttt -100.34 -15.77 17.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.136 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 178' ' ' LEU . 18.7 m-85 -128.74 152.77 79.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.019 0.437 . . . . 0.0 111.035 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.537 ' C ' ' HG ' ' A' ' 183' ' ' SER . 82.6 Cg_exo -38.88 -77.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.884 2.389 . . . . 0.0 112.523 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 69.2 m -162.45 166.26 25.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.3 -16.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.776 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 16.3 tt0 -72.24 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -87.51 -35.35 18.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.74 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.594 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -48.78 -52.28 24.71 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.284 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 184' ' ' ILE . 3.4 p -61.36 -13.0 16.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.717 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.596 ' ND2' ' CZ ' ' A' ' 211' ' ' PHE . 24.2 t-20 -109.08 10.13 26.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.425 ' CB ' ' CE2' ' A' ' 181' ' ' PHE . . . -56.8 150.25 16.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.57 ' CB ' ' OE1' ' A' ' 194' ' ' GLU . 0.8 OUTLIER -44.89 136.67 4.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 204' ' ' ALA . 31.0 mm -52.13 -52.03 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.2 3.41 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.57 ' OE1' ' CB ' ' A' ' 191' ' ' SER . 8.2 mt-10 -81.82 -61.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.292 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.0 mt -53.44 -32.84 51.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.63 ' C ' ' H ' ' A' ' 198' ' ' VAL . 8.8 tt0 -71.71 -61.2 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.417 HE21 ' HA ' ' A' ' 197' ' ' GLN . 0.9 OUTLIER -66.48 7.27 0.35 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.63 ' H ' ' C ' ' A' ' 196' ' ' GLU . 5.1 t -108.89 -36.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.58 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.458 HG11 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -143.89 -38.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.457 -179.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.458 ' N ' HG11 ' A' ' 199' ' ' VAL . . . -178.49 139.11 3.93 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.882 -1.152 . . . . 0.0 112.402 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -61.69 -46.1 91.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -70.62 -42.49 70.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 40.0 t -53.54 -61.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.277 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 192' ' ' ILE . . . -53.65 -29.21 37.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.928 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -24.64 48.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.997 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.8 mt-30 -81.35 -53.75 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.438 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.688 ' O ' ' CE2' ' A' ' 211' ' ' PHE . 16.9 mt -55.64 -28.9 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.66 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.478 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 86.4 t60 -71.67 -43.0 66.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.12 -18.76 29.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.498 ' CD1' ' CD1' ' A' ' 166' ' ' ILE . 27.2 t80 -58.05 -60.88 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.228 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.688 ' CE2' ' O ' ' A' ' 207' ' ' ILE . 13.5 p90 -73.92 -8.4 55.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.139 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 93.1 m -65.11 -38.28 90.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.81 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.14 97.56 50.58 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.813 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -64.69 115.85 3.46 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.222 1.948 . . . . 0.0 111.911 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.495 -179.965 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.772 0.32 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.45 147.11 34.64 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.464 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.14 104.91 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.754 2.302 . . . . 0.0 111.959 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -64.08 -25.38 68.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.653 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.65 -30.26 5.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.345 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.444 HD21 ' N ' ' A' ' 161' ' ' ARG . 0.7 OUTLIER -82.76 -63.09 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.444 ' N ' HD21 ' A' ' 160' ' ' LEU . 38.2 mtp85 -56.59 -17.34 8.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 158' ' ' SER . 98.8 m -85.6 -25.85 26.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.893 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 166' ' ' ILE . 1.4 t -74.78 -53.06 17.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.298 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.79 -18.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.223 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 163' ' ' VAL . 7.1 mt-30 -84.46 10.89 9.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.124 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 163' ' ' VAL . 7.4 mt -75.51 130.41 79.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.81 129.71 12.79 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.033 1.822 . . . . 0.0 111.082 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.32 -49.85 0.83 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 39.6 t -49.7 -44.35 19.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 79.8 80.91 0.78 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.6 pttt -43.13 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 170' ' ' GLY . 40.8 t -67.88 -48.68 74.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.116 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.651 ' O ' ' N ' ' A' ' 176' ' ' LEU . 4.3 tttp -77.96 -34.85 50.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.796 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.529 ' C ' ' O ' ' A' ' 173' ' ' LYS . . . -29.12 -59.98 0.24 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.41 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 18.8 Cg_endo -60.99 -32.47 92.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.36 2.04 . . . . 0.0 111.645 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 173' ' ' LYS . 12.7 tp -70.42 -56.81 5.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.458 0.647 . . . . 0.0 109.829 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.477 HD22 ' CD1' ' A' ' 181' ' ' PHE . 0.8 OUTLIER -70.53 -18.34 62.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.204 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.623 ' CD1' ' O ' ' A' ' 182' ' ' PRO . 5.8 tp -55.85 -43.55 77.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.256 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -56.39 -20.64 20.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.382 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -99.17 -17.57 18.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' A' ' 178' ' ' LEU . 68.0 m-85 -136.79 150.4 69.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.623 ' O ' ' CD1' ' A' ' 178' ' ' LEU . 88.1 Cg_exo -37.34 -79.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.044 2.496 . . . . 0.0 112.814 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.3 OUTLIER -163.29 171.58 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.672 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.489 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -38.91 -17.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.899 0.38 . . . . 0.0 110.103 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.671 ' N ' ' O ' ' A' ' 183' ' ' SER . 1.5 tm0? -67.35 -62.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.484 HE21 HD21 ' A' ' 189' ' ' ASN . 21.5 tp60 -88.22 -34.85 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.24 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.611 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -45.36 -56.96 4.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.474 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 38.9 m -59.88 -4.72 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.484 HD21 HE21 ' A' ' 186' ' ' GLN . 25.9 t30 -113.95 2.03 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.465 ' HB2' ' CE2' ' A' ' 181' ' ' PHE . . . -47.57 154.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.539 ' H ' ' HG ' ' A' ' 191' ' ' SER . 0.8 OUTLIER -46.81 154.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 -179.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.43 HG21 HD12 ' A' ' 192' ' ' ILE . 29.4 mm -65.49 -50.83 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.557 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -48.96 -47.23 32.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.559 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 2.8 mm-40 -64.29 -62.9 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.859 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.3 mt -57.1 -21.7 34.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' A' ' 198' ' ' VAL . 9.0 tt0 -79.5 -61.59 1.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.043 0.449 . . . . 0.0 110.823 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -67.76 7.52 0.5 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.611 ' H ' ' C ' ' A' ' 196' ' ' GLU . 14.7 t -106.64 -37.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.131 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -144.19 -38.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.33 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.15 138.39 3.71 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.36 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -66.55 -38.76 87.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -78.34 -28.55 47.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 206' ' ' GLN . 13.6 t -70.01 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -48.81 -39.35 25.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.57 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -70.37 -25.4 63.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.663 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.503 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.13 -36.37 22.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.525 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.469 ' N ' ' HG3' ' A' ' 206' ' ' GLN . 66.4 mt -65.79 -43.16 93.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.966 0.412 . . . . 0.0 110.203 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.455 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 8.9 t60 -63.68 -42.26 98.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.039 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.8 -18.4 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.814 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.526 ' CD1' ' CD1' ' A' ' 166' ' ' ILE . 42.6 t80 -56.12 -60.05 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.873 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.455 ' CE2' ' HA ' ' A' ' 208' ' ' HIS . 25.7 p90 -78.29 -5.51 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.053 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 41.1 m -65.11 -37.59 87.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -118.53 97.66 50.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.636 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 215' ' ' ARG . 8.2 Cg_exo -65.0 117.48 4.58 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.221 1.947 . . . . 0.0 111.996 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 214' ' ' PRO . 37.4 mtm180 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.67 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.713 0.292 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.02 159.41 30.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.507 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.02 140.69 25.69 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.866 2.377 . . . . 0.0 112.367 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.659 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -68.92 -39.74 79.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -35.58 -23.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.464 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -82.74 -63.39 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.453 ' N ' HD21 ' A' ' 160' ' ' LEU . 8.2 ttt-85 -55.73 -21.73 20.23 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.5 m -85.78 -33.63 21.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.213 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 159' ' ' LEU . 2.1 t -64.64 -46.46 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.45 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 165' ' ' GLN . 1.5 pp0? -54.83 -21.44 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.47 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.404 ' N ' ' HG3' ' A' ' 164' ' ' GLN . 19.0 mt-30 -83.14 0.35 45.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.4 mt -59.56 131.42 88.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.473 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.61 129.12 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.907 1.738 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 119.64 -50.77 0.8 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.7 t -49.51 -59.48 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.123 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 93.56 84.81 1.59 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 170' ' ' GLY . 28.7 pttt -42.75 -18.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 170' ' ' GLY . 26.1 t -68.17 -43.28 85.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.3 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 170' ' ' GLY . 18.5 tttt -91.9 -7.79 48.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.654 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.475 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -45.79 -59.73 4.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.62 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 33.3 Cg_endo -66.64 -32.6 37.98 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.581 2.187 . . . . 0.0 111.836 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.5 tp -66.84 -57.85 6.2 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.608 0.718 . . . . 0.0 110.71 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 5.6 tt -67.27 -30.11 69.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.608 ' O ' ' O ' ' A' ' 181' ' ' PHE . 2.1 tt -57.83 -42.37 84.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.969 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.46 ' N ' HD22 ' A' ' 178' ' ' LEU . 10.5 pt20 -38.75 -32.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.157 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 178' ' ' LEU . 7.4 mtpt -92.85 -34.92 13.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.203 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.608 ' O ' ' O ' ' A' ' 178' ' ' LEU . 8.2 m-85 -112.76 149.21 40.85 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 110.892 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -35.3 -77.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.866 2.377 . . . . 0.0 112.496 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 57.0 p -162.71 173.5 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.813 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.477 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.73 -14.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.917 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 9.5 tt0 -69.53 -62.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 189' ' ' ASN . 20.4 tt0 -87.89 -34.46 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.955 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -45.32 -56.56 4.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.376 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.442 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 3.8 m -59.27 -13.09 6.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.012 0.434 . . . . 0.0 110.256 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.676 ' ND2' ' O ' ' A' ' 189' ' ' ASN . 1.1 t-20 -103.97 2.65 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.651 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.488 ' HB2' ' CE2' ' A' ' 181' ' ' PHE . . . -51.01 157.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.408 ' OG ' ' OE1' ' A' ' 194' ' ' GLU . 0.7 OUTLIER -47.53 135.78 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.664 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.47 HD13 HG21 ' A' ' 192' ' ' ILE . 48.0 mm -54.54 -47.3 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.364 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.19 -46.56 62.57 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.52 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 4.3 mt-10 -63.9 -65.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.193 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 1.8 mt -50.05 -23.42 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.013 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 198' ' ' VAL . 10.8 tt0 -79.37 -61.11 2.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.717 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.24 4.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.597 ' H ' ' C ' ' A' ' 196' ' ' GLU . 71.4 t -108.99 -35.03 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.34 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.424 HG11 ' N ' ' A' ' 200' ' ' GLY . 1.0 OUTLIER -144.14 -39.24 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.942 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.424 ' N ' HG11 ' A' ' 199' ' ' VAL . . . -179.57 138.5 3.48 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -67.07 -42.09 85.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.13 -21.38 54.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.457 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 206' ' ' GLN . 41.3 t -78.4 -60.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.057 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -47.47 -31.5 4.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.685 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -81.13 -27.5 35.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -81.48 -23.42 37.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.593 ' O ' ' CE2' ' A' ' 211' ' ' PHE . 65.0 mt -78.38 -36.02 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.51 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.47 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 61.0 t-80 -80.69 -32.13 36.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.215 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.58 -18.78 30.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -66.11 -62.94 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.242 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 207' ' ' ILE . 13.9 p90 -75.0 -1.05 20.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.254 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 1.2 m -68.32 -37.27 80.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -117.87 97.63 50.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.707 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.45 117.54 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.321 2.014 . . . . 0.0 112.18 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.439 ' CG ' HH11 ' A' ' 215' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.481 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' A' ' 155' ' ' SER . 4.2 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.838 0.352 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.22 157.56 52.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.08 33.29 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.786 2.324 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 160' ' ' LEU . 3.2 p -65.75 -17.86 64.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.52 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 158' ' ' SER . 5.0 tp -38.43 -20.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.658 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.6 pp -83.83 -45.32 13.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' SER . 9.2 ttt180 -75.28 -20.13 59.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 45.7 m -85.92 -34.81 20.82 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.307 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.3 t -72.26 -52.9 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.505 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.54 ' C ' ' H ' ' A' ' 166' ' ' ILE . 8.3 pt20 -49.33 -31.69 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.04 12.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.097 0.475 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.54 ' H ' ' C ' ' A' ' 164' ' ' GLN . 4.5 mt -76.4 132.39 72.93 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.13 128.95 14.47 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.033 1.822 . . . . 0.0 110.856 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.49 -50.41 0.81 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 37.2 t -48.56 -49.64 13.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.103 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 173' ' ' LYS . . . 84.73 82.6 1.03 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' GLY . 25.1 pttt -42.96 -19.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 170' ' ' GLY . 65.8 t -70.46 -42.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.845 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 19.0 tttm -86.91 -12.62 47.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.475 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -43.97 -60.02 3.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.293 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 29.0 Cg_endo -65.66 -29.68 51.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.507 2.138 . . . . 0.0 111.788 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.9 tp -70.92 -57.92 4.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.587 0.708 . . . . 0.0 110.37 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.7 tt -67.69 -31.6 71.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.131 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.61 ' O ' ' O ' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -55.61 -21.35 17.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.675 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.94 -26.89 68.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -97.53 -18.03 19.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 178' ' ' LEU . 35.2 m-85 -132.88 150.92 77.01 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -38.56 -74.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.213 2.609 . . . . 0.0 112.944 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 1.3 t -160.51 169.33 23.2 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.066 0.46 . . . . 0.0 111.298 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.65 -15.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.731 -179.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 5.6 tt0 -66.53 -63.59 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -89.41 -31.26 17.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.173 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.603 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -48.09 -55.22 10.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.631 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.477 ' O ' ' CG2' ' A' ' 207' ' ' ILE . 1.0 OUTLIER -62.58 -17.67 60.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.721 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -101.39 8.09 42.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.511 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.402 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -49.77 154.51 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -45.2 146.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.568 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 30.7 mm -59.49 -43.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -57.88 -50.41 66.03 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.581 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 39.3 mt-10 -62.28 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.727 0.299 . . . . 0.0 110.598 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 3.4 mt -53.0 -21.42 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.56 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.554 ' C ' ' H ' ' A' ' 198' ' ' VAL . 11.5 tt0 -77.84 -61.23 2.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.446 ' NE2' HG21 ' A' ' 198' ' ' VAL . 3.7 pp0? -68.14 5.22 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.581 ' CG2' ' O ' ' A' ' 194' ' ' GLU . 71.9 t -108.59 -36.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.365 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.7 OUTLIER -143.34 -39.09 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.705 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.456 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.84 136.7 2.96 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.472 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -47.75 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -72.77 -36.92 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.439 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.37 -61.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -50.92 -34.01 26.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.79 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -69.94 -27.14 64.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.76 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 1.0 OUTLIER -84.23 -55.98 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.422 . . . . 0.0 110.545 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 188' ' ' SER . 26.8 mt -48.52 -28.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.906 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -80.69 -32.6 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.88 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.45 -22.49 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.589 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.474 ' CD1' HD13 ' A' ' 166' ' ' ILE . 32.4 t80 -57.54 -47.58 81.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.825 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -46.6 -51.94 14.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.636 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 19.8 m -68.46 -37.96 80.64 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.218 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -118.89 97.53 50.78 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.531 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -74.53 113.98 3.92 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.359 2.039 . . . . 0.0 111.684 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.579 -179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.837 0.351 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 158' ' ' SER . 4.0 mm-40 -110.97 95.91 26.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.394 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.547 ' O ' ' CD2' ' A' ' 160' ' ' LEU . 72.1 Cg_exo -46.38 81.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.427 2.085 . . . . 0.0 112.001 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 160' ' ' LEU . 22.9 p -66.46 -18.75 65.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.862 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 158' ' ' SER . 1.0 OUTLIER -32.04 -32.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.641 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.61 ' HG ' ' H ' ' A' ' 161' ' ' ARG . 0.3 OUTLIER -84.06 -51.25 7.24 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.61 ' H ' ' HG ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -62.86 -18.04 62.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 158' ' ' SER . 60.6 m -85.76 -46.08 11.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.98 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 166' ' ' ILE . 1.8 t -53.22 -48.9 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.44 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -18.97 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.708 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -83.27 2.36 36.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.653 ' CD1' ' CD1' ' A' ' 210' ' ' PHE . 6.1 mt -67.11 131.2 93.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.433 ' O ' ' NE2' ' A' ' 206' ' ' GLN . 30.5 Cg_endo -68.14 128.66 17.94 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.52 1.48 . . . . 0.0 110.351 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.89 -49.97 0.84 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.0 t -49.29 -57.58 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.812 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 99.94 87.28 1.94 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.2 pttt -43.2 -19.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.9 t -72.27 -45.12 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.2 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.2 tttm -87.24 -17.53 32.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' 173' ' ' LYS . . . -35.53 -58.77 0.78 Allowed Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.307 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 53.5 Cg_endo -72.5 -36.26 5.36 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.686 2.258 . . . . 0.0 111.451 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.7 -57.61 11.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.247 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.473 ' CD2' ' O ' ' A' ' 177' ' ' LEU . 3.0 tt -65.69 -31.63 72.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -51.53 -14.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.167 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -79.05 -35.24 42.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.063 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -85.13 -6.93 59.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.652 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.598 ' O ' ' O ' ' A' ' 178' ' ' LEU . 38.6 m-85 -147.29 153.56 44.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.664 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -38.27 -73.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.097 2.531 . . . . 0.0 112.836 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -160.79 168.93 23.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -39.13 -26.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 183' ' ' SER . 7.6 tt0 -63.19 -56.34 17.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.5 tp60 -87.39 -38.81 15.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.999 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.575 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.36 -50.67 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.142 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.474 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 22.9 p -64.16 -17.84 63.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.526 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.512 ' O ' ' OD1' ' A' ' 189' ' ' ASN . 48.7 t-20 -106.12 1.2 26.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -44.24 159.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.415 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.1 p -52.29 137.76 28.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.534 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.477 HD12 HG23 ' A' ' 192' ' ' ILE . 44.2 mm -54.92 -43.59 69.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.681 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.0 -33.87 45.14 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.579 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 67.5 mm-40 -81.78 -65.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.645 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.4 mt -47.86 -29.53 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.595 ' C ' ' H ' ' A' ' 198' ' ' VAL . 2.5 tm-20 -72.54 -61.01 1.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.897 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.511 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 7.1 pt20 -67.76 6.76 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.595 ' H ' ' C ' ' A' ' 196' ' ' GLU . 72.7 t -106.24 -38.94 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.79 -39.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.361 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 199' ' ' VAL . . . -178.57 139.25 3.98 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.266 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.429 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 37.7 tt0 -65.27 -44.72 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.69 -31.2 64.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.465 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 206' ' ' GLN . 18.6 t -68.31 -61.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.884 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -46.96 -33.48 4.69 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -81.4 -23.47 37.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.992 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 203' ' ' VAL . 4.1 pt20 -83.23 -31.56 26.94 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.557 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.37 -50.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.102 0.477 . . . . 0.0 110.007 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.594 ' O ' ' OG1' ' A' ' 212' ' ' THR . 66.1 t60 -54.21 -35.72 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.894 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.5 -20.68 27.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.653 ' CD1' ' CD1' ' A' ' 166' ' ' ILE . 27.0 t80 -61.57 -61.51 2.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.485 ' CE2' ' HA ' ' A' ' 208' ' ' HIS . 26.8 p90 -78.75 1.36 23.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.235 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.594 ' OG1' ' O ' ' A' ' 208' ' ' HIS . 21.2 m -65.34 -38.06 88.98 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -119.16 97.84 50.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.529 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 215' ' ' ARG . 12.0 Cg_exo -63.73 115.19 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.173 1.915 . . . . 0.0 112.013 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 214' ' ' PRO . 9.6 mtt85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.614 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.802 0.334 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -112.48 95.08 30.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.676 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.27 90.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.624 2.216 . . . . 0.0 112.083 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.8 t -88.08 -17.74 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.6 ' O ' ' CG2' ' A' ' 163' ' ' VAL . 1.9 tp -48.79 -20.31 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.576 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 161' ' ' ARG . 1.0 OUTLIER -83.83 -63.26 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.14 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.461 ' N ' HD22 ' A' ' 160' ' ' LEU . 34.4 ttt-85 -62.27 -21.84 65.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.533 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 29.7 m -85.92 -29.32 23.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.903 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.6 ' CG2' ' O ' ' A' ' 159' ' ' LEU . 2.4 t -73.12 -47.95 45.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -53.05 -22.58 6.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.827 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -80.61 13.51 2.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 5.8 mt -78.15 130.44 72.32 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.869 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.74 129.2 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.897 1.732 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.65 -51.45 0.78 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.477 HG23 ' HG ' ' A' ' 188' ' ' SER . 63.6 t -49.39 -45.66 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.945 0.402 . . . . 0.0 110.112 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 82.21 81.1 0.92 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.37 -19.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 170' ' ' GLY . 46.4 t -66.91 -44.68 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.069 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 176' ' ' LEU . 2.7 ttmm -84.06 -32.49 24.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.549 ' C ' ' O ' ' A' ' 173' ' ' LYS . . . -28.27 -62.69 0.19 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.425 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.505 ' CD ' ' CB ' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -55.51 -36.4 94.23 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.245 1.963 . . . . 0.0 111.115 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.679 ' N ' ' O ' ' A' ' 173' ' ' LYS . 19.5 tp -77.74 -57.01 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.555 0.693 . . . . 0.0 109.54 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 173' ' ' LYS . 23.6 tp -59.98 -18.59 46.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.095 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.604 ' CD2' ' C ' ' A' ' 178' ' ' LEU . 1.0 OUTLIER -73.58 -38.24 65.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.16 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.438 ' N ' HD23 ' A' ' 178' ' ' LEU . 22.5 mt-30 -47.02 -20.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.326 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.405 ' N ' ' C ' ' A' ' 178' ' ' LEU . 6.2 mmtt -101.38 -26.5 13.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 178' ' ' LEU . 21.6 m-85 -126.23 148.53 63.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -36.79 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.199 2.6 . . . . 0.0 113.31 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.7 OUTLIER -157.17 168.18 28.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.021 -179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -39.52 -16.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 183' ' ' SER . 1.9 tp-100 -66.33 -62.95 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -88.09 -32.3 18.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.034 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.3 OUTLIER -49.89 -54.03 22.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.632 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.477 ' HG ' HG23 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -68.94 -12.61 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 110.417 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -107.72 6.51 27.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.645 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.87 163.26 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.557 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.1 t -43.98 159.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.698 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 50.3 mm -76.33 -42.96 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.625 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.8 -37.16 92.06 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.529 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 16.4 mt-10 -69.34 -65.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.771 0.32 . . . . 0.0 110.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.52 -22.62 45.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 198' ' ' VAL . 3.8 tm-20 -74.11 -60.39 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.494 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -66.77 2.9 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.565 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 194' ' ' GLU . 45.3 t -96.94 -48.9 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.07 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 200' ' ' GLY . 0.4 OUTLIER -134.62 -39.62 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.679 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.487 ' N ' HG13 ' A' ' 199' ' ' VAL . . . -178.79 143.27 5.77 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.947 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 205' ' ' GLN . 12.6 tt0 -65.66 -36.36 83.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -71.56 -43.34 66.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.563 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.6 t -58.44 -61.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.531 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -50.27 -27.3 5.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.644 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.431 ' CG ' ' O ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -80.0 -25.32 40.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.291 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.9 mt-30 -84.48 -43.09 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.412 ' CG2' ' O ' ' A' ' 188' ' ' SER . 17.3 mt -63.19 -48.99 85.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.877 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -58.9 -37.03 75.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -81.82 -27.2 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 213' ' ' GLN . 14.1 t80 -44.86 -53.65 7.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.523 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -46.59 -36.6 7.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.303 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 9.0 m -65.33 -37.81 88.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.907 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 210' ' ' PHE . 29.9 mt-30 -118.47 97.35 50.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.756 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.63 119.76 6.82 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.325 2.017 . . . . 0.0 112.114 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.606 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.732 0.301 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.37 149.94 35.66 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.561 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.48 165.68 19.57 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.708 2.272 . . . . 0.0 112.033 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.674 ' O ' ' N ' ' A' ' 160' ' ' LEU . 11.0 p -88.2 -20.23 25.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 158' ' ' SER . 1.6 tt -35.59 -22.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.502 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 158' ' ' SER . 1.9 pp -83.7 -48.24 10.36 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.579 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 0.1 OUTLIER -65.17 -17.49 64.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.5 m -85.66 -25.16 26.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.248 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.637 ' C ' ' H ' ' A' ' 165' ' ' GLN . 14.5 t -79.72 -56.25 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.782 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.674 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 0.1 OUTLIER -47.89 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.74 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.674 ' N ' ' OE1' ' A' ' 164' ' ' GLN . 20.5 mt-30 -94.29 3.93 54.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.43 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.594 ' CD1' ' CD2' ' A' ' 210' ' ' PHE . 5.3 mt -71.81 131.14 86.1 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.86 129.12 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.794 1.663 . . . . 0.0 110.899 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 -49.64 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 22.6 t -53.79 -37.55 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.999 0.428 . . . . 0.0 110.205 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 75.35 82.65 0.45 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -42.83 -19.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 170' ' ' GLY . 49.9 t -68.14 -51.6 46.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.091 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 174' ' ' ALA . 21.7 tttm -75.67 -29.27 59.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.785 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.529 ' CB ' ' CD ' ' A' ' 175' ' ' PRO . . . -29.3 -64.68 0.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.669 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.529 ' CD ' ' CB ' ' A' ' 174' ' ' ALA . 18.5 Cg_endo -61.28 -36.33 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.542 2.161 . . . . 0.0 111.657 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 173' ' ' LYS . 43.3 tp -64.12 -57.32 9.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.424 HD23 ' CD1' ' A' ' 181' ' ' PHE . 1.4 tt -68.84 -28.25 66.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.592 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.603 ' CD2' ' C ' ' A' ' 178' ' ' LEU . 0.8 OUTLIER -55.17 -39.03 69.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.909 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.443 ' N ' HD22 ' A' ' 178' ' ' LEU . 76.4 mt-30 -45.04 -30.29 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.993 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -100.24 -17.9 17.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.261 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' A' ' 178' ' ' LEU . 62.6 m-85 -124.73 149.05 61.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 111.006 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -37.57 -78.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.677 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.56 167.03 23.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.905 0.383 . . . . 0.0 111.079 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.591 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.58 -13.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.811 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.677 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.0 OUTLIER -72.1 -60.96 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.43 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 189' ' ' ASN . 46.8 tt0 -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.026 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.591 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.84 -50.17 14.53 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.397 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.507 ' H ' ' HG ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -62.45 -10.79 12.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 186' ' ' GLN . 40.6 t30 -111.63 4.69 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.711 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -46.45 158.11 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.372 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.82 131.37 15.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.41 HG22 HD12 ' A' ' 192' ' ' ILE . 30.9 mm -47.88 -50.61 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -45.63 -42.86 10.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.02 -62.05 1.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.873 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.8 mt -53.84 -25.41 19.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.907 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.64 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 2.6 tm-20 -78.21 -60.75 2.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 110.836 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.64 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 1.6 pt20 -67.1 3.52 1.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 196' ' ' GLU . 3.4 t -103.74 -37.67 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.094 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.7 OUTLIER -144.07 -38.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.749 -178.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.462 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.48 138.25 3.59 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.578 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.442 ' NE2' ' HG3' ' A' ' 196' ' ' GLU . 3.9 tp-100 -58.79 -52.53 65.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.11 84.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.736 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 21.0 t -53.87 -60.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.276 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.14 -29.17 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.799 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.89 -27.61 43.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.401 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 210' ' ' PHE . 1.2 mt-30 -80.49 -51.37 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.111 0.482 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.627 ' O ' ' CE2' ' A' ' 211' ' ' PHE . 25.3 mt -52.75 -34.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.669 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.467 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 21.1 t-80 -71.56 -40.92 69.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -84.17 -18.47 36.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.594 ' CD2' ' CD1' ' A' ' 166' ' ' ILE . 69.6 t80 -58.36 -65.09 0.71 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.202 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.627 ' CE2' ' O ' ' A' ' 207' ' ' ILE . 27.5 p90 -72.42 -3.57 24.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.23 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 66.1 m -65.5 -38.45 89.76 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.821 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -119.46 97.5 50.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.904 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -64.8 116.82 4.03 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.12 1.88 . . . . 0.0 111.851 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.516 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.806 0.336 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.78 144.81 98.92 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.658 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -74.79 156.5 43.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.638 2.226 . . . . 0.0 112.198 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -71.28 -15.74 62.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.338 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.534 ' O ' ' CG2' ' A' ' 163' ' ' VAL . 3.8 tp -37.46 -19.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.513 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.686 ' N ' ' O ' ' A' ' 158' ' ' SER . 2.4 pp -83.81 -44.76 14.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.612 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -74.17 -22.42 59.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.9 m -86.0 -32.7 21.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.625 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 159' ' ' LEU . 3.4 t -71.9 -51.17 33.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.847 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 165' ' ' GLN . 9.3 pt20 -46.58 -27.55 1.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.428 ' N ' ' HG3' ' A' ' 164' ' ' GLN . 10.5 mt-30 -76.37 8.5 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.424 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 210' ' ' PHE . 5.1 mt -69.43 131.54 90.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.589 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.98 129.53 14.37 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.876 1.717 . . . . 0.0 110.822 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.91 -49.71 0.85 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.6 t -54.79 -45.97 74.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 109.96 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 85.68 83.89 1.06 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.5 OUTLIER -43.03 -19.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 170' ' ' GLY . 63.9 t -71.22 -55.7 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.917 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 174' ' ' ALA . 0.3 OUTLIER -71.71 -29.0 64.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.439 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.558 ' CB ' ' CD ' ' A' ' 175' ' ' PRO . . . -29.32 -64.83 0.18 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.558 ' CD ' ' CB ' ' A' ' 174' ' ' ALA . 11.0 Cg_endo -57.13 -45.38 35.96 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.703 2.269 . . . . 0.0 111.495 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 173' ' ' LYS . 21.3 tp -54.27 -57.24 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.507 0.67 . . . . 0.0 110.399 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.8 tt -72.35 -17.68 61.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.679 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -59.47 -30.74 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -62.28 -21.79 65.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -96.86 -22.29 16.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.122 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 178' ' ' LEU . 48.1 m-85 -132.32 150.21 75.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -36.77 -76.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.997 2.464 . . . . 0.0 112.65 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.678 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.59 171.26 17.22 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.015 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.474 HD11 HG21 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.38 -15.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 -179.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.678 ' N ' ' O ' ' A' ' 183' ' ' SER . 24.0 tt0 -70.78 -60.21 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 189' ' ' ASN . 1.3 tt0 -87.99 -34.46 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.025 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.595 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.33 -51.02 11.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.25 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.454 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 54.5 m -61.68 -15.02 36.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.301 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 186' ' ' GLN . 5.3 t-20 -105.51 12.22 31.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.083 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.466 ' HB3' ' CE2' ' A' ' 181' ' ' PHE . . . -53.71 149.55 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.31 128.7 4.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.653 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.2 mm -48.26 -49.17 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -50.72 -35.94 31.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.405 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 18.4 mt-10 -77.8 -64.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.7 mt -51.4 -23.91 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.606 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.629 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 3.2 tm-20 -79.73 -60.98 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.629 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 0.8 OUTLIER -66.44 3.67 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.598 ' H ' ' C ' ' A' ' 196' ' ' GLU . 13.4 t -104.06 -37.54 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.131 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 200' ' ' GLY . 0.7 OUTLIER -143.67 -39.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.436 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.46 ' N ' HG13 ' A' ' 199' ' ' VAL . . . -178.89 139.08 3.83 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.413 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.423 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 6.5 tp-100 -63.71 -40.63 97.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.35 68.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.872 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.8 t -63.83 -61.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.209 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -50.07 -33.37 18.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.734 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -78.46 -26.37 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.927 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.498 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.69 -36.18 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.649 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.508 ' O ' ' CD2' ' A' ' 211' ' ' PHE . 72.3 mt -65.34 -43.35 94.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.088 0.47 . . . . 0.0 109.959 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 3.8 t60 -66.99 -35.41 79.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.703 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.2 -18.42 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.533 ' CD2' ' CD1' ' A' ' 166' ' ' ILE . 45.1 t80 -64.65 -65.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.491 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 207' ' ' ILE . 40.2 p90 -75.03 1.19 13.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.041 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -66.02 -38.35 88.21 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.67 97.41 49.86 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.036 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -65.92 120.5 7.67 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.262 1.974 . . . . 0.0 111.885 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.545 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.845 0.355 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.98 165.14 25.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.523 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.644 ' O ' ' CD2' ' A' ' 160' ' ' LEU . 29.0 Cg_endo -66.73 158.51 55.75 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.786 2.324 . . . . 0.0 112.078 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 161' ' ' ARG . 26.1 t -88.41 -15.84 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.793 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER -35.93 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.268 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.644 ' CD2' ' O ' ' A' ' 157' ' ' PRO . 2.7 pt? -83.36 -40.32 19.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.605 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -74.15 -18.02 60.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.5 m -85.97 -40.01 16.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.135 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 166' ' ' ILE . 2.9 t -66.22 -53.28 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.676 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.56 -22.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.628 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -84.94 10.32 12.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.299 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 163' ' ' VAL . 4.5 mt -70.21 132.01 88.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.04 129.17 16.85 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.021 1.814 . . . . 0.0 111.247 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.64 -47.86 1.0 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.9 t -50.64 -46.31 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.232 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 81.2 82.12 0.82 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.522 ' CB ' ' NZ ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -42.75 -18.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 43.8 t -66.9 -42.04 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.013 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.8 tttt -87.6 -22.25 24.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.672 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.488 ' CB ' ' CD ' ' A' ' 175' ' ' PRO . . . -33.93 -61.83 0.39 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.597 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 174' ' ' ALA . 24.4 Cg_endo -63.69 -37.42 46.48 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.603 2.202 . . . . 0.0 111.707 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 22.0 tp -59.26 -56.68 19.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.562 0.696 . . . . 0.0 110.562 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 tt -74.47 -28.2 60.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.722 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.8 tt -50.32 -17.87 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.847 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 179' ' ' GLN . 9.2 mm100 -78.04 -36.55 48.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.826 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -82.39 -18.62 41.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 178' ' ' LEU . 20.9 m-85 -131.82 154.34 81.74 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.194 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -36.62 -76.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.841 2.361 . . . . 0.0 112.462 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 68.8 m -162.8 169.4 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.789 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.567 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.54 -14.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.481 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.1 OUTLIER -73.26 -60.91 2.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -87.7 -26.66 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.088 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.58 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -55.11 -53.93 49.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.51 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.467 ' OG ' ' CZ ' ' A' ' 211' ' ' PHE . 1.4 t -64.32 -19.99 65.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.086 0.469 . . . . 0.0 110.13 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.571 ' O ' ' OD1' ' A' ' 189' ' ' ASN . 22.8 t-20 -104.05 11.09 35.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.927 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.464 ' HB2' ' CE2' ' A' ' 181' ' ' PHE . . . -57.87 163.59 2.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.635 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.1 p -51.25 131.86 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.703 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 192' ' ' ILE . 41.4 mm -49.46 -49.82 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.791 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -47.48 -46.93 23.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.561 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 64.1 mm-40 -66.68 -66.12 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.647 0.261 . . . . 0.0 110.56 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.7 mt -49.4 -25.53 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.686 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.556 ' C ' ' H ' ' A' ' 198' ' ' VAL . 4.3 tt0 -73.29 -60.93 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -69.03 6.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 194' ' ' GLU . 89.7 t -108.71 -36.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.505 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.82 -38.98 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.606 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.463 ' N ' HG11 ' A' ' 199' ' ' VAL . . . -178.53 137.48 3.29 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.263 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.73 -45.89 87.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.29 59.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.58 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 206' ' ' GLN . 19.7 t -68.08 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.094 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -47.68 -31.05 4.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.852 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.62 -26.48 41.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -84.76 -32.98 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.449 ' N ' ' HG3' ' A' ' 206' ' ' GLN . 63.3 mt -68.46 -34.02 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -71.99 -41.58 67.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.137 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . 0.538 ' O ' ' OG1' ' A' ' 212' ' ' THR . . . -76.11 -29.71 57.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.547 ' C ' ' CD1' ' A' ' 210' ' ' PHE . 9.2 t80 -50.77 -41.55 56.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.467 ' CZ ' ' OG ' ' A' ' 188' ' ' SER . 73.5 m-85 -46.32 -19.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.625 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.538 ' OG1' ' O ' ' A' ' 209' ' ' ALA . 0.2 OUTLIER -76.53 -36.8 57.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.667 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -117.65 97.44 50.76 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.426 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -76.54 114.6 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.402 2.068 . . . . 0.0 111.841 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.584 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.772 0.32 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -51.8 143.9 20.74 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.53 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.415 ' O ' ' CD2' ' A' ' 160' ' ' LEU . 57.4 Cg_endo -73.78 64.09 4.86 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.569 2.179 . . . . 0.0 112.008 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 160' ' ' LEU . 15.7 t -84.64 -20.63 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.641 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 158' ' ' SER . 0.8 OUTLIER -34.12 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -83.92 -46.94 11.56 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.539 ' H ' ' HG ' ' A' ' 160' ' ' LEU . 14.2 mtp180 -70.12 -18.21 63.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 158' ' ' SER . 7.5 m -85.7 -25.85 26.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.059 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' A' ' 165' ' ' GLN . 2.7 t -80.17 -46.0 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.581 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.48 -12.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 163' ' ' VAL . 4.2 mt-30 -96.12 4.39 52.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.522 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.583 ' CD1' ' CD1' ' A' ' 210' ' ' PHE . 3.6 mt -56.52 115.76 10.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.556 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.28 129.57 29.36 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.788 1.658 . . . . 0.0 111.288 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.72 -46.26 1.2 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -48.86 -55.2 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.333 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 83.83 82.33 0.98 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 172' ' ' VAL . 0.0 OUTLIER -42.83 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 170' ' ' GLY . 48.6 t -64.14 -41.81 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.945 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -85.86 -31.12 22.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.888 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.528 ' CB ' ' CD ' ' A' ' 175' ' ' PRO . . . -29.07 -65.13 0.17 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 174' ' ' ALA . 18.7 Cg_endo -60.77 -33.42 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.561 2.174 . . . . 0.0 111.691 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 173' ' ' LYS . 53.9 tp -67.9 -56.47 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.605 0.717 . . . . 0.0 109.734 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.47 -17.06 61.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.233 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.624 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.7 tt -52.59 -54.16 36.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.449 ' N ' HD22 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -48.48 -23.91 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.533 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.419 ' N ' ' HG3' ' A' ' 179' ' ' GLN . 49.2 mttp -88.91 -16.15 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.869 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.624 ' O ' ' O ' ' A' ' 178' ' ' LEU . 95.3 m-85 -148.6 145.73 20.75 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 121.003 0.43 . . . . 0.0 110.922 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 181' ' ' PHE . 80.8 Cg_exo -31.82 -78.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.17 2.58 . . . . 0.0 112.87 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.2 OUTLIER -163.11 175.8 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.857 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.481 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.78 -14.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.516 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.685 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.5 OUTLIER -69.29 -62.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.1 tt0 -88.37 -33.26 18.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.033 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.576 ' C ' ' CD1' ' A' ' 187' ' ' LEU . 0.1 OUTLIER -46.06 -52.07 12.61 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.234 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.46 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 0.4 OUTLIER -65.63 -3.69 5.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.51 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 186' ' ' GLN . 49.1 t-20 -121.98 3.98 9.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.474 ' HB1' ' CE2' ' A' ' 181' ' ' PHE . . . -48.71 161.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.487 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.43 140.7 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -62.51 -47.54 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.528 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -52.41 -28.53 28.41 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.45 ' O ' ' CG2' ' A' ' 198' ' ' VAL . 4.2 mm-40 -81.87 -64.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.782 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.58 -30.21 29.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.807 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.563 ' C ' ' H ' ' A' ' 198' ' ' VAL . 15.1 tt0 -72.39 -61.09 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.49 4.25 1.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.563 ' H ' ' C ' ' A' ' 196' ' ' GLU . 25.4 t -108.78 -35.58 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 200' ' ' GLY . 0.8 OUTLIER -143.01 -39.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.551 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.463 ' N ' HG11 ' A' ' 199' ' ' VAL . . . -179.69 138.03 3.29 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.445 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -63.79 -43.5 96.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.97 -32.88 69.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.545 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.459 HG11 HE21 ' A' ' 206' ' ' GLN . 48.6 t -66.3 -61.68 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.446 ' HB2' ' N ' ' A' ' 196' ' ' GLU . . . -50.69 -29.97 12.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.491 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -81.09 -28.01 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.813 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 210' ' ' PHE . 3.4 pt20 -84.44 -42.77 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.599 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.461 ' N ' ' CG ' ' A' ' 206' ' ' GLN . 65.4 mt -58.62 -42.5 85.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.654 ' O ' ' CZ ' ' A' ' 211' ' ' PHE . 58.4 t-80 -66.72 -42.63 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.0 -18.57 32.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.038 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.605 ' N ' ' O ' ' A' ' 206' ' ' GLN . 6.5 t80 -51.91 -56.93 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.035 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.654 ' CZ ' ' O ' ' A' ' 208' ' ' HIS . 8.4 p90 -74.74 18.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.451 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.437 ' H ' ' C ' ' A' ' 210' ' ' PHE . 41.8 m -71.58 -37.87 70.96 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.975 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -118.95 97.3 50.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.291 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.43 114.13 3.91 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.296 1.997 . . . . 0.0 112.08 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.65 179.925 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 164' ' ' GLN . 33.2 m . . . . . 0 C--O 1.228 -0.062 0 CA-C-O 120.462 0.172 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.54 ' N ' HG23 ' A' ' 163' ' ' VAL . 19.1 pt20 -49.55 -21.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.641 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -83.45 2.6 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.336 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.769 HD11 ' CD1' ' A' ' 210' ' ' PHE . 5.8 mt -66.59 130.16 94.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.32 128.99 16.27 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.648 1.566 . . . . 0.0 110.684 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.502 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 120.87 -51.57 0.77 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.887 HG22 HD13 ' A' ' 207' ' ' ILE . 17.0 t -49.57 -49.73 18.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.207 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 88.19 83.0 1.24 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.55 -19.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.6 t -69.74 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.051 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 170' ' ' GLY . 22.6 tttm -85.96 -19.19 30.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.476 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -35.39 -58.54 0.78 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.534 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 41.1 Cg_endo -71.02 -29.11 18.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.534 2.156 . . . . 0.0 111.847 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.48 HD23 ' HG3' ' A' ' 173' ' ' LYS . 31.8 tp -70.55 -57.48 4.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.552 0.691 . . . . 0.0 110.306 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.026 HD22 HD13 ' A' ' 187' ' ' LEU . 5.1 tt -67.68 -21.98 65.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.541 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.854 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.6 OUTLIER -68.56 -42.34 78.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.928 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.851 ' N ' HD23 ' A' ' 178' ' ' LEU . 9.5 mm-40 -42.37 -28.32 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.097 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 178' ' ' LEU . 17.8 mttt -100.34 -15.77 17.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.136 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 178' ' ' LEU . 18.7 m-85 -128.74 152.77 79.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.019 0.437 . . . . 0.0 111.035 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -38.88 -77.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.884 2.389 . . . . 0.0 112.523 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 69.2 m -162.45 166.26 25.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.734 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.3 -16.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.776 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 16.3 tt0 -72.24 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -87.51 -35.35 18.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.74 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 1.026 HD13 HD22 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -48.78 -52.28 24.71 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.284 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.532 ' OG ' ' O ' ' A' ' 184' ' ' ILE . 3.4 p -61.36 -13.0 16.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.717 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.532 ' OD1' ' O ' ' A' ' 189' ' ' ASN . 24.2 t-20 -109.08 10.13 26.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.425 ' CB ' ' CE2' ' A' ' 181' ' ' PHE . . . -56.8 150.25 16.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.57 ' CB ' ' OE1' ' A' ' 194' ' ' GLU . 0.8 OUTLIER -44.89 136.67 4.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 208' ' ' HIS . 31.0 mm -52.13 -52.03 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.2 3.41 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.606 ' O ' HG23 ' A' ' 198' ' ' VAL . 8.2 mt-10 -81.82 -61.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.292 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.44 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.0 mt -53.44 -32.84 51.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 198' ' ' VAL . 8.8 tt0 -71.71 -61.2 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -66.48 7.27 0.35 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.652 HG11 HD12 ' A' ' 177' ' ' LEU . 5.1 t -108.89 -36.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.58 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.679 HG11 HG11 ' A' ' 203' ' ' VAL . 0.5 OUTLIER -143.89 -38.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.457 -179.256 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.44 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.49 139.11 3.93 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.882 -1.152 . . . . 0.0 112.402 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -61.69 -46.1 91.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -70.62 -42.49 70.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.679 HG11 HG11 ' A' ' 199' ' ' VAL . 40.0 t -53.54 -61.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.277 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 192' ' ' ILE . . . -53.65 -29.21 37.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.928 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -77.91 -24.64 48.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.997 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.8 mt-30 -81.35 -53.75 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.438 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.887 HD13 HG22 ' A' ' 169' ' ' VAL . 16.9 mt -55.64 -28.9 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.66 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' HIS . . . . . 0.595 ' HB2' HD11 ' A' ' 192' ' ' ILE . 86.4 t60 -71.67 -43.0 66.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.12 -18.76 29.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.769 ' CD1' HD11 ' A' ' 166' ' ' ILE . 27.2 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.228 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 166' ' ' ILE . 1.4 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.678 0.275 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.442 ' N ' HG12 ' A' ' 163' ' ' VAL . 1.4 pp0? -46.79 -18.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.223 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 163' ' ' VAL . 7.1 mt-30 -84.46 10.89 9.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.124 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.794 HD11 ' CD1' ' A' ' 210' ' ' PHE . 7.4 mt -75.51 130.41 79.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.81 129.71 12.79 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.033 1.822 . . . . 0.0 111.082 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.32 -49.85 0.83 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.888 HG22 HD13 ' A' ' 207' ' ' ILE . 39.6 t -49.7 -44.35 19.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 79.8 80.91 0.78 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.6 pttt -43.13 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 170' ' ' GLY . 40.8 t -67.88 -48.68 74.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.116 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.651 ' O ' ' N ' ' A' ' 176' ' ' LEU . 4.3 tttp -77.96 -34.85 50.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.796 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -29.12 -59.98 0.24 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.41 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 18.8 Cg_endo -60.99 -32.47 92.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.36 2.04 . . . . 0.0 111.645 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 173' ' ' LYS . 12.7 tp -70.42 -56.81 5.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.458 0.647 . . . . 0.0 109.829 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.706 ' CD2' HD13 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -70.53 -18.34 62.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.204 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 181' ' ' PHE . 5.8 tp -55.85 -43.55 77.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.256 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -56.39 -20.64 20.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.382 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -99.17 -17.57 18.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.692 ' O ' HD12 ' A' ' 178' ' ' LEU . 68.0 m-85 -136.79 150.4 69.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.623 ' O ' ' CD1' ' A' ' 178' ' ' LEU . 88.1 Cg_exo -37.34 -79.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.044 2.496 . . . . 0.0 112.814 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.3 OUTLIER -163.29 171.58 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.672 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.623 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -38.91 -17.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.899 0.38 . . . . 0.0 110.103 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.671 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.6 OUTLIER -67.35 -62.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.389 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 189' ' ' ASN . 21.5 tp60 -88.22 -34.85 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.24 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -45.36 -56.96 4.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.483 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 38.9 m -59.88 -4.72 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 186' ' ' GLN . 26.6 t-20 -113.95 2.03 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.683 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -47.57 154.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -46.81 154.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.4 mm -65.49 -50.83 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.557 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -48.96 -47.23 32.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 198' ' ' VAL . 2.8 mm-40 -64.29 -62.9 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.859 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.683 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 1.3 mt -57.1 -21.7 34.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.583 ' C ' ' H ' ' A' ' 198' ' ' VAL . 9.0 tt0 -79.5 -61.59 1.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.043 0.449 . . . . 0.0 110.823 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -67.76 7.52 0.5 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 194' ' ' GLU . 14.7 t -106.64 -37.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.131 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -144.19 -38.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.33 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.444 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.15 138.39 3.71 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.36 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -66.55 -38.76 87.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -78.34 -28.55 47.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 206' ' ' GLN . 13.6 t -70.01 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -48.81 -39.35 25.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.57 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -70.37 -25.4 63.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.663 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.503 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.13 -36.37 22.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.525 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.888 HD13 HG22 ' A' ' 169' ' ' VAL . 66.4 mt -65.79 -43.16 93.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.966 0.412 . . . . 0.0 110.203 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -63.68 -42.26 98.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.039 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.8 -18.4 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.814 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.794 ' CD1' HD11 ' A' ' 166' ' ' ILE . 42.6 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.873 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.525 HG13 HD12 ' A' ' 166' ' ' ILE . 2.1 t . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.691 0.282 . . . . 0.0 110.45 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -54.83 -21.44 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.47 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -83.14 0.35 45.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.57 HG22 HG23 ' A' ' 169' ' ' VAL . 4.4 mt -59.56 131.42 88.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.473 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.61 129.12 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.907 1.738 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.514 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 119.64 -50.77 0.8 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.868 HG22 HD13 ' A' ' 207' ' ' ILE . 15.7 t -49.51 -59.48 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.123 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 93.56 84.81 1.59 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 170' ' ' GLY . 28.7 pttt -42.75 -18.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 170' ' ' GLY . 26.1 t -68.17 -43.28 85.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.3 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 170' ' ' GLY . 18.5 tttt -91.9 -7.79 48.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.654 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -45.79 -59.73 4.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.62 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 33.3 Cg_endo -66.64 -32.6 37.98 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.581 2.187 . . . . 0.0 111.836 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.5 tp -66.84 -57.85 6.2 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.608 0.718 . . . . 0.0 110.71 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.954 HD22 HD13 ' A' ' 187' ' ' LEU . 5.6 tt -67.27 -30.11 69.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.847 HD23 ' C ' ' A' ' 178' ' ' LEU . 2.1 tt -57.83 -42.37 84.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.969 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.641 ' N ' HD23 ' A' ' 178' ' ' LEU . 10.5 pt20 -38.75 -32.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.157 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 178' ' ' LEU . 7.4 mtpt -92.85 -34.92 13.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.203 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.608 ' O ' ' O ' ' A' ' 178' ' ' LEU . 8.2 m-85 -112.76 149.21 40.85 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 110.892 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -35.3 -77.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.866 2.377 . . . . 0.0 112.496 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 57.0 p -162.71 173.5 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.813 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.615 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.73 -14.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.917 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 9.5 tt0 -69.53 -62.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 189' ' ' ASN . 20.4 tt0 -87.89 -34.46 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.955 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.954 HD13 HD22 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -45.32 -56.56 4.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.376 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.457 ' O ' HG22 ' A' ' 207' ' ' ILE . 3.8 m -59.27 -13.09 6.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.012 0.434 . . . . 0.0 110.256 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.526 ' OD1' ' O ' ' A' ' 189' ' ' ASN . 41.9 t30 -103.97 2.65 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.651 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -51.01 157.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.53 135.78 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.664 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.406 HD11 ' CB ' ' A' ' 208' ' ' HIS . 48.0 mm -54.54 -47.3 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.364 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.19 -46.56 62.57 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 198' ' ' VAL . 4.3 mt-10 -63.9 -65.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.193 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.615 HD22 HD12 ' A' ' 207' ' ' ILE . 1.8 mt -50.05 -23.42 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.013 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 198' ' ' VAL . 10.8 tt0 -79.37 -61.11 2.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.717 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.24 4.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 194' ' ' GLU . 71.4 t -108.99 -35.03 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.34 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.523 ' CG1' HG11 ' A' ' 203' ' ' VAL . 1.0 OUTLIER -144.14 -39.24 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.942 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -179.57 138.5 3.48 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -67.07 -42.09 85.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.13 -21.38 54.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.457 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.523 HG11 ' CG1' ' A' ' 199' ' ' VAL . 41.3 t -78.4 -60.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.057 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -47.47 -31.5 4.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.685 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -81.13 -27.5 35.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -81.48 -23.42 37.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.868 HD13 HG22 ' A' ' 169' ' ' VAL . 65.0 mt -78.38 -36.02 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.51 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' HIS . . . . . 0.406 ' CB ' HD11 ' A' ' 192' ' ' ILE . 61.0 t-80 -80.69 -32.13 36.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.215 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.58 -18.78 30.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.564 ' CD2' HD11 ' A' ' 166' ' ' ILE . 41.7 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.242 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.754 0.311 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.52 ' C ' ' H ' ' A' ' 166' ' ' ILE . 8.3 pt20 -49.33 -31.69 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.04 12.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.097 0.475 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.629 HD11 ' CD1' ' A' ' 210' ' ' PHE . 4.5 mt -76.4 132.39 72.93 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.13 128.95 14.47 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.033 1.822 . . . . 0.0 110.856 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 118.49 -50.41 0.81 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.848 HG22 HD13 ' A' ' 207' ' ' ILE . 37.2 t -48.56 -49.64 13.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.103 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 173' ' ' LYS . . . 84.73 82.6 1.03 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' GLY . 25.1 pttt -42.96 -19.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 170' ' ' GLY . 65.8 t -70.46 -42.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.845 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 19.0 tttm -86.91 -12.62 47.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -43.97 -60.02 3.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.293 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 29.0 Cg_endo -65.66 -29.68 51.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.507 2.138 . . . . 0.0 111.788 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.49 HD23 ' HG3' ' A' ' 173' ' ' LYS . 39.9 tp -70.92 -57.92 4.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.587 0.708 . . . . 0.0 110.37 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.025 HD22 HD13 ' A' ' 187' ' ' LEU . 5.7 tt -67.69 -31.6 71.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.131 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.766 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -55.61 -21.35 17.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.675 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.522 ' N ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -61.94 -26.89 68.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -97.53 -18.03 19.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 178' ' ' LEU . 35.2 m-85 -132.88 150.92 77.01 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -38.56 -74.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.213 2.609 . . . . 0.0 112.944 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 1.3 t -160.51 169.33 23.2 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.066 0.46 . . . . 0.0 111.298 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.727 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.65 -15.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.731 -179.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 5.6 tt0 -66.53 -63.59 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -89.41 -31.26 17.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.173 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 1.025 HD13 HD22 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -48.09 -55.22 10.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.631 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.676 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.0 OUTLIER -62.58 -17.67 60.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.721 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.39 8.09 42.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.511 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.606 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -49.77 154.51 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -45.2 146.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.568 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 30.7 mm -59.49 -43.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -57.88 -50.41 66.03 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.846 ' O ' HG23 ' A' ' 198' ' ' VAL . 39.3 mt-10 -62.28 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.727 0.299 . . . . 0.0 110.598 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.606 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 3.4 mt -53.0 -21.42 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.56 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 198' ' ' VAL . 11.5 tt0 -77.84 -61.23 2.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -68.14 5.22 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 194' ' ' GLU . 71.9 t -108.59 -36.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.365 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -143.34 -39.09 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.705 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.84 136.7 2.96 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.472 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -47.75 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -72.77 -36.92 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.439 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.527 HG11 ' CG1' ' A' ' 199' ' ' VAL . 23.5 t -58.37 -61.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.444 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.92 -34.01 26.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.79 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -69.94 -27.14 64.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.76 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 1.0 OUTLIER -84.23 -55.98 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.422 . . . . 0.0 110.545 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.848 HD13 HG22 ' A' ' 169' ' ' VAL . 26.8 mt -48.52 -28.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.906 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -80.69 -32.6 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.88 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.45 -22.49 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.589 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.629 ' CD1' HD11 ' A' ' 166' ' ' ILE . 32.4 t80 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.825 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.529 HG13 HD12 ' A' ' 166' ' ' ILE . 1.8 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.761 0.315 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -18.97 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.708 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -83.27 2.36 36.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.831 HD11 ' CD1' ' A' ' 210' ' ' PHE . 6.1 mt -67.11 131.2 93.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.14 128.66 17.94 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.52 1.48 . . . . 0.0 110.351 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.404 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 118.89 -49.97 0.84 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.466 HG23 ' H ' ' A' ' 169' ' ' VAL . 2.0 t -49.29 -57.58 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.812 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 99.94 87.28 1.94 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.2 pttt -43.2 -19.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.9 t -72.27 -45.12 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.2 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.2 tttm -87.24 -17.53 32.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.829 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -35.53 -58.77 0.78 Allowed Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.307 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 53.5 Cg_endo -72.5 -36.26 5.36 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.686 2.258 . . . . 0.0 111.451 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 176' ' ' LEU . 15.0 tp -60.7 -57.61 11.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.247 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.893 ' O ' HD23 ' A' ' 177' ' ' LEU . 3.0 tt -65.69 -31.63 72.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -51.53 -14.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.167 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -79.05 -35.24 42.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.063 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -85.13 -6.93 59.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.652 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.644 ' CZ ' ' HB1' ' A' ' 190' ' ' ALA . 38.6 m-85 -147.29 153.56 44.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.664 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -38.27 -73.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.097 2.531 . . . . 0.0 112.836 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -160.79 168.93 23.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.419 HG23 ' H ' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -39.13 -26.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 183' ' ' SER . 44.7 tt0 -63.19 -56.34 17.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.5 tp60 -87.39 -38.81 15.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.999 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.36 -50.67 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.142 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.482 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 22.9 p -64.16 -17.84 63.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.526 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.512 ' OD1' ' O ' ' A' ' 189' ' ' ASN . 48.7 t-20 -106.12 1.2 26.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.644 ' HB1' ' CZ ' ' A' ' 181' ' ' PHE . . . -44.24 159.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.415 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.1 p -52.29 137.76 28.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.534 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.2 mm -54.92 -43.59 69.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.681 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.0 -33.87 45.14 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.885 ' O ' HG23 ' A' ' 198' ' ' VAL . 67.5 mm-40 -81.78 -65.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.645 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.438 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 2.4 mt -47.86 -29.53 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.867 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 198' ' ' VAL . 2.5 tm-20 -72.54 -61.01 1.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.897 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.511 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 7.1 pt20 -67.76 6.76 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 194' ' ' GLU . 72.7 t -106.24 -38.94 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.79 -39.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.361 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.57 139.25 3.98 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.266 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.445 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 37.7 tt0 -65.27 -44.72 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.69 -31.2 64.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.465 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 206' ' ' GLN . 18.6 t -68.31 -61.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.884 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.438 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -46.96 -33.48 4.69 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -81.4 -23.47 37.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.992 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -83.23 -31.56 26.94 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.557 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.37 -50.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.102 0.477 . . . . 0.0 110.007 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.21 -35.72 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.5 -20.68 27.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.831 ' CD1' HD11 ' A' ' 166' ' ' ILE . 27.0 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 166' ' ' ILE . 2.4 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.654 0.264 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -53.05 -22.58 6.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.827 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -80.61 13.51 2.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.631 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.8 mt -78.15 130.44 72.32 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.869 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.74 129.2 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.897 1.732 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.46 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 120.65 -51.45 0.78 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.819 HG22 HD13 ' A' ' 207' ' ' ILE . 63.6 t -49.39 -45.66 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.945 0.402 . . . . 0.0 110.112 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 82.21 81.1 0.92 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.37 -19.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 170' ' ' GLY . 46.4 t -66.91 -44.68 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.069 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 176' ' ' LEU . 2.7 ttmm -84.06 -32.49 24.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.739 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -28.27 -62.69 0.19 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.425 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.739 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -55.51 -36.4 94.23 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.245 1.963 . . . . 0.0 111.115 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.679 ' N ' ' O ' ' A' ' 173' ' ' LYS . 19.5 tp -77.74 -57.01 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.555 0.693 . . . . 0.0 109.54 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.054 HD23 HD11 ' A' ' 187' ' ' LEU . 23.6 tp -59.98 -18.59 46.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.095 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.875 HD23 ' C ' ' A' ' 178' ' ' LEU . 1.0 OUTLIER -73.58 -38.24 65.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.16 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.683 ' N ' HD23 ' A' ' 178' ' ' LEU . 69.0 mt-30 -47.02 -20.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.326 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.405 ' N ' ' C ' ' A' ' 178' ' ' LEU . 6.2 mmtt -101.38 -26.5 13.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 178' ' ' LEU . 21.6 m-85 -126.23 148.53 63.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -36.79 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.199 2.6 . . . . 0.0 113.31 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.7 OUTLIER -157.17 168.18 28.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.021 -179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.774 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -39.52 -16.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 183' ' ' SER . 1.9 tp-100 -66.33 -62.95 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -88.09 -32.3 18.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.034 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 1.054 HD11 HD23 ' A' ' 177' ' ' LEU . 0.3 OUTLIER -49.89 -54.03 22.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.632 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.671 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.8 OUTLIER -68.94 -12.61 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 110.417 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -107.72 6.51 27.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.645 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 195' ' ' LEU . . . -53.87 163.26 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.557 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.1 t -43.98 159.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.698 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 50.3 mm -76.33 -42.96 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.625 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.8 -37.16 92.06 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.9 ' O ' HG23 ' A' ' 198' ' ' VAL . 16.4 mt-10 -69.34 -65.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.771 0.32 . . . . 0.0 110.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.503 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 0.8 OUTLIER -57.52 -22.62 45.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 198' ' ' VAL . 3.8 tm-20 -74.11 -60.39 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.494 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.77 2.9 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.565 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 194' ' ' GLU . 45.3 t -96.94 -48.9 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.07 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 203' ' ' VAL . 0.4 OUTLIER -134.62 -39.62 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.679 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 199' ' ' VAL . . . -178.79 143.27 5.77 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.947 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 205' ' ' GLN . 12.6 tt0 -65.66 -36.36 83.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -71.56 -43.34 66.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.563 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 199' ' ' VAL . 46.6 t -58.44 -61.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.531 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.503 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.27 -27.3 5.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.644 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.431 ' CG ' ' O ' ' A' ' 201' ' ' GLN . 12.0 mm-40 -80.0 -25.32 40.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.291 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.9 mt-30 -84.48 -43.09 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.819 HD13 HG22 ' A' ' 169' ' ' VAL . 17.3 mt -63.19 -48.99 85.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.877 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' HIS . . . . . 0.474 ' CB ' HD11 ' A' ' 192' ' ' ILE . 60.7 t-80 -58.9 -37.03 75.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -81.82 -27.2 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.631 ' CD2' HD11 ' A' ' 166' ' ' ILE . 14.1 t80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.523 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.613 ' C ' ' H ' ' A' ' 165' ' ' GLN . 14.5 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.636 0.255 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.674 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 0.1 OUTLIER -47.89 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.74 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.674 ' N ' ' OE1' ' A' ' 164' ' ' GLN . 20.5 mt-30 -94.29 3.93 54.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.43 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.998 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.3 mt -71.81 131.14 86.1 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.86 129.12 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.794 1.663 . . . . 0.0 110.899 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 -49.64 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.886 HG22 HD13 ' A' ' 207' ' ' ILE . 22.6 t -53.79 -37.55 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.999 0.428 . . . . 0.0 110.205 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 75.35 82.65 0.45 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -42.83 -19.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 170' ' ' GLY . 49.9 t -68.14 -51.6 46.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.091 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 174' ' ' ALA . 21.7 tttm -75.67 -29.27 59.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.785 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.765 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -29.3 -64.68 0.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.669 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.765 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 18.5 Cg_endo -61.28 -36.33 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.542 2.161 . . . . 0.0 111.657 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 173' ' ' LYS . 43.3 tp -64.12 -57.32 9.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.734 HD22 HD13 ' A' ' 187' ' ' LEU . 1.4 tt -68.84 -28.25 66.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.592 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.863 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.8 OUTLIER -55.17 -39.03 69.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.909 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.751 ' N ' HD23 ' A' ' 178' ' ' LEU . 76.4 mt-30 -45.04 -30.29 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.993 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -100.24 -17.9 17.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.261 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' A' ' 178' ' ' LEU . 62.6 m-85 -124.73 149.05 61.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 111.006 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -37.57 -78.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.677 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.56 167.03 23.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.905 0.383 . . . . 0.0 111.079 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.737 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.58 -13.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.811 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.677 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.0 OUTLIER -72.1 -60.96 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 189' ' ' ASN . 46.8 tt0 -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.026 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.89 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.84 -50.17 14.53 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.397 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.53 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.8 OUTLIER -62.45 -10.79 12.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 186' ' ' GLN . 40.6 t30 -111.63 4.69 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.711 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 181' ' ' PHE . . . -46.45 158.11 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.372 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.82 131.37 15.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 30.9 mm -47.88 -50.61 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -45.63 -42.86 10.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 198' ' ' VAL . 5.1 mm-40 -73.02 -62.05 1.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.873 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.485 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.8 mt -53.84 -25.41 19.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.907 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.64 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 2.6 tm-20 -78.21 -60.75 2.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 110.836 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.64 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 10.2 pt20 -67.1 3.52 1.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 196' ' ' GLU . 3.4 t -103.74 -37.67 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.094 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.615 ' CG1' HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -144.07 -38.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.749 -178.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.48 138.25 3.59 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.578 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.452 ' NE2' ' HG3' ' A' ' 196' ' ' GLU . 3.9 tp-100 -58.79 -52.53 65.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.11 84.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.736 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.615 HG11 ' CG1' ' A' ' 199' ' ' VAL . 21.0 t -53.87 -60.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.276 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -52.14 -29.17 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.799 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.89 -27.61 43.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.401 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 210' ' ' PHE . 1.2 mt-30 -80.49 -51.37 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.111 0.482 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.886 HD13 HG22 ' A' ' 169' ' ' VAL . 25.3 mt -52.75 -34.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.669 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -71.56 -40.92 69.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -84.17 -18.47 36.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.998 ' CD2' HD11 ' A' ' 166' ' ' ILE . 69.6 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.202 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 166' ' ' ILE . 3.4 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 165' ' ' GLN . 9.3 pt20 -46.58 -27.55 1.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.438 ' N ' ' HG3' ' A' ' 164' ' ' GLN . 10.5 mt-30 -76.37 8.5 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.424 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.781 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.1 mt -69.43 131.54 90.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.589 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.98 129.53 14.37 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.876 1.717 . . . . 0.0 110.822 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.488 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 117.91 -49.71 0.85 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 207' ' ' ILE . 17.6 t -54.79 -45.97 74.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 109.96 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 85.68 83.89 1.06 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.5 OUTLIER -43.03 -19.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 170' ' ' GLY . 63.9 t -71.22 -55.7 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.917 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 174' ' ' ALA . 0.3 OUTLIER -71.71 -29.0 64.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.439 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.795 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -29.32 -64.83 0.18 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.795 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 11.0 Cg_endo -57.13 -45.38 35.96 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.703 2.269 . . . . 0.0 111.495 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 173' ' ' LYS . 21.3 tp -54.27 -57.24 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.507 0.67 . . . . 0.0 110.399 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.795 HD22 HD13 ' A' ' 187' ' ' LEU . 1.8 tt -72.35 -17.68 61.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.679 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -59.47 -30.74 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -62.28 -21.79 65.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -96.86 -22.29 16.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.122 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 178' ' ' LEU . 48.1 m-85 -132.32 150.21 75.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -36.77 -76.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.997 2.464 . . . . 0.0 112.65 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.678 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.59 171.26 17.22 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.015 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.565 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.38 -15.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 -179.396 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.678 ' N ' ' O ' ' A' ' 183' ' ' SER . 24.0 tt0 -70.78 -60.21 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 189' ' ' ASN . 1.3 tt0 -87.99 -34.46 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.025 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.909 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.33 -51.02 11.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.25 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 207' ' ' ILE . 54.5 m -61.68 -15.02 36.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.301 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 186' ' ' GLN . 39.1 t30 -105.51 12.22 31.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.083 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -53.71 149.55 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.31 128.7 4.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.653 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.2 mm -48.26 -49.17 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -50.72 -35.94 31.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 198' ' ' VAL . 18.4 mt-10 -77.8 -64.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.697 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 1.7 mt -51.4 -23.91 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.606 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.629 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 3.2 tm-20 -79.73 -60.98 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.661 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -66.44 3.67 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 196' ' ' GLU . 13.4 t -104.06 -37.54 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.131 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -143.67 -39.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.436 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.89 139.08 3.83 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.413 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.437 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 6.5 tp-100 -63.71 -40.63 97.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.35 68.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.872 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 199' ' ' VAL . 29.8 t -63.83 -61.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.209 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.07 -33.37 18.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.734 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -78.46 -26.37 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.927 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.498 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.69 -36.18 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.649 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 169' ' ' VAL . 72.3 mt -65.34 -43.35 94.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.088 0.47 . . . . 0.0 109.959 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -66.99 -35.41 79.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.703 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.2 -18.42 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.781 ' CD2' HD11 ' A' ' 166' ' ' ILE . 45.1 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.491 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.821 HG13 HD12 ' A' ' 166' ' ' ILE . 2.9 t . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.64 0.257 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -46.56 -22.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.628 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -84.94 10.32 12.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.299 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.821 HD12 HG13 ' A' ' 163' ' ' VAL . 4.5 mt -70.21 132.01 88.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.04 129.17 16.85 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.021 1.814 . . . . 0.0 111.247 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.64 -47.86 1.0 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.839 HG22 HD13 ' A' ' 207' ' ' ILE . 93.9 t -50.64 -46.31 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.232 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 81.2 82.12 0.82 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -42.75 -18.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 43.8 t -66.9 -42.04 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.013 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.8 tttt -87.6 -22.25 24.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.672 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.793 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -33.93 -61.83 0.39 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.597 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 24.4 Cg_endo -63.69 -37.42 46.48 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.603 2.202 . . . . 0.0 111.707 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.473 HD23 ' HG3' ' A' ' 173' ' ' LYS . 22.0 tp -59.26 -56.68 19.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.562 0.696 . . . . 0.0 110.562 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.051 HD22 HD13 ' A' ' 187' ' ' LEU . 5.9 tt -74.47 -28.2 60.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.722 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.8 tt -50.32 -17.87 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.847 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -78.04 -36.55 48.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.826 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -82.39 -18.62 41.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 178' ' ' LEU . 20.9 m-85 -131.82 154.34 81.74 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.194 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -36.62 -76.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.841 2.361 . . . . 0.0 112.462 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 68.8 m -162.8 169.4 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.789 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.712 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.54 -14.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.481 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 2.0 tt0 -73.26 -60.91 2.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -87.7 -26.66 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.088 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 1.051 HD13 HD22 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -55.11 -53.93 49.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.51 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.495 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.4 t -64.32 -19.99 65.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.086 0.469 . . . . 0.0 110.13 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 189' ' ' ASN . 22.8 t-20 -104.05 11.09 35.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.927 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.504 ' HB1' ' CE2' ' A' ' 181' ' ' PHE . . . -57.87 163.59 2.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.635 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.1 p -51.25 131.86 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.703 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.528 HG21 ' NE2' ' A' ' 205' ' ' GLN . 41.4 mm -49.46 -49.82 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.791 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -47.48 -46.93 23.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.896 ' O ' HG23 ' A' ' 198' ' ' VAL . 64.1 mm-40 -66.68 -66.12 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.647 0.261 . . . . 0.0 110.56 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.458 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.7 mt -49.4 -25.53 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.686 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 198' ' ' VAL . 4.3 tt0 -73.29 -60.93 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -69.03 6.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.926 HG11 HD12 ' A' ' 177' ' ' LEU . 89.7 t -108.71 -36.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.505 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.82 -38.98 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.606 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.53 137.48 3.29 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.263 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.73 -45.89 87.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.29 59.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.58 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 206' ' ' GLN . 19.7 t -68.08 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.094 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -47.68 -31.05 4.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.852 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.528 ' NE2' HG21 ' A' ' 192' ' ' ILE . 31.5 mm-40 -79.62 -26.48 41.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.9 OUTLIER -84.76 -32.98 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.839 HD13 HG22 ' A' ' 169' ' ' VAL . 63.3 mt -68.46 -34.02 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -71.99 -41.58 67.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.137 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -76.11 -29.71 57.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.708 ' CD1' HD11 ' A' ' 166' ' ' ILE . 9.2 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 166' ' ' ILE . 2.7 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.833 0.349 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.48 -12.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -96.12 4.39 52.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.522 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.805 HD11 ' CD1' ' A' ' 210' ' ' PHE . 3.6 mt -56.52 115.76 10.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.556 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.28 129.57 29.36 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.788 1.658 . . . . 0.0 111.288 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 110.72 -46.26 1.2 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 207' ' ' ILE . 4.1 t -48.86 -55.2 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.333 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 83.83 82.33 0.98 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.83 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 170' ' ' GLY . 48.6 t -64.14 -41.81 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.945 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -85.86 -31.12 22.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.888 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -29.07 -65.13 0.17 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 18.7 Cg_endo -60.77 -33.42 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.561 2.174 . . . . 0.0 111.691 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 173' ' ' LYS . 53.9 tp -67.9 -56.47 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.605 0.717 . . . . 0.0 109.734 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.668 ' CD2' HD13 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -72.47 -17.06 61.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.233 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.624 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.7 tt -52.59 -54.16 36.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.435 ' N ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -48.48 -23.91 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.533 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 179' ' ' GLN . 49.2 mttp -88.91 -16.15 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.869 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.624 ' O ' ' O ' ' A' ' 178' ' ' LEU . 95.3 m-85 -148.6 145.73 20.75 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 121.003 0.43 . . . . 0.0 110.922 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 181' ' ' PHE . 80.8 Cg_exo -31.82 -78.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.17 2.58 . . . . 0.0 112.87 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.2 OUTLIER -163.11 175.8 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.857 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.78 -14.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.516 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.685 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.5 OUTLIER -69.29 -62.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.1 tt0 -88.37 -33.26 18.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.033 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -46.06 -52.07 12.61 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.234 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.824 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.4 OUTLIER -65.63 -3.69 5.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.51 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 186' ' ' GLN . 49.1 t-20 -121.98 3.98 9.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.63 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -48.71 161.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.487 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.43 140.7 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -62.51 -47.54 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.528 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -52.41 -28.53 28.41 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 198' ' ' VAL . 4.2 mm-40 -81.87 -64.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.782 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.63 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 0.7 OUTLIER -52.58 -30.21 29.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.807 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 198' ' ' VAL . 15.1 tt0 -72.39 -61.09 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.49 4.25 1.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 194' ' ' GLU . 25.4 t -108.78 -35.58 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -143.01 -39.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.551 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.447 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -179.69 138.03 3.29 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.445 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -63.79 -43.5 96.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.97 -32.88 69.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.545 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 199' ' ' VAL . 48.6 t -66.3 -61.68 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.473 ' HB2' ' N ' ' A' ' 196' ' ' GLU . . . -50.69 -29.97 12.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.491 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -81.09 -28.01 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.813 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 210' ' ' PHE . 1.7 pt20 -84.44 -42.77 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.599 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 188' ' ' SER . 65.4 mt -58.62 -42.5 85.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -66.72 -42.63 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.0 -18.57 32.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.038 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.805 ' CD1' HD11 ' A' ' 166' ' ' ILE . 6.5 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.035 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.799 0.333 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.89 150.26 36.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.685 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.541 ' O ' ' CD2' ' A' ' 160' ' ' LEU . 39.3 Cg_endo -70.93 122.17 8.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.747 2.298 . . . . 0.0 111.944 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.586 ' O ' ' N ' ' A' ' 162' ' ' THR . 50.8 p -80.33 -20.67 43.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.88 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.914 ' O ' HG13 ' A' ' 163' ' ' VAL . 6.3 tp -38.03 -28.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.087 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 157' ' ' PRO . 0.9 OUTLIER -83.52 -41.75 17.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 109.988 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.528 ' H ' ' HG ' ' A' ' 160' ' ' LEU . 13.6 ttm180 -79.16 -15.86 57.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.586 ' N ' ' O ' ' A' ' 158' ' ' SER . 18.6 m -85.57 -47.24 10.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.496 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.914 HG13 ' O ' ' A' ' 159' ' ' LEU . 33.2 m -66.04 -45.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.829 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.54 ' N ' HG23 ' A' ' 163' ' ' VAL . 1.8 pt20 -49.55 -21.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.641 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -83.45 2.6 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.336 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.769 HD11 ' CD1' ' A' ' 210' ' ' PHE . 5.8 mt -66.59 130.16 94.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.32 128.99 16.27 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.648 1.566 . . . . 0.0 110.684 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.502 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 120.87 -51.57 0.77 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.887 HG22 HD13 ' A' ' 207' ' ' ILE . 17.0 t -49.57 -49.73 18.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.207 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 88.19 83.0 1.24 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.55 -19.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.6 t -69.74 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.051 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 170' ' ' GLY . 22.6 tttm -85.96 -19.19 30.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.476 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -35.39 -58.54 0.78 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.534 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 41.1 Cg_endo -71.02 -29.11 18.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.534 2.156 . . . . 0.0 111.847 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.48 HD23 ' HG3' ' A' ' 173' ' ' LYS . 31.8 tp -70.55 -57.48 4.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.552 0.691 . . . . 0.0 110.306 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.026 HD22 HD13 ' A' ' 187' ' ' LEU . 5.1 tt -67.68 -21.98 65.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.541 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.854 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.6 OUTLIER -68.56 -42.34 78.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.928 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.851 ' N ' HD23 ' A' ' 178' ' ' LEU . 9.5 mm-40 -42.37 -28.32 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.097 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 178' ' ' LEU . 17.8 mttt -100.34 -15.77 17.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.136 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 178' ' ' LEU . 18.7 m-85 -128.74 152.77 79.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.019 0.437 . . . . 0.0 111.035 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -38.88 -77.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.884 2.389 . . . . 0.0 112.523 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 69.2 m -162.45 166.26 25.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.734 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.3 -16.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.776 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 16.3 tt0 -72.24 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -87.51 -35.35 18.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.74 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 1.026 HD13 HD22 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -48.78 -52.28 24.71 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.284 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.532 ' OG ' ' O ' ' A' ' 184' ' ' ILE . 3.4 p -61.36 -13.0 16.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.717 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.596 ' ND2' ' CZ ' ' A' ' 211' ' ' PHE . 24.2 t-20 -109.08 10.13 26.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.425 ' CB ' ' CE2' ' A' ' 181' ' ' PHE . . . -56.8 150.25 16.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.57 ' CB ' ' OE1' ' A' ' 194' ' ' GLU . 0.8 OUTLIER -44.89 136.67 4.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 208' ' ' HIS . 31.0 mm -52.13 -52.03 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.2 3.41 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.606 ' O ' HG23 ' A' ' 198' ' ' VAL . 8.2 mt-10 -81.82 -61.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.292 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.44 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.0 mt -53.44 -32.84 51.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 198' ' ' VAL . 8.8 tt0 -71.71 -61.2 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -66.48 7.27 0.35 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.652 HG11 HD12 ' A' ' 177' ' ' LEU . 5.1 t -108.89 -36.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.58 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.679 HG11 HG11 ' A' ' 203' ' ' VAL . 0.5 OUTLIER -143.89 -38.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.457 -179.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.44 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.49 139.11 3.93 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.882 -1.152 . . . . 0.0 112.402 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -61.69 -46.1 91.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -70.62 -42.49 70.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.679 HG11 HG11 ' A' ' 199' ' ' VAL . 40.0 t -53.54 -61.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.277 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 192' ' ' ILE . . . -53.65 -29.21 37.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.928 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -77.91 -24.64 48.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.997 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.8 mt-30 -81.35 -53.75 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.438 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.887 HD13 HG22 ' A' ' 169' ' ' VAL . 16.9 mt -55.64 -28.9 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.66 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.595 ' HB2' HD11 ' A' ' 192' ' ' ILE . 86.4 t60 -71.67 -43.0 66.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.12 -18.76 29.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.769 ' CD1' HD11 ' A' ' 166' ' ' ILE . 27.2 t80 -58.05 -60.88 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.228 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.688 ' CE2' ' O ' ' A' ' 207' ' ' ILE . 13.5 p90 -73.92 -8.4 55.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.139 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 93.1 m -65.11 -38.28 90.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.81 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.14 97.56 50.58 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.813 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -64.69 115.85 3.46 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.222 1.948 . . . . 0.0 111.911 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.495 -179.965 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.772 0.32 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.45 147.11 34.64 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.464 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.14 104.91 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.754 2.302 . . . . 0.0 111.959 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -64.08 -25.38 68.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.653 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.65 -30.26 5.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.345 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.72 HD11 HD11 ' A' ' 184' ' ' ILE . 0.7 OUTLIER -82.76 -63.09 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.453 ' N ' HD23 ' A' ' 160' ' ' LEU . 38.2 mtp85 -56.59 -17.34 8.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 158' ' ' SER . 98.8 m -85.6 -25.85 26.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.893 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 166' ' ' ILE . 1.4 t -74.78 -53.06 17.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.298 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.442 ' N ' HG12 ' A' ' 163' ' ' VAL . 1.4 pp0? -46.79 -18.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.223 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 163' ' ' VAL . 29.4 mt-30 -84.46 10.89 9.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.124 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.794 HD11 ' CD1' ' A' ' 210' ' ' PHE . 7.4 mt -75.51 130.41 79.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.81 129.71 12.79 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.033 1.822 . . . . 0.0 111.082 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.32 -49.85 0.83 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.888 HG22 HD13 ' A' ' 207' ' ' ILE . 39.6 t -49.7 -44.35 19.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 79.8 80.91 0.78 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.6 pttt -43.13 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 170' ' ' GLY . 40.8 t -67.88 -48.68 74.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.116 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.651 ' O ' ' N ' ' A' ' 176' ' ' LEU . 4.3 tttp -77.96 -34.85 50.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.796 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -29.12 -59.98 0.24 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.41 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 18.8 Cg_endo -60.99 -32.47 92.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.36 2.04 . . . . 0.0 111.645 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 173' ' ' LYS . 12.7 tp -70.42 -56.81 5.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.458 0.647 . . . . 0.0 109.829 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.706 ' CD2' HD13 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -70.53 -18.34 62.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.204 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 181' ' ' PHE . 5.8 tp -55.85 -43.55 77.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.256 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -56.39 -20.64 20.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.382 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -99.17 -17.57 18.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.692 ' O ' HD12 ' A' ' 178' ' ' LEU . 68.0 m-85 -136.79 150.4 69.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.623 ' O ' ' CD1' ' A' ' 178' ' ' LEU . 88.1 Cg_exo -37.34 -79.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.044 2.496 . . . . 0.0 112.814 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.3 OUTLIER -163.29 171.58 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.672 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.72 HD11 HD11 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -38.91 -17.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.899 0.38 . . . . 0.0 110.103 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.671 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.6 OUTLIER -67.35 -62.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.389 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 189' ' ' ASN . 21.5 tp60 -88.22 -34.85 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.24 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -45.36 -56.96 4.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.483 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 38.9 m -59.88 -4.72 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.598 HD21 ' HZ ' ' A' ' 211' ' ' PHE . 26.6 t-20 -113.95 2.03 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.683 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -47.57 154.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -46.81 154.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.4 mm -65.49 -50.83 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.557 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -48.96 -47.23 32.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 198' ' ' VAL . 2.8 mm-40 -64.29 -62.9 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.859 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.683 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 1.3 mt -57.1 -21.7 34.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.583 ' C ' ' H ' ' A' ' 198' ' ' VAL . 9.0 tt0 -79.5 -61.59 1.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.043 0.449 . . . . 0.0 110.823 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -67.76 7.52 0.5 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 194' ' ' GLU . 14.7 t -106.64 -37.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.131 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -144.19 -38.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.33 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.444 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.15 138.39 3.71 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.36 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -66.55 -38.76 87.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -78.34 -28.55 47.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 206' ' ' GLN . 13.6 t -70.01 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -48.81 -39.35 25.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.57 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -70.37 -25.4 63.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.663 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.503 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.13 -36.37 22.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.525 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.888 HD13 HG22 ' A' ' 169' ' ' VAL . 66.4 mt -65.79 -43.16 93.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.966 0.412 . . . . 0.0 110.203 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.474 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 32.5 t-80 -63.68 -42.26 98.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.039 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.8 -18.4 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.814 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.794 ' CD1' HD11 ' A' ' 166' ' ' ILE . 42.6 t80 -56.12 -60.05 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.873 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.598 ' HZ ' HD21 ' A' ' 189' ' ' ASN . 25.7 p90 -78.29 -5.51 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.053 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 41.1 m -65.11 -37.59 87.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -118.53 97.66 50.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.636 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 215' ' ' ARG . 8.2 Cg_exo -65.0 117.48 4.58 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.221 1.947 . . . . 0.0 111.996 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 214' ' ' PRO . 37.4 mtm180 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.67 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.713 0.292 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.02 159.41 30.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.507 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.02 140.69 25.69 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.866 2.377 . . . . 0.0 112.367 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.659 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -68.92 -39.74 79.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.721 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -35.58 -23.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.464 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.771 HD11 HD11 ' A' ' 184' ' ' ILE . 0.7 OUTLIER -82.74 -63.39 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.52 ' N ' HD23 ' A' ' 160' ' ' LEU . 8.2 ttt-85 -55.73 -21.73 20.23 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.5 m -85.78 -33.63 21.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.213 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 159' ' ' LEU . 2.1 t -64.64 -46.46 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.45 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -54.83 -21.44 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.47 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -83.14 0.35 45.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.57 HG22 HG23 ' A' ' 169' ' ' VAL . 4.4 mt -59.56 131.42 88.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.473 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.61 129.12 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.907 1.738 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.514 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 119.64 -50.77 0.8 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.868 HG22 HD13 ' A' ' 207' ' ' ILE . 15.7 t -49.51 -59.48 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.123 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 93.56 84.81 1.59 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 170' ' ' GLY . 28.7 pttt -42.75 -18.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 170' ' ' GLY . 26.1 t -68.17 -43.28 85.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.3 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 170' ' ' GLY . 18.5 tttt -91.9 -7.79 48.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.654 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -45.79 -59.73 4.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.62 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 33.3 Cg_endo -66.64 -32.6 37.98 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.581 2.187 . . . . 0.0 111.836 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.5 tp -66.84 -57.85 6.2 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.608 0.718 . . . . 0.0 110.71 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.954 HD22 HD13 ' A' ' 187' ' ' LEU . 5.6 tt -67.27 -30.11 69.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.847 HD23 ' C ' ' A' ' 178' ' ' LEU . 2.1 tt -57.83 -42.37 84.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.969 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.641 ' N ' HD23 ' A' ' 178' ' ' LEU . 10.5 pt20 -38.75 -32.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.157 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 178' ' ' LEU . 7.4 mtpt -92.85 -34.92 13.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.203 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.608 ' O ' ' O ' ' A' ' 178' ' ' LEU . 8.2 m-85 -112.76 149.21 40.85 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 110.892 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -35.3 -77.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.866 2.377 . . . . 0.0 112.496 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 57.0 p -162.71 173.5 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.813 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.771 HD11 HD11 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -39.73 -14.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.917 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 9.5 tt0 -69.53 -62.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 189' ' ' ASN . 20.4 tt0 -87.89 -34.46 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.955 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.954 HD13 HD22 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -45.32 -56.56 4.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.376 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.457 ' O ' HG22 ' A' ' 207' ' ' ILE . 3.8 m -59.27 -13.09 6.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.012 0.434 . . . . 0.0 110.256 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.526 ' OD1' ' O ' ' A' ' 189' ' ' ASN . 41.9 t30 -103.97 2.65 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.651 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -51.01 157.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.53 135.78 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.664 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.406 HD11 ' CB ' ' A' ' 208' ' ' HIS . 48.0 mm -54.54 -47.3 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.364 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.19 -46.56 62.57 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 198' ' ' VAL . 4.3 mt-10 -63.9 -65.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.193 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.615 HD22 HD12 ' A' ' 207' ' ' ILE . 1.8 mt -50.05 -23.42 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.013 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 198' ' ' VAL . 10.8 tt0 -79.37 -61.11 2.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.717 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.24 4.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 194' ' ' GLU . 71.4 t -108.99 -35.03 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.34 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.523 ' CG1' HG11 ' A' ' 203' ' ' VAL . 1.0 OUTLIER -144.14 -39.24 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.942 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -179.57 138.5 3.48 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -67.07 -42.09 85.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.13 -21.38 54.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.457 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.523 HG11 ' CG1' ' A' ' 199' ' ' VAL . 41.3 t -78.4 -60.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.057 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -47.47 -31.5 4.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.685 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -81.13 -27.5 35.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -81.48 -23.42 37.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.868 HD13 HG22 ' A' ' 169' ' ' VAL . 65.0 mt -78.38 -36.02 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.51 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.492 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 61.0 t-80 -80.69 -32.13 36.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.215 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.58 -18.78 30.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.564 ' CD2' HD11 ' A' ' 166' ' ' ILE . 41.7 t80 -66.11 -62.94 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.242 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 207' ' ' ILE . 13.9 p90 -75.0 -1.05 20.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.254 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 1.2 m -68.32 -37.27 80.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -117.87 97.63 50.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.707 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.45 117.54 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.321 2.014 . . . . 0.0 112.18 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.448 ' CG ' HH11 ' A' ' 215' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.481 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.471 ' O ' ' OG ' ' A' ' 155' ' ' SER . 4.2 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.838 0.352 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.22 157.56 52.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.08 33.29 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.786 2.324 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 160' ' ' LEU . 3.2 p -65.75 -17.86 64.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.52 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 158' ' ' SER . 5.0 tp -38.43 -20.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.658 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.6 pp -83.83 -45.32 13.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.601 ' N ' HD12 ' A' ' 160' ' ' LEU . 9.2 ttt180 -75.28 -20.13 59.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 45.7 m -85.92 -34.81 20.82 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.307 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.461 HG21 ' CE2' ' A' ' 211' ' ' PHE . 2.3 t -72.26 -52.9 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.505 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.52 ' C ' ' H ' ' A' ' 166' ' ' ILE . 8.3 pt20 -49.33 -31.69 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.04 12.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.097 0.475 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.629 HD11 ' CD1' ' A' ' 210' ' ' PHE . 4.5 mt -76.4 132.39 72.93 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.13 128.95 14.47 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.033 1.822 . . . . 0.0 110.856 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 118.49 -50.41 0.81 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.848 HG22 HD13 ' A' ' 207' ' ' ILE . 37.2 t -48.56 -49.64 13.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.103 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 173' ' ' LYS . . . 84.73 82.6 1.03 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' GLY . 25.1 pttt -42.96 -19.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 170' ' ' GLY . 65.8 t -70.46 -42.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.845 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 19.0 tttm -86.91 -12.62 47.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -43.97 -60.02 3.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.293 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 29.0 Cg_endo -65.66 -29.68 51.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.507 2.138 . . . . 0.0 111.788 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.49 HD23 ' HG3' ' A' ' 173' ' ' LYS . 39.9 tp -70.92 -57.92 4.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.587 0.708 . . . . 0.0 110.37 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.025 HD22 HD13 ' A' ' 187' ' ' LEU . 5.7 tt -67.69 -31.6 71.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.131 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.766 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -55.61 -21.35 17.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.675 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.522 ' N ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -61.94 -26.89 68.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -97.53 -18.03 19.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 178' ' ' LEU . 35.2 m-85 -132.88 150.92 77.01 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -38.56 -74.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.213 2.609 . . . . 0.0 112.944 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 1.3 t -160.51 169.33 23.2 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.066 0.46 . . . . 0.0 111.298 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.727 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.65 -15.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.731 -179.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 5.6 tt0 -66.53 -63.59 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -89.41 -31.26 17.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.173 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 1.025 HD13 HD22 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -48.09 -55.22 10.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.631 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.676 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.0 OUTLIER -62.58 -17.67 60.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.721 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -101.39 8.09 42.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.511 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.606 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -49.77 154.51 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -45.2 146.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.568 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 30.7 mm -59.49 -43.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -57.88 -50.41 66.03 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.846 ' O ' HG23 ' A' ' 198' ' ' VAL . 39.3 mt-10 -62.28 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.727 0.299 . . . . 0.0 110.598 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.606 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 3.4 mt -53.0 -21.42 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.56 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 198' ' ' VAL . 11.5 tt0 -77.84 -61.23 2.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -68.14 5.22 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 194' ' ' GLU . 71.9 t -108.59 -36.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.365 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -143.34 -39.09 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.705 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.84 136.7 2.96 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.472 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -47.75 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -72.77 -36.92 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.439 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.527 HG11 ' CG1' ' A' ' 199' ' ' VAL . 23.5 t -58.37 -61.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.444 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.92 -34.01 26.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.79 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -69.94 -27.14 64.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.76 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 1.0 OUTLIER -84.23 -55.98 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.422 . . . . 0.0 110.545 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.848 HD13 HG22 ' A' ' 169' ' ' VAL . 26.8 mt -48.52 -28.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.906 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -80.69 -32.6 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.88 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.45 -22.49 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.589 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.629 ' CD1' HD11 ' A' ' 166' ' ' ILE . 32.4 t80 -57.54 -47.58 81.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.825 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.461 ' CE2' HG21 ' A' ' 163' ' ' VAL . 76.4 m-85 -46.6 -51.94 14.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.636 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 19.8 m -68.46 -37.96 80.64 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.218 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -118.89 97.53 50.78 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.531 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -74.53 113.98 3.92 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.359 2.039 . . . . 0.0 111.684 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.579 -179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.837 0.351 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 158' ' ' SER . 4.0 mm-40 -110.97 95.91 26.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.394 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.547 ' O ' ' CD2' ' A' ' 160' ' ' LEU . 72.1 Cg_exo -46.38 81.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.427 2.085 . . . . 0.0 112.001 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 160' ' ' LEU . 22.9 p -66.46 -18.75 65.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.862 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.597 ' O ' HD23 ' A' ' 159' ' ' LEU . 1.0 OUTLIER -32.04 -32.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.641 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.604 ' HG ' ' H ' ' A' ' 161' ' ' ARG . 0.3 OUTLIER -84.06 -51.25 7.24 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.604 ' H ' ' HG ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -62.86 -18.04 62.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 158' ' ' SER . 60.6 m -85.76 -46.08 11.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.98 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.529 HG13 HD12 ' A' ' 166' ' ' ILE . 1.8 t -53.22 -48.9 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.44 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -18.97 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.708 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -83.27 2.36 36.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.831 HD11 ' CD1' ' A' ' 210' ' ' PHE . 6.1 mt -67.11 131.2 93.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.14 128.66 17.94 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.52 1.48 . . . . 0.0 110.351 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.404 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 118.89 -49.97 0.84 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.466 HG23 ' H ' ' A' ' 169' ' ' VAL . 2.0 t -49.29 -57.58 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.812 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 99.94 87.28 1.94 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.2 pttt -43.2 -19.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.9 t -72.27 -45.12 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.2 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.2 tttm -87.24 -17.53 32.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.829 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -35.53 -58.77 0.78 Allowed Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.307 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 53.5 Cg_endo -72.5 -36.26 5.36 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.686 2.258 . . . . 0.0 111.451 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 176' ' ' LEU . 15.0 tp -60.7 -57.61 11.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.247 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.893 ' O ' HD23 ' A' ' 177' ' ' LEU . 3.0 tt -65.69 -31.63 72.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -51.53 -14.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.167 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -79.05 -35.24 42.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.063 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -85.13 -6.93 59.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.652 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.644 ' CZ ' ' HB1' ' A' ' 190' ' ' ALA . 38.6 m-85 -147.29 153.56 44.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.664 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -38.27 -73.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.097 2.531 . . . . 0.0 112.836 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -160.79 168.93 23.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.419 HG23 ' H ' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -39.13 -26.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 183' ' ' SER . 44.7 tt0 -63.19 -56.34 17.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.5 tp60 -87.39 -38.81 15.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.999 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.36 -50.67 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.142 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.482 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 22.9 p -64.16 -17.84 63.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.526 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.512 ' OD1' ' O ' ' A' ' 189' ' ' ASN . 48.7 t-20 -106.12 1.2 26.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.644 ' HB1' ' CZ ' ' A' ' 181' ' ' PHE . . . -44.24 159.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.415 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.1 p -52.29 137.76 28.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.534 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.2 mm -54.92 -43.59 69.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.681 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.0 -33.87 45.14 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.885 ' O ' HG23 ' A' ' 198' ' ' VAL . 67.5 mm-40 -81.78 -65.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.645 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.438 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 2.4 mt -47.86 -29.53 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.867 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 198' ' ' VAL . 2.5 tm-20 -72.54 -61.01 1.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.897 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.511 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 7.1 pt20 -67.76 6.76 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 194' ' ' GLU . 72.7 t -106.24 -38.94 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.79 -39.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.361 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.57 139.25 3.98 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.266 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.445 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 37.7 tt0 -65.27 -44.72 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.69 -31.2 64.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.465 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 206' ' ' GLN . 18.6 t -68.31 -61.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.884 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.438 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -46.96 -33.48 4.69 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -81.4 -23.47 37.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.992 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -83.23 -31.56 26.94 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.557 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.37 -50.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.102 0.477 . . . . 0.0 110.007 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.582 ' O ' ' OG1' ' A' ' 212' ' ' THR . 66.1 t60 -54.21 -35.72 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.894 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.5 -20.68 27.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.831 ' CD1' HD11 ' A' ' 166' ' ' ILE . 27.0 t80 -61.57 -61.51 2.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.505 ' CE2' ' HA ' ' A' ' 208' ' ' HIS . 26.8 p90 -78.75 1.36 23.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.235 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 208' ' ' HIS . 21.2 m -65.34 -38.06 88.98 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -119.16 97.84 50.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.529 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 215' ' ' ARG . 12.0 Cg_exo -63.73 115.19 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.173 1.915 . . . . 0.0 112.013 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 214' ' ' PRO . 9.6 mtt85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.614 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.802 0.334 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -112.48 95.08 30.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.676 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.27 90.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.624 2.216 . . . . 0.0 112.083 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.8 t -88.08 -17.74 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.721 ' O ' HG23 ' A' ' 163' ' ' VAL . 1.9 tp -48.79 -20.31 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.576 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.757 HD11 HD11 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -83.83 -63.26 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.14 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.514 ' N ' HD23 ' A' ' 160' ' ' LEU . 34.4 ttt-85 -62.27 -21.84 65.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.533 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 29.7 m -85.92 -29.32 23.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.903 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 159' ' ' LEU . 2.4 t -73.12 -47.95 45.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -53.05 -22.58 6.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.827 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -80.61 13.51 2.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.631 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.8 mt -78.15 130.44 72.32 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.869 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.74 129.2 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.897 1.732 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.46 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 120.65 -51.45 0.78 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.819 HG22 HD13 ' A' ' 207' ' ' ILE . 63.6 t -49.39 -45.66 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.945 0.402 . . . . 0.0 110.112 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 82.21 81.1 0.92 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.37 -19.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 170' ' ' GLY . 46.4 t -66.91 -44.68 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.069 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 176' ' ' LEU . 2.7 ttmm -84.06 -32.49 24.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.739 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -28.27 -62.69 0.19 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.425 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.739 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -55.51 -36.4 94.23 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.245 1.963 . . . . 0.0 111.115 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.679 ' N ' ' O ' ' A' ' 173' ' ' LYS . 19.5 tp -77.74 -57.01 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.555 0.693 . . . . 0.0 109.54 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.054 HD23 HD11 ' A' ' 187' ' ' LEU . 23.6 tp -59.98 -18.59 46.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.095 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.875 HD23 ' C ' ' A' ' 178' ' ' LEU . 1.0 OUTLIER -73.58 -38.24 65.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.16 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.683 ' N ' HD23 ' A' ' 178' ' ' LEU . 69.0 mt-30 -47.02 -20.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.326 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.405 ' N ' ' C ' ' A' ' 178' ' ' LEU . 6.2 mmtt -101.38 -26.5 13.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 178' ' ' LEU . 21.6 m-85 -126.23 148.53 63.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -36.79 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.199 2.6 . . . . 0.0 113.31 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.7 OUTLIER -157.17 168.18 28.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.021 -179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.774 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -39.52 -16.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 183' ' ' SER . 1.9 tp-100 -66.33 -62.95 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -88.09 -32.3 18.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.034 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 1.054 HD11 HD23 ' A' ' 177' ' ' LEU . 0.3 OUTLIER -49.89 -54.03 22.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.632 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.671 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.8 OUTLIER -68.94 -12.61 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 110.417 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -107.72 6.51 27.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.645 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 195' ' ' LEU . . . -53.87 163.26 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.557 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.1 t -43.98 159.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.698 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 50.3 mm -76.33 -42.96 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.625 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.8 -37.16 92.06 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.9 ' O ' HG23 ' A' ' 198' ' ' VAL . 16.4 mt-10 -69.34 -65.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.771 0.32 . . . . 0.0 110.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.503 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 0.8 OUTLIER -57.52 -22.62 45.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 198' ' ' VAL . 3.8 tm-20 -74.11 -60.39 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.494 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.77 2.9 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.565 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 194' ' ' GLU . 45.3 t -96.94 -48.9 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.07 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 203' ' ' VAL . 0.4 OUTLIER -134.62 -39.62 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.679 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 199' ' ' VAL . . . -178.79 143.27 5.77 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.947 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 205' ' ' GLN . 12.6 tt0 -65.66 -36.36 83.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -71.56 -43.34 66.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.563 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 199' ' ' VAL . 46.6 t -58.44 -61.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.531 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.503 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.27 -27.3 5.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.644 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.431 ' CG ' ' O ' ' A' ' 201' ' ' GLN . 12.0 mm-40 -80.0 -25.32 40.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.291 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.9 mt-30 -84.48 -43.09 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.819 HD13 HG22 ' A' ' 169' ' ' VAL . 17.3 mt -63.19 -48.99 85.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.877 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.474 ' CB ' HD11 ' A' ' 192' ' ' ILE . 60.7 t-80 -58.9 -37.03 75.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -81.82 -27.2 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.631 ' CD2' HD11 ' A' ' 166' ' ' ILE . 14.1 t80 -44.86 -53.65 7.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.523 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.58 ' CE2' HG21 ' A' ' 163' ' ' VAL . 71.4 m-85 -46.59 -36.6 7.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.303 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 9.0 m -65.33 -37.81 88.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.907 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 210' ' ' PHE . 29.9 mt-30 -118.47 97.35 50.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.756 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.63 119.76 6.82 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.325 2.017 . . . . 0.0 112.114 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.606 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.732 0.301 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.37 149.94 35.66 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.561 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.48 165.68 19.57 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.708 2.272 . . . . 0.0 112.033 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.674 ' O ' ' N ' ' A' ' 160' ' ' LEU . 11.0 p -88.2 -20.23 25.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.817 ' O ' HD23 ' A' ' 159' ' ' LEU . 1.6 tt -35.59 -22.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.502 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 158' ' ' SER . 1.9 pp -83.7 -48.24 10.36 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.579 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 0.1 OUTLIER -65.17 -17.49 64.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.5 m -85.66 -25.16 26.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.248 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.613 ' C ' ' H ' ' A' ' 165' ' ' GLN . 14.5 t -79.72 -56.25 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.782 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.674 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 0.1 OUTLIER -47.89 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.74 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.674 ' N ' ' OE1' ' A' ' 164' ' ' GLN . 20.5 mt-30 -94.29 3.93 54.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.43 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.998 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.3 mt -71.81 131.14 86.1 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.86 129.12 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.794 1.663 . . . . 0.0 110.899 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 -49.64 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.886 HG22 HD13 ' A' ' 207' ' ' ILE . 22.6 t -53.79 -37.55 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.999 0.428 . . . . 0.0 110.205 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 75.35 82.65 0.45 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -42.83 -19.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 170' ' ' GLY . 49.9 t -68.14 -51.6 46.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.091 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 174' ' ' ALA . 21.7 tttm -75.67 -29.27 59.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.785 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.765 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -29.3 -64.68 0.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.669 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.765 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 18.5 Cg_endo -61.28 -36.33 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.542 2.161 . . . . 0.0 111.657 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 173' ' ' LYS . 43.3 tp -64.12 -57.32 9.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.734 HD22 HD13 ' A' ' 187' ' ' LEU . 1.4 tt -68.84 -28.25 66.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.592 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.863 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.8 OUTLIER -55.17 -39.03 69.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.909 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.751 ' N ' HD23 ' A' ' 178' ' ' LEU . 76.4 mt-30 -45.04 -30.29 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.993 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -100.24 -17.9 17.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.261 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' A' ' 178' ' ' LEU . 62.6 m-85 -124.73 149.05 61.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 111.006 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -37.57 -78.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.677 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.56 167.03 23.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.905 0.383 . . . . 0.0 111.079 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.737 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.58 -13.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.811 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.677 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.0 OUTLIER -72.1 -60.96 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 189' ' ' ASN . 46.8 tt0 -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.026 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.89 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.84 -50.17 14.53 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.397 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.53 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.8 OUTLIER -62.45 -10.79 12.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 186' ' ' GLN . 40.6 t30 -111.63 4.69 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.711 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 181' ' ' PHE . . . -46.45 158.11 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.372 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.82 131.37 15.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 30.9 mm -47.88 -50.61 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -45.63 -42.86 10.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 198' ' ' VAL . 5.1 mm-40 -73.02 -62.05 1.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.873 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.485 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.8 mt -53.84 -25.41 19.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.907 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.64 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 2.6 tm-20 -78.21 -60.75 2.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 110.836 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.64 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 10.2 pt20 -67.1 3.52 1.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 196' ' ' GLU . 3.4 t -103.74 -37.67 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.094 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.615 ' CG1' HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -144.07 -38.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.749 -178.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.48 138.25 3.59 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.578 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.452 ' NE2' ' HG3' ' A' ' 196' ' ' GLU . 3.9 tp-100 -58.79 -52.53 65.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.11 84.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.736 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.615 HG11 ' CG1' ' A' ' 199' ' ' VAL . 21.0 t -53.87 -60.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.276 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -52.14 -29.17 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.799 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.89 -27.61 43.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.401 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 210' ' ' PHE . 1.2 mt-30 -80.49 -51.37 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.111 0.482 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.886 HD13 HG22 ' A' ' 169' ' ' VAL . 25.3 mt -52.75 -34.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.669 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.487 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 21.1 t-80 -71.56 -40.92 69.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -84.17 -18.47 36.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.998 ' CD2' HD11 ' A' ' 166' ' ' ILE . 69.6 t80 -58.36 -65.09 0.71 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.202 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.627 ' CE2' ' O ' ' A' ' 207' ' ' ILE . 27.5 p90 -72.42 -3.57 24.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.23 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 66.1 m -65.5 -38.45 89.76 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.821 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -119.46 97.5 50.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.904 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -64.8 116.82 4.03 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.12 1.88 . . . . 0.0 111.851 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.516 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.806 0.336 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.78 144.81 98.92 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.658 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.45 ' O ' HD23 ' A' ' 160' ' ' LEU . 58.6 Cg_endo -74.79 156.5 43.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.638 2.226 . . . . 0.0 112.198 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -71.28 -15.74 62.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.338 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.697 ' O ' HG23 ' A' ' 163' ' ' VAL . 3.8 tp -37.46 -19.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.513 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.686 ' N ' ' O ' ' A' ' 158' ' ' SER . 2.4 pp -83.81 -44.76 14.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.612 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -74.17 -22.42 59.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.9 m -86.0 -32.7 21.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.625 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 166' ' ' ILE . 3.4 t -71.9 -51.17 33.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.847 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 165' ' ' GLN . 9.3 pt20 -46.58 -27.55 1.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.438 ' N ' ' HG3' ' A' ' 164' ' ' GLN . 10.5 mt-30 -76.37 8.5 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.424 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.781 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.1 mt -69.43 131.54 90.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.589 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.98 129.53 14.37 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.876 1.717 . . . . 0.0 110.822 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.488 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 117.91 -49.71 0.85 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 207' ' ' ILE . 17.6 t -54.79 -45.97 74.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 109.96 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 85.68 83.89 1.06 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.5 OUTLIER -43.03 -19.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 170' ' ' GLY . 63.9 t -71.22 -55.7 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.917 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 174' ' ' ALA . 0.3 OUTLIER -71.71 -29.0 64.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.439 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.795 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -29.32 -64.83 0.18 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.795 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 11.0 Cg_endo -57.13 -45.38 35.96 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.703 2.269 . . . . 0.0 111.495 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 173' ' ' LYS . 21.3 tp -54.27 -57.24 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.507 0.67 . . . . 0.0 110.399 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.795 HD22 HD13 ' A' ' 187' ' ' LEU . 1.8 tt -72.35 -17.68 61.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.679 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -59.47 -30.74 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -62.28 -21.79 65.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -96.86 -22.29 16.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.122 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 178' ' ' LEU . 48.1 m-85 -132.32 150.21 75.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -36.77 -76.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.997 2.464 . . . . 0.0 112.65 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.678 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.59 171.26 17.22 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.015 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.565 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.38 -15.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 -179.396 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.678 ' N ' ' O ' ' A' ' 183' ' ' SER . 24.0 tt0 -70.78 -60.21 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 189' ' ' ASN . 1.3 tt0 -87.99 -34.46 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.025 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.909 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.33 -51.02 11.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.25 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 207' ' ' ILE . 54.5 m -61.68 -15.02 36.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.301 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 186' ' ' GLN . 39.1 t30 -105.51 12.22 31.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.083 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -53.71 149.55 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.31 128.7 4.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.653 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.2 mm -48.26 -49.17 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -50.72 -35.94 31.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 198' ' ' VAL . 18.4 mt-10 -77.8 -64.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.697 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 1.7 mt -51.4 -23.91 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.606 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.629 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 3.2 tm-20 -79.73 -60.98 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.661 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -66.44 3.67 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 196' ' ' GLU . 13.4 t -104.06 -37.54 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.131 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -143.67 -39.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.436 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.89 139.08 3.83 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.413 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.437 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 6.5 tp-100 -63.71 -40.63 97.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.35 68.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.872 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 199' ' ' VAL . 29.8 t -63.83 -61.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.209 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.07 -33.37 18.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.734 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -78.46 -26.37 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.927 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.498 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.69 -36.18 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.649 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 169' ' ' VAL . 72.3 mt -65.34 -43.35 94.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.088 0.47 . . . . 0.0 109.959 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.447 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 3.8 t60 -66.99 -35.41 79.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.703 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.2 -18.42 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.781 ' CD2' HD11 ' A' ' 166' ' ' ILE . 45.1 t80 -64.65 -65.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.491 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 207' ' ' ILE . 40.2 p90 -75.03 1.19 13.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.041 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -66.02 -38.35 88.21 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -119.67 97.41 49.86 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.036 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -65.92 120.5 7.67 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.262 1.974 . . . . 0.0 111.885 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.545 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.845 0.355 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.98 165.14 25.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.523 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.644 ' O ' ' CD2' ' A' ' 160' ' ' LEU . 29.0 Cg_endo -66.73 158.51 55.75 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.786 2.324 . . . . 0.0 112.078 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 161' ' ' ARG . 26.1 t -88.41 -15.84 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.793 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER -35.93 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.268 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.777 ' H ' HD23 ' A' ' 160' ' ' LEU . 2.7 pt? -83.36 -40.32 19.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.605 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -74.15 -18.02 60.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.5 m -85.97 -40.01 16.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.135 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.821 HG13 HD12 ' A' ' 166' ' ' ILE . 2.9 t -66.22 -53.28 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.676 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.56 -22.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.628 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -84.94 10.32 12.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.299 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.821 HD12 HG13 ' A' ' 163' ' ' VAL . 4.5 mt -70.21 132.01 88.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.04 129.17 16.85 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.021 1.814 . . . . 0.0 111.247 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.64 -47.86 1.0 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.839 HG22 HD13 ' A' ' 207' ' ' ILE . 93.9 t -50.64 -46.31 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.232 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 81.2 82.12 0.82 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.522 ' NZ ' ' CB ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -42.75 -18.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 43.8 t -66.9 -42.04 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.013 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.8 tttt -87.6 -22.25 24.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.672 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.793 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -33.93 -61.83 0.39 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.597 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 24.4 Cg_endo -63.69 -37.42 46.48 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.603 2.202 . . . . 0.0 111.707 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.473 HD23 ' HG3' ' A' ' 173' ' ' LYS . 22.0 tp -59.26 -56.68 19.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.562 0.696 . . . . 0.0 110.562 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.051 HD22 HD13 ' A' ' 187' ' ' LEU . 5.9 tt -74.47 -28.2 60.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.722 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.8 tt -50.32 -17.87 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.847 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -78.04 -36.55 48.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.826 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -82.39 -18.62 41.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 178' ' ' LEU . 20.9 m-85 -131.82 154.34 81.74 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.194 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -36.62 -76.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.841 2.361 . . . . 0.0 112.462 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 68.8 m -162.8 169.4 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.789 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.712 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.54 -14.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.481 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 2.0 tt0 -73.26 -60.91 2.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -87.7 -26.66 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.088 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 1.051 HD13 HD22 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -55.11 -53.93 49.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.51 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.495 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.4 t -64.32 -19.99 65.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.086 0.469 . . . . 0.0 110.13 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' A' ' 189' ' ' ASN . 22.8 t-20 -104.05 11.09 35.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.927 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.504 ' HB1' ' CE2' ' A' ' 181' ' ' PHE . . . -57.87 163.59 2.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.635 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.1 p -51.25 131.86 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.703 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.528 HG21 ' NE2' ' A' ' 205' ' ' GLN . 41.4 mm -49.46 -49.82 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.791 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -47.48 -46.93 23.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.896 ' O ' HG23 ' A' ' 198' ' ' VAL . 64.1 mm-40 -66.68 -66.12 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.647 0.261 . . . . 0.0 110.56 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.458 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.7 mt -49.4 -25.53 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.686 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 198' ' ' VAL . 4.3 tt0 -73.29 -60.93 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -69.03 6.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.926 HG11 HD12 ' A' ' 177' ' ' LEU . 89.7 t -108.71 -36.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.505 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.82 -38.98 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.606 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.53 137.48 3.29 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.263 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.73 -45.89 87.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.29 59.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.58 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 206' ' ' GLN . 19.7 t -68.08 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.094 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -47.68 -31.05 4.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.852 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.528 ' NE2' HG21 ' A' ' 192' ' ' ILE . 31.5 mm-40 -79.62 -26.48 41.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.9 OUTLIER -84.76 -32.98 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.839 HD13 HG22 ' A' ' 169' ' ' VAL . 63.3 mt -68.46 -34.02 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -71.99 -41.58 67.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.137 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' A' ' 212' ' ' THR . . . -76.11 -29.71 57.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.708 ' CD1' HD11 ' A' ' 166' ' ' ILE . 9.2 t80 -50.77 -41.55 56.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.434 ' CZ ' ' OG ' ' A' ' 188' ' ' SER . 73.5 m-85 -46.32 -19.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.625 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 209' ' ' ALA . 0.2 OUTLIER -76.53 -36.8 57.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.667 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -117.65 97.44 50.76 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.426 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -76.54 114.6 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.402 2.068 . . . . 0.0 111.841 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.584 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.772 0.32 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -51.8 143.9 20.74 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.53 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.601 ' O ' HD21 ' A' ' 160' ' ' LEU . 57.4 Cg_endo -73.78 64.09 4.86 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.569 2.179 . . . . 0.0 112.008 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 160' ' ' LEU . 15.7 t -84.64 -20.63 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.641 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -34.12 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.601 HD21 ' O ' ' A' ' 157' ' ' PRO . 0.4 OUTLIER -83.92 -46.94 11.56 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.548 ' H ' ' HG ' ' A' ' 160' ' ' LEU . 14.2 mtp180 -70.12 -18.21 63.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 158' ' ' SER . 7.5 m -85.7 -25.85 26.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.059 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 166' ' ' ILE . 2.7 t -80.17 -46.0 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.581 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.48 -12.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -96.12 4.39 52.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.522 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.805 HD11 ' CD1' ' A' ' 210' ' ' PHE . 3.6 mt -56.52 115.76 10.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.556 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.28 129.57 29.36 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.788 1.658 . . . . 0.0 111.288 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 110.72 -46.26 1.2 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 207' ' ' ILE . 4.1 t -48.86 -55.2 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.333 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 83.83 82.33 0.98 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.83 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 170' ' ' GLY . 48.6 t -64.14 -41.81 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.945 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -85.86 -31.12 22.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.888 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -29.07 -65.13 0.17 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 18.7 Cg_endo -60.77 -33.42 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.561 2.174 . . . . 0.0 111.691 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 173' ' ' LYS . 53.9 tp -67.9 -56.47 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.605 0.717 . . . . 0.0 109.734 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.668 ' CD2' HD13 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -72.47 -17.06 61.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.233 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.624 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.7 tt -52.59 -54.16 36.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.435 ' N ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -48.48 -23.91 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.533 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 179' ' ' GLN . 49.2 mttp -88.91 -16.15 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.869 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.624 ' O ' ' O ' ' A' ' 178' ' ' LEU . 95.3 m-85 -148.6 145.73 20.75 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 121.003 0.43 . . . . 0.0 110.922 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 181' ' ' PHE . 80.8 Cg_exo -31.82 -78.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.17 2.58 . . . . 0.0 112.87 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.2 OUTLIER -163.11 175.8 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.857 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.78 -14.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.516 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.685 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.5 OUTLIER -69.29 -62.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.1 tt0 -88.37 -33.26 18.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.033 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -46.06 -52.07 12.61 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.234 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.824 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.4 OUTLIER -65.63 -3.69 5.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.51 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 186' ' ' GLN . 49.1 t-20 -121.98 3.98 9.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.63 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -48.71 161.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.487 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.43 140.7 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -62.51 -47.54 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.528 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -52.41 -28.53 28.41 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 198' ' ' VAL . 4.2 mm-40 -81.87 -64.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.782 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.63 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 0.7 OUTLIER -52.58 -30.21 29.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.807 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 198' ' ' VAL . 15.1 tt0 -72.39 -61.09 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.49 4.25 1.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 194' ' ' GLU . 25.4 t -108.78 -35.58 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -143.01 -39.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.551 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.447 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -179.69 138.03 3.29 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.445 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -63.79 -43.5 96.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.97 -32.88 69.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.545 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 199' ' ' VAL . 48.6 t -66.3 -61.68 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.473 ' HB2' ' N ' ' A' ' 196' ' ' GLU . . . -50.69 -29.97 12.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.491 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -81.09 -28.01 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.813 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 210' ' ' PHE . 1.7 pt20 -84.44 -42.77 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.599 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 188' ' ' SER . 65.4 mt -58.62 -42.5 85.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.654 ' O ' ' CZ ' ' A' ' 211' ' ' PHE . 58.4 t-80 -66.72 -42.63 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.0 -18.57 32.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.038 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.805 ' CD1' HD11 ' A' ' 166' ' ' ILE . 6.5 t80 -51.91 -56.93 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.035 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.654 ' CZ ' ' O ' ' A' ' 208' ' ' HIS . 8.4 p90 -74.74 18.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.451 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 210' ' ' PHE . 41.8 m -71.58 -37.87 70.96 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.975 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -118.95 97.3 50.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.291 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.43 114.13 3.91 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.296 1.997 . . . . 0.0 112.08 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.65 179.925 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 164' ' ' GLN . 33.2 m . . . . . 0 C--O 1.228 -0.062 0 CA-C-O 120.462 0.172 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.54 ' N ' HG23 ' A' ' 163' ' ' VAL . 1.8 pt20 -49.55 -21.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.641 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -83.45 2.6 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.336 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.769 HD11 ' CD1' ' A' ' 210' ' ' PHE . 5.8 mt -66.59 130.16 94.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.32 128.99 16.27 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.648 1.566 . . . . 0.0 110.684 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.502 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 120.87 -51.57 0.77 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.887 HG22 HD13 ' A' ' 207' ' ' ILE . 17.0 t -49.57 -49.73 18.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.207 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 88.19 83.0 1.24 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.55 -19.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.6 t -69.74 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.051 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 170' ' ' GLY . 22.6 tttm -85.96 -19.19 30.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.476 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -35.39 -58.54 0.78 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.534 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 41.1 Cg_endo -71.02 -29.11 18.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.534 2.156 . . . . 0.0 111.847 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.48 HD23 ' HG3' ' A' ' 173' ' ' LYS . 31.8 tp -70.55 -57.48 4.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.552 0.691 . . . . 0.0 110.306 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.026 HD22 HD13 ' A' ' 187' ' ' LEU . 5.1 tt -67.68 -21.98 65.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.541 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.854 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.6 OUTLIER -68.56 -42.34 78.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.928 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.851 ' N ' HD23 ' A' ' 178' ' ' LEU . 9.5 mm-40 -42.37 -28.32 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.097 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 178' ' ' LEU . 17.8 mttt -100.34 -15.77 17.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.136 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 178' ' ' LEU . 18.7 m-85 -128.74 152.77 79.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.019 0.437 . . . . 0.0 111.035 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -38.88 -77.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.884 2.389 . . . . 0.0 112.523 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 69.2 m -162.45 166.26 25.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.734 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.3 -16.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.776 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 16.3 tt0 -72.24 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -87.51 -35.35 18.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.74 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 1.026 HD13 HD22 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -48.78 -52.28 24.71 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.284 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.532 ' OG ' ' O ' ' A' ' 184' ' ' ILE . 3.4 p -61.36 -13.0 16.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.717 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.532 ' O ' ' OD1' ' A' ' 189' ' ' ASN . 24.2 t-20 -109.08 10.13 26.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.425 ' CB ' ' CE2' ' A' ' 181' ' ' PHE . . . -56.8 150.25 16.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.57 ' CB ' ' OE1' ' A' ' 194' ' ' GLU . 0.8 OUTLIER -44.89 136.67 4.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 208' ' ' HIS . 31.0 mm -52.13 -52.03 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.2 3.41 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.606 ' O ' HG23 ' A' ' 198' ' ' VAL . 8.2 mt-10 -81.82 -61.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.292 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.44 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.0 mt -53.44 -32.84 51.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 198' ' ' VAL . 8.8 tt0 -71.71 -61.2 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.458 HE21 ' HA ' ' A' ' 197' ' ' GLN . 0.9 OUTLIER -66.48 7.27 0.35 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.652 HG11 HD12 ' A' ' 177' ' ' LEU . 5.1 t -108.89 -36.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.58 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.679 HG11 HG11 ' A' ' 203' ' ' VAL . 0.5 OUTLIER -143.89 -38.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.457 -179.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.44 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.49 139.11 3.93 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.882 -1.152 . . . . 0.0 112.402 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -61.69 -46.1 91.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -70.62 -42.49 70.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.679 HG11 HG11 ' A' ' 199' ' ' VAL . 40.0 t -53.54 -61.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.277 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 192' ' ' ILE . . . -53.65 -29.21 37.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.928 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -24.64 48.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.997 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.8 mt-30 -81.35 -53.75 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.438 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.887 HD13 HG22 ' A' ' 169' ' ' VAL . 16.9 mt -55.64 -28.9 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.66 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . 0.595 ' HB2' HD11 ' A' ' 192' ' ' ILE . 86.4 t60 -71.67 -43.0 66.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.12 -18.76 29.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.769 ' CD1' HD11 ' A' ' 166' ' ' ILE . 27.2 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.228 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 166' ' ' ILE . 1.4 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.678 0.275 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.442 ' N ' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -46.79 -18.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.223 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 163' ' ' VAL . 7.1 mt-30 -84.46 10.89 9.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.124 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.794 HD11 ' CD1' ' A' ' 210' ' ' PHE . 7.4 mt -75.51 130.41 79.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.81 129.71 12.79 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.033 1.822 . . . . 0.0 111.082 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.32 -49.85 0.83 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.888 HG22 HD13 ' A' ' 207' ' ' ILE . 39.6 t -49.7 -44.35 19.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 79.8 80.91 0.78 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.6 pttt -43.13 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 170' ' ' GLY . 40.8 t -67.88 -48.68 74.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.116 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.651 ' O ' ' N ' ' A' ' 176' ' ' LEU . 4.3 tttp -77.96 -34.85 50.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.796 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -29.12 -59.98 0.24 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.41 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 18.8 Cg_endo -60.99 -32.47 92.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.36 2.04 . . . . 0.0 111.645 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 173' ' ' LYS . 12.7 tp -70.42 -56.81 5.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.458 0.647 . . . . 0.0 109.829 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.706 ' CD2' HD13 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -70.53 -18.34 62.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.204 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 181' ' ' PHE . 5.8 tp -55.85 -43.55 77.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.256 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -56.39 -20.64 20.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.382 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -99.17 -17.57 18.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.692 ' O ' HD12 ' A' ' 178' ' ' LEU . 68.0 m-85 -136.79 150.4 69.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.623 ' O ' ' CD1' ' A' ' 178' ' ' LEU . 88.1 Cg_exo -37.34 -79.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.044 2.496 . . . . 0.0 112.814 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.3 OUTLIER -163.29 171.58 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.672 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.623 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -38.91 -17.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.899 0.38 . . . . 0.0 110.103 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.671 ' N ' ' O ' ' A' ' 183' ' ' SER . 1.5 tm0? -67.35 -62.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.55 HE21 HD22 ' A' ' 189' ' ' ASN . 21.5 tp60 -88.22 -34.85 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.24 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -45.36 -56.96 4.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.483 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 38.9 m -59.88 -4.72 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.55 HD22 HE21 ' A' ' 186' ' ' GLN . 25.9 t30 -113.95 2.03 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.683 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -47.57 154.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -46.81 154.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.4 mm -65.49 -50.83 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.557 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -48.96 -47.23 32.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 198' ' ' VAL . 2.8 mm-40 -64.29 -62.9 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.859 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.683 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 1.3 mt -57.1 -21.7 34.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.583 ' C ' ' H ' ' A' ' 198' ' ' VAL . 9.0 tt0 -79.5 -61.59 1.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.043 0.449 . . . . 0.0 110.823 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -67.76 7.52 0.5 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 194' ' ' GLU . 14.7 t -106.64 -37.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.131 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -144.19 -38.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.33 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.444 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.15 138.39 3.71 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.36 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -66.55 -38.76 87.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -78.34 -28.55 47.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 206' ' ' GLN . 13.6 t -70.01 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -48.81 -39.35 25.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.57 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -70.37 -25.4 63.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.663 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.503 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.13 -36.37 22.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.525 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.888 HD13 HG22 ' A' ' 169' ' ' VAL . 66.4 mt -65.79 -43.16 93.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.966 0.412 . . . . 0.0 110.203 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -63.68 -42.26 98.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.039 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.8 -18.4 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.814 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.794 ' CD1' HD11 ' A' ' 166' ' ' ILE . 42.6 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.873 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.525 HG13 HD12 ' A' ' 166' ' ' ILE . 2.1 t . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.691 0.282 . . . . 0.0 110.45 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -54.83 -21.44 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.47 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -83.14 0.35 45.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.57 HG22 HG23 ' A' ' 169' ' ' VAL . 4.4 mt -59.56 131.42 88.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.473 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.61 129.12 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.907 1.738 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.514 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 119.64 -50.77 0.8 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.868 HG22 HD13 ' A' ' 207' ' ' ILE . 15.7 t -49.51 -59.48 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.123 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 93.56 84.81 1.59 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 170' ' ' GLY . 28.7 pttt -42.75 -18.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 170' ' ' GLY . 26.1 t -68.17 -43.28 85.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.3 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 170' ' ' GLY . 18.5 tttt -91.9 -7.79 48.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.654 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -45.79 -59.73 4.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.62 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 33.3 Cg_endo -66.64 -32.6 37.98 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.581 2.187 . . . . 0.0 111.836 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.5 tp -66.84 -57.85 6.2 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.608 0.718 . . . . 0.0 110.71 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.954 HD22 HD13 ' A' ' 187' ' ' LEU . 5.6 tt -67.27 -30.11 69.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.847 HD23 ' C ' ' A' ' 178' ' ' LEU . 2.1 tt -57.83 -42.37 84.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.969 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.641 ' N ' HD23 ' A' ' 178' ' ' LEU . 10.5 pt20 -38.75 -32.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.157 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 178' ' ' LEU . 7.4 mtpt -92.85 -34.92 13.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.203 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.608 ' O ' ' O ' ' A' ' 178' ' ' LEU . 8.2 m-85 -112.76 149.21 40.85 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 110.892 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -35.3 -77.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.866 2.377 . . . . 0.0 112.496 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 57.0 p -162.71 173.5 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.813 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.615 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.73 -14.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.917 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 9.5 tt0 -69.53 -62.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 189' ' ' ASN . 20.4 tt0 -87.89 -34.46 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.955 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.954 HD13 HD22 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -45.32 -56.56 4.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.376 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.457 ' O ' HG22 ' A' ' 207' ' ' ILE . 3.8 m -59.27 -13.09 6.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.012 0.434 . . . . 0.0 110.256 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.676 ' ND2' ' O ' ' A' ' 189' ' ' ASN . 1.1 t-20 -103.97 2.65 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.651 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -51.01 157.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.53 135.78 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.664 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.406 HD11 ' CB ' ' A' ' 208' ' ' HIS . 48.0 mm -54.54 -47.3 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.364 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.19 -46.56 62.57 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 198' ' ' VAL . 4.3 mt-10 -63.9 -65.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.193 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.615 HD22 HD12 ' A' ' 207' ' ' ILE . 1.8 mt -50.05 -23.42 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.013 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 198' ' ' VAL . 10.8 tt0 -79.37 -61.11 2.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.717 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.24 4.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 194' ' ' GLU . 71.4 t -108.99 -35.03 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.34 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.523 ' CG1' HG11 ' A' ' 203' ' ' VAL . 1.0 OUTLIER -144.14 -39.24 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.942 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -179.57 138.5 3.48 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -67.07 -42.09 85.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.13 -21.38 54.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.457 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.523 HG11 ' CG1' ' A' ' 199' ' ' VAL . 41.3 t -78.4 -60.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.057 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -47.47 -31.5 4.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.685 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -81.13 -27.5 35.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -81.48 -23.42 37.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.868 HD13 HG22 ' A' ' 169' ' ' VAL . 65.0 mt -78.38 -36.02 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.51 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . 0.406 ' CB ' HD11 ' A' ' 192' ' ' ILE . 61.0 t-80 -80.69 -32.13 36.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.215 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.58 -18.78 30.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.564 ' CD2' HD11 ' A' ' 166' ' ' ILE . 41.7 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.242 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.754 0.311 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.52 ' C ' ' H ' ' A' ' 166' ' ' ILE . 8.3 pt20 -49.33 -31.69 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.04 12.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.097 0.475 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.629 HD11 ' CD1' ' A' ' 210' ' ' PHE . 4.5 mt -76.4 132.39 72.93 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.13 128.95 14.47 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.033 1.822 . . . . 0.0 110.856 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 118.49 -50.41 0.81 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.848 HG22 HD13 ' A' ' 207' ' ' ILE . 37.2 t -48.56 -49.64 13.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.103 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 173' ' ' LYS . . . 84.73 82.6 1.03 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' GLY . 25.1 pttt -42.96 -19.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 170' ' ' GLY . 65.8 t -70.46 -42.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.845 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 19.0 tttm -86.91 -12.62 47.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -43.97 -60.02 3.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.293 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 29.0 Cg_endo -65.66 -29.68 51.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.507 2.138 . . . . 0.0 111.788 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.49 HD23 ' HG3' ' A' ' 173' ' ' LYS . 39.9 tp -70.92 -57.92 4.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.587 0.708 . . . . 0.0 110.37 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.025 HD22 HD13 ' A' ' 187' ' ' LEU . 5.7 tt -67.69 -31.6 71.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.131 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.766 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -55.61 -21.35 17.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.675 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.522 ' N ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -61.94 -26.89 68.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -97.53 -18.03 19.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 178' ' ' LEU . 35.2 m-85 -132.88 150.92 77.01 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -38.56 -74.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.213 2.609 . . . . 0.0 112.944 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 1.3 t -160.51 169.33 23.2 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.066 0.46 . . . . 0.0 111.298 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.727 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.65 -15.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.731 -179.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 5.6 tt0 -66.53 -63.59 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -89.41 -31.26 17.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.173 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 1.025 HD13 HD22 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -48.09 -55.22 10.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.631 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.676 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.0 OUTLIER -62.58 -17.67 60.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.721 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -101.39 8.09 42.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.511 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.606 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -49.77 154.51 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -45.2 146.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.568 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 30.7 mm -59.49 -43.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -57.88 -50.41 66.03 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.846 ' O ' HG23 ' A' ' 198' ' ' VAL . 39.3 mt-10 -62.28 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.727 0.299 . . . . 0.0 110.598 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.606 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 3.4 mt -53.0 -21.42 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.56 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 198' ' ' VAL . 11.5 tt0 -77.84 -61.23 2.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -68.14 5.22 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 194' ' ' GLU . 71.9 t -108.59 -36.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.365 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -143.34 -39.09 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.705 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.84 136.7 2.96 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.472 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -47.75 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -72.77 -36.92 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.439 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.527 HG11 ' CG1' ' A' ' 199' ' ' VAL . 23.5 t -58.37 -61.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.444 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.92 -34.01 26.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.79 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -69.94 -27.14 64.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.76 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 1.0 OUTLIER -84.23 -55.98 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.422 . . . . 0.0 110.545 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.848 HD13 HG22 ' A' ' 169' ' ' VAL . 26.8 mt -48.52 -28.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.906 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -80.69 -32.6 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.88 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.45 -22.49 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.589 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.629 ' CD1' HD11 ' A' ' 166' ' ' ILE . 32.4 t80 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.825 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.529 HG13 HD12 ' A' ' 166' ' ' ILE . 1.8 t . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.761 0.315 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -18.97 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.708 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -83.27 2.36 36.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.831 HD11 ' CD1' ' A' ' 210' ' ' PHE . 6.1 mt -67.11 131.2 93.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.433 ' O ' ' NE2' ' A' ' 206' ' ' GLN . 30.5 Cg_endo -68.14 128.66 17.94 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.52 1.48 . . . . 0.0 110.351 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.404 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 118.89 -49.97 0.84 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.466 HG23 ' H ' ' A' ' 169' ' ' VAL . 2.0 t -49.29 -57.58 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.812 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 99.94 87.28 1.94 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.2 pttt -43.2 -19.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.9 t -72.27 -45.12 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.2 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.2 tttm -87.24 -17.53 32.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.829 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -35.53 -58.77 0.78 Allowed Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.307 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 53.5 Cg_endo -72.5 -36.26 5.36 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.686 2.258 . . . . 0.0 111.451 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 176' ' ' LEU . 15.0 tp -60.7 -57.61 11.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.247 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.893 ' O ' HD23 ' A' ' 177' ' ' LEU . 3.0 tt -65.69 -31.63 72.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -51.53 -14.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.167 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -79.05 -35.24 42.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.063 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -85.13 -6.93 59.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.652 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.644 ' CZ ' ' HB1' ' A' ' 190' ' ' ALA . 38.6 m-85 -147.29 153.56 44.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.664 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -38.27 -73.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.097 2.531 . . . . 0.0 112.836 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -160.79 168.93 23.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.419 HG23 ' H ' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -39.13 -26.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 183' ' ' SER . 7.6 tt0 -63.19 -56.34 17.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.5 tp60 -87.39 -38.81 15.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.999 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.36 -50.67 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.142 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.482 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 22.9 p -64.16 -17.84 63.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.526 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.512 ' O ' ' OD1' ' A' ' 189' ' ' ASN . 48.7 t-20 -106.12 1.2 26.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.644 ' HB1' ' CZ ' ' A' ' 181' ' ' PHE . . . -44.24 159.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.415 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.1 p -52.29 137.76 28.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.534 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.2 mm -54.92 -43.59 69.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.681 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.0 -33.87 45.14 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.885 ' O ' HG23 ' A' ' 198' ' ' VAL . 67.5 mm-40 -81.78 -65.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.645 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.438 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 2.4 mt -47.86 -29.53 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.867 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 198' ' ' VAL . 2.5 tm-20 -72.54 -61.01 1.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.897 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.511 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 7.1 pt20 -67.76 6.76 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 194' ' ' GLU . 72.7 t -106.24 -38.94 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.79 -39.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.361 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.57 139.25 3.98 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.266 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.445 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 37.7 tt0 -65.27 -44.72 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.69 -31.2 64.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.465 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 206' ' ' GLN . 18.6 t -68.31 -61.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.884 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.438 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -46.96 -33.48 4.69 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -81.4 -23.47 37.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.992 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 203' ' ' VAL . 4.1 pt20 -83.23 -31.56 26.94 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.557 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.37 -50.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.102 0.477 . . . . 0.0 110.007 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -54.21 -35.72 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.894 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.5 -20.68 27.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.831 ' CD1' HD11 ' A' ' 166' ' ' ILE . 27.0 t80 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 166' ' ' ILE . 2.4 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.654 0.264 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -53.05 -22.58 6.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.827 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -80.61 13.51 2.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.631 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.8 mt -78.15 130.44 72.32 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.869 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.74 129.2 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.897 1.732 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.46 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 120.65 -51.45 0.78 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.819 HG22 HD13 ' A' ' 207' ' ' ILE . 63.6 t -49.39 -45.66 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.945 0.402 . . . . 0.0 110.112 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 82.21 81.1 0.92 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.37 -19.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 170' ' ' GLY . 46.4 t -66.91 -44.68 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.069 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 176' ' ' LEU . 2.7 ttmm -84.06 -32.49 24.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.739 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -28.27 -62.69 0.19 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.425 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.739 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -55.51 -36.4 94.23 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.245 1.963 . . . . 0.0 111.115 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.679 ' N ' ' O ' ' A' ' 173' ' ' LYS . 19.5 tp -77.74 -57.01 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.555 0.693 . . . . 0.0 109.54 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.054 HD23 HD11 ' A' ' 187' ' ' LEU . 23.6 tp -59.98 -18.59 46.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.095 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.875 HD23 ' C ' ' A' ' 178' ' ' LEU . 1.0 OUTLIER -73.58 -38.24 65.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.16 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.683 ' N ' HD23 ' A' ' 178' ' ' LEU . 22.5 mt-30 -47.02 -20.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.326 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.405 ' N ' ' C ' ' A' ' 178' ' ' LEU . 6.2 mmtt -101.38 -26.5 13.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 178' ' ' LEU . 21.6 m-85 -126.23 148.53 63.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -36.79 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.199 2.6 . . . . 0.0 113.31 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.7 OUTLIER -157.17 168.18 28.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.021 -179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.774 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -39.52 -16.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 183' ' ' SER . 1.9 tp-100 -66.33 -62.95 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -88.09 -32.3 18.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.034 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 1.054 HD11 HD23 ' A' ' 177' ' ' LEU . 0.3 OUTLIER -49.89 -54.03 22.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.632 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.671 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.8 OUTLIER -68.94 -12.61 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 110.417 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -107.72 6.51 27.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.645 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 195' ' ' LEU . . . -53.87 163.26 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.557 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.1 t -43.98 159.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.698 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 50.3 mm -76.33 -42.96 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.625 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.8 -37.16 92.06 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.9 ' O ' HG23 ' A' ' 198' ' ' VAL . 16.4 mt-10 -69.34 -65.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.771 0.32 . . . . 0.0 110.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.503 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 0.8 OUTLIER -57.52 -22.62 45.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 198' ' ' VAL . 3.8 tm-20 -74.11 -60.39 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.494 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -66.77 2.9 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.565 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 194' ' ' GLU . 45.3 t -96.94 -48.9 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.07 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 203' ' ' VAL . 0.4 OUTLIER -134.62 -39.62 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.679 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 199' ' ' VAL . . . -178.79 143.27 5.77 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.947 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 205' ' ' GLN . 12.6 tt0 -65.66 -36.36 83.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -71.56 -43.34 66.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.563 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 199' ' ' VAL . 46.6 t -58.44 -61.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.531 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.503 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.27 -27.3 5.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.644 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.431 ' CG ' ' O ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -80.0 -25.32 40.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.291 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.9 mt-30 -84.48 -43.09 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.819 HD13 HG22 ' A' ' 169' ' ' VAL . 17.3 mt -63.19 -48.99 85.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.877 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . 0.474 ' CB ' HD11 ' A' ' 192' ' ' ILE . 60.7 t-80 -58.9 -37.03 75.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -81.82 -27.2 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.631 ' CD2' HD11 ' A' ' 166' ' ' ILE . 14.1 t80 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.523 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.613 ' C ' ' H ' ' A' ' 165' ' ' GLN . 14.5 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.636 0.255 . . . . 0.0 110.782 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.674 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 0.1 OUTLIER -47.89 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.74 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.674 ' N ' ' OE1' ' A' ' 164' ' ' GLN . 20.5 mt-30 -94.29 3.93 54.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.43 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.998 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.3 mt -71.81 131.14 86.1 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.86 129.12 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.794 1.663 . . . . 0.0 110.899 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 -49.64 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.886 HG22 HD13 ' A' ' 207' ' ' ILE . 22.6 t -53.79 -37.55 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.999 0.428 . . . . 0.0 110.205 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 75.35 82.65 0.45 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -42.83 -19.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 170' ' ' GLY . 49.9 t -68.14 -51.6 46.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.091 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 174' ' ' ALA . 21.7 tttm -75.67 -29.27 59.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.785 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.765 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -29.3 -64.68 0.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.669 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.765 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 18.5 Cg_endo -61.28 -36.33 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.542 2.161 . . . . 0.0 111.657 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 173' ' ' LYS . 43.3 tp -64.12 -57.32 9.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.734 HD22 HD13 ' A' ' 187' ' ' LEU . 1.4 tt -68.84 -28.25 66.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.592 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.863 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.8 OUTLIER -55.17 -39.03 69.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.909 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.751 ' N ' HD23 ' A' ' 178' ' ' LEU . 76.4 mt-30 -45.04 -30.29 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.993 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -100.24 -17.9 17.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.261 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' A' ' 178' ' ' LEU . 62.6 m-85 -124.73 149.05 61.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 111.006 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -37.57 -78.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.677 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.56 167.03 23.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.905 0.383 . . . . 0.0 111.079 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.737 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.58 -13.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.811 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.677 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.0 OUTLIER -72.1 -60.96 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 189' ' ' ASN . 46.8 tt0 -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.026 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.89 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.84 -50.17 14.53 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.397 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.53 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.8 OUTLIER -62.45 -10.79 12.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 186' ' ' GLN . 40.6 t30 -111.63 4.69 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.711 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 181' ' ' PHE . . . -46.45 158.11 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.372 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.82 131.37 15.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 30.9 mm -47.88 -50.61 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -45.63 -42.86 10.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 198' ' ' VAL . 5.1 mm-40 -73.02 -62.05 1.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.873 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.485 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.8 mt -53.84 -25.41 19.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.907 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.64 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 2.6 tm-20 -78.21 -60.75 2.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 110.836 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.64 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 1.6 pt20 -67.1 3.52 1.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 196' ' ' GLU . 3.4 t -103.74 -37.67 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.094 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.615 ' CG1' HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -144.07 -38.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.749 -178.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.48 138.25 3.59 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.578 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.452 ' NE2' ' HG3' ' A' ' 196' ' ' GLU . 3.9 tp-100 -58.79 -52.53 65.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.11 84.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.736 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.615 HG11 ' CG1' ' A' ' 199' ' ' VAL . 21.0 t -53.87 -60.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.276 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -52.14 -29.17 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.799 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.89 -27.61 43.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.401 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 210' ' ' PHE . 1.2 mt-30 -80.49 -51.37 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.111 0.482 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.886 HD13 HG22 ' A' ' 169' ' ' VAL . 25.3 mt -52.75 -34.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.669 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -71.56 -40.92 69.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -84.17 -18.47 36.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.998 ' CD2' HD11 ' A' ' 166' ' ' ILE . 69.6 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.202 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 166' ' ' ILE . 3.4 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.74 0.305 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 165' ' ' GLN . 9.3 pt20 -46.58 -27.55 1.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.438 ' N ' ' HG3' ' A' ' 164' ' ' GLN . 10.5 mt-30 -76.37 8.5 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.424 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.781 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.1 mt -69.43 131.54 90.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.589 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.98 129.53 14.37 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.876 1.717 . . . . 0.0 110.822 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.488 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 117.91 -49.71 0.85 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 207' ' ' ILE . 17.6 t -54.79 -45.97 74.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 109.96 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 85.68 83.89 1.06 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.5 OUTLIER -43.03 -19.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 170' ' ' GLY . 63.9 t -71.22 -55.7 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.917 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 174' ' ' ALA . 0.3 OUTLIER -71.71 -29.0 64.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.439 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.795 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -29.32 -64.83 0.18 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.795 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 11.0 Cg_endo -57.13 -45.38 35.96 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.703 2.269 . . . . 0.0 111.495 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 173' ' ' LYS . 21.3 tp -54.27 -57.24 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.507 0.67 . . . . 0.0 110.399 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.795 HD22 HD13 ' A' ' 187' ' ' LEU . 1.8 tt -72.35 -17.68 61.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.679 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -59.47 -30.74 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -62.28 -21.79 65.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -96.86 -22.29 16.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.122 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 178' ' ' LEU . 48.1 m-85 -132.32 150.21 75.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -36.77 -76.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.997 2.464 . . . . 0.0 112.65 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.678 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.59 171.26 17.22 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.015 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.565 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.38 -15.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 -179.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.678 ' N ' ' O ' ' A' ' 183' ' ' SER . 24.0 tt0 -70.78 -60.21 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 189' ' ' ASN . 1.3 tt0 -87.99 -34.46 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.025 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.909 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.33 -51.02 11.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.25 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 207' ' ' ILE . 54.5 m -61.68 -15.02 36.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.301 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 186' ' ' GLN . 5.3 t-20 -105.51 12.22 31.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.083 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -53.71 149.55 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.31 128.7 4.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.653 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.2 mm -48.26 -49.17 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -50.72 -35.94 31.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 198' ' ' VAL . 18.4 mt-10 -77.8 -64.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.697 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 1.7 mt -51.4 -23.91 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.606 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.629 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 3.2 tm-20 -79.73 -60.98 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.629 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 0.8 OUTLIER -66.44 3.67 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 196' ' ' GLU . 13.4 t -104.06 -37.54 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.131 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -143.67 -39.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.436 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.89 139.08 3.83 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.413 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.437 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 6.5 tp-100 -63.71 -40.63 97.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.35 68.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.872 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 199' ' ' VAL . 29.8 t -63.83 -61.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.209 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.07 -33.37 18.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.734 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -78.46 -26.37 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.927 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.498 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.69 -36.18 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.649 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 169' ' ' VAL . 72.3 mt -65.34 -43.35 94.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.088 0.47 . . . . 0.0 109.959 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -66.99 -35.41 79.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.703 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.2 -18.42 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.781 ' CD2' HD11 ' A' ' 166' ' ' ILE . 45.1 t80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.491 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.821 HG13 HD12 ' A' ' 166' ' ' ILE . 2.9 t . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.64 0.257 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.56 -22.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.628 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -84.94 10.32 12.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.299 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.821 HD12 HG13 ' A' ' 163' ' ' VAL . 4.5 mt -70.21 132.01 88.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.04 129.17 16.85 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.021 1.814 . . . . 0.0 111.247 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.64 -47.86 1.0 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.839 HG22 HD13 ' A' ' 207' ' ' ILE . 93.9 t -50.64 -46.31 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.232 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 81.2 82.12 0.82 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.522 ' CB ' ' NZ ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -42.75 -18.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 43.8 t -66.9 -42.04 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.013 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.8 tttt -87.6 -22.25 24.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.672 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.793 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -33.93 -61.83 0.39 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.597 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 24.4 Cg_endo -63.69 -37.42 46.48 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.603 2.202 . . . . 0.0 111.707 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.473 HD23 ' HG3' ' A' ' 173' ' ' LYS . 22.0 tp -59.26 -56.68 19.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.562 0.696 . . . . 0.0 110.562 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.051 HD22 HD13 ' A' ' 187' ' ' LEU . 5.9 tt -74.47 -28.2 60.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.722 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.8 tt -50.32 -17.87 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.847 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 179' ' ' GLN . 9.2 mm100 -78.04 -36.55 48.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.826 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -82.39 -18.62 41.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 178' ' ' LEU . 20.9 m-85 -131.82 154.34 81.74 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.194 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -36.62 -76.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.841 2.361 . . . . 0.0 112.462 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 68.8 m -162.8 169.4 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.789 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.712 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.54 -14.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.481 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.1 OUTLIER -73.26 -60.91 2.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -87.7 -26.66 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.088 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 1.051 HD13 HD22 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -55.11 -53.93 49.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.51 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.495 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.4 t -64.32 -19.99 65.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.086 0.469 . . . . 0.0 110.13 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.571 ' O ' ' OD1' ' A' ' 189' ' ' ASN . 22.8 t-20 -104.05 11.09 35.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.927 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.504 ' HB1' ' CE2' ' A' ' 181' ' ' PHE . . . -57.87 163.59 2.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.635 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.1 p -51.25 131.86 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.703 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.4 mm -49.46 -49.82 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.791 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -47.48 -46.93 23.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.896 ' O ' HG23 ' A' ' 198' ' ' VAL . 64.1 mm-40 -66.68 -66.12 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.647 0.261 . . . . 0.0 110.56 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.458 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.7 mt -49.4 -25.53 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.686 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 198' ' ' VAL . 4.3 tt0 -73.29 -60.93 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -69.03 6.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.926 HG11 HD12 ' A' ' 177' ' ' LEU . 89.7 t -108.71 -36.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.505 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.82 -38.98 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.606 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.53 137.48 3.29 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.263 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.73 -45.89 87.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.29 59.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.58 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 206' ' ' GLN . 19.7 t -68.08 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.094 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -47.68 -31.05 4.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.852 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.62 -26.48 41.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -84.76 -32.98 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.839 HD13 HG22 ' A' ' 169' ' ' VAL . 63.3 mt -68.46 -34.02 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -71.99 -41.58 67.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.137 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -76.11 -29.71 57.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.708 ' CD1' HD11 ' A' ' 166' ' ' ILE . 9.2 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 166' ' ' ILE . 2.7 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.833 0.349 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.48 -12.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -96.12 4.39 52.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.522 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.805 HD11 ' CD1' ' A' ' 210' ' ' PHE . 3.6 mt -56.52 115.76 10.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.556 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.28 129.57 29.36 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.788 1.658 . . . . 0.0 111.288 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 110.72 -46.26 1.2 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 207' ' ' ILE . 4.1 t -48.86 -55.2 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.333 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 83.83 82.33 0.98 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.83 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 170' ' ' GLY . 48.6 t -64.14 -41.81 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.945 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -85.86 -31.12 22.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.888 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -29.07 -65.13 0.17 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 18.7 Cg_endo -60.77 -33.42 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.561 2.174 . . . . 0.0 111.691 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 173' ' ' LYS . 53.9 tp -67.9 -56.47 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.605 0.717 . . . . 0.0 109.734 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.668 ' CD2' HD13 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -72.47 -17.06 61.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.233 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.624 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.7 tt -52.59 -54.16 36.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.435 ' N ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -48.48 -23.91 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.533 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 179' ' ' GLN . 49.2 mttp -88.91 -16.15 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.869 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.624 ' O ' ' O ' ' A' ' 178' ' ' LEU . 95.3 m-85 -148.6 145.73 20.75 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 121.003 0.43 . . . . 0.0 110.922 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 181' ' ' PHE . 80.8 Cg_exo -31.82 -78.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.17 2.58 . . . . 0.0 112.87 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.2 OUTLIER -163.11 175.8 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.857 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.78 -14.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.516 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.685 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.5 OUTLIER -69.29 -62.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.1 tt0 -88.37 -33.26 18.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.033 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -46.06 -52.07 12.61 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.234 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.824 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.4 OUTLIER -65.63 -3.69 5.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.51 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 186' ' ' GLN . 49.1 t-20 -121.98 3.98 9.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.63 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -48.71 161.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.487 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.43 140.7 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -62.51 -47.54 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.528 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -52.41 -28.53 28.41 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 198' ' ' VAL . 4.2 mm-40 -81.87 -64.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.782 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.63 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 0.7 OUTLIER -52.58 -30.21 29.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.807 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 198' ' ' VAL . 15.1 tt0 -72.39 -61.09 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.49 4.25 1.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 194' ' ' GLU . 25.4 t -108.78 -35.58 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -143.01 -39.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.551 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.447 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -179.69 138.03 3.29 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.445 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -63.79 -43.5 96.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.97 -32.88 69.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.545 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 199' ' ' VAL . 48.6 t -66.3 -61.68 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.473 ' HB2' ' N ' ' A' ' 196' ' ' GLU . . . -50.69 -29.97 12.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.491 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -81.09 -28.01 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.813 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 210' ' ' PHE . 3.4 pt20 -84.44 -42.77 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.599 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 188' ' ' SER . 65.4 mt -58.62 -42.5 85.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -66.72 -42.63 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.0 -18.57 32.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.038 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.805 ' CD1' HD11 ' A' ' 166' ' ' ILE . 6.5 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.035 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.799 0.333 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.89 150.26 36.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.685 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.541 ' O ' ' CD2' ' A' ' 160' ' ' LEU . 39.3 Cg_endo -70.93 122.17 8.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.747 2.298 . . . . 0.0 111.944 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.586 ' O ' ' N ' ' A' ' 162' ' ' THR . 50.8 p -80.33 -20.67 43.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.88 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.914 ' O ' HG13 ' A' ' 163' ' ' VAL . 6.3 tp -38.03 -28.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.087 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 157' ' ' PRO . 0.9 OUTLIER -83.52 -41.75 17.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.099 0.476 . . . . 0.0 109.988 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 158' ' ' SER . 13.6 ttm180 -79.16 -15.86 57.47 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.586 ' N ' ' O ' ' A' ' 158' ' ' SER . 18.6 m -85.57 -47.24 10.05 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.496 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.914 HG13 ' O ' ' A' ' 159' ' ' LEU . 33.2 m -66.04 -45.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.829 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.54 ' N ' HG23 ' A' ' 163' ' ' VAL . 1.8 pt20 -49.55 -21.38 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.641 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -83.45 2.6 35.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.042 0.448 . . . . 0.0 110.336 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.769 HD11 ' CD1' ' A' ' 210' ' ' PHE . 5.8 mt -66.59 130.16 94.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.32 128.99 16.27 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.648 1.566 . . . . 0.0 110.684 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.502 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 120.87 -51.57 0.77 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.887 HG22 HD13 ' A' ' 207' ' ' ILE . 17.0 t -49.57 -49.73 18.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.207 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 88.19 83.0 1.24 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.55 -19.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.6 t -69.74 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.051 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 170' ' ' GLY . 22.6 tttm -85.96 -19.19 30.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.476 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -35.39 -58.54 0.78 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.534 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 41.1 Cg_endo -71.02 -29.11 18.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.534 2.156 . . . . 0.0 111.847 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.48 HD23 ' HG3' ' A' ' 173' ' ' LYS . 31.8 tp -70.55 -57.48 4.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.552 0.691 . . . . 0.0 110.306 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.026 HD22 HD13 ' A' ' 187' ' ' LEU . 5.1 tt -67.68 -21.98 65.31 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.541 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.854 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.6 OUTLIER -68.56 -42.34 78.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.928 179.533 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.851 ' N ' HD23 ' A' ' 178' ' ' LEU . 9.5 mm-40 -42.37 -28.32 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.097 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.406 ' N ' ' C ' ' A' ' 178' ' ' LEU . 17.8 mttt -100.34 -15.77 17.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.136 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.611 ' O ' ' O ' ' A' ' 178' ' ' LEU . 18.7 m-85 -128.74 152.77 79.35 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.019 0.437 . . . . 0.0 111.035 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -38.88 -77.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.884 2.389 . . . . 0.0 112.523 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 69.2 m -162.45 166.26 25.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.734 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.3 -16.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.776 -179.428 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 16.3 tt0 -72.24 -57.91 3.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -87.51 -35.35 18.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.74 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 1.026 HD13 HD22 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -48.78 -52.28 24.71 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.284 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.532 ' OG ' ' O ' ' A' ' 184' ' ' ILE . 3.4 p -61.36 -13.0 16.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.717 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.596 ' ND2' ' CZ ' ' A' ' 211' ' ' PHE . 24.2 t-20 -109.08 10.13 26.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.425 ' CB ' ' CE2' ' A' ' 181' ' ' PHE . . . -56.8 150.25 16.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.395 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.57 ' CB ' ' OE1' ' A' ' 194' ' ' GLU . 0.8 OUTLIER -44.89 136.67 4.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.658 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 208' ' ' HIS . 31.0 mm -52.13 -52.03 26.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.2 3.41 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.606 ' O ' HG23 ' A' ' 198' ' ' VAL . 8.2 mt-10 -81.82 -61.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.714 0.292 . . . . 0.0 110.719 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.44 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.0 mt -53.44 -32.84 51.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.842 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 198' ' ' VAL . 8.8 tt0 -71.71 -61.2 1.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.458 HE21 ' HA ' ' A' ' 197' ' ' GLN . 0.9 OUTLIER -66.48 7.27 0.35 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.652 HG11 HD12 ' A' ' 177' ' ' LEU . 5.1 t -108.89 -36.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.58 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.679 HG11 HG11 ' A' ' 203' ' ' VAL . 0.5 OUTLIER -143.89 -38.6 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 119.531 -0.868 . . . . 0.0 112.457 -179.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.44 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.49 139.11 3.93 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 119.882 -1.152 . . . . 0.0 112.402 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -61.69 -46.1 91.13 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.42 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -70.62 -42.49 70.87 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.679 HG11 HG11 ' A' ' 199' ' ' VAL . 40.0 t -53.54 -61.44 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.277 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.528 ' O ' ' CD1' ' A' ' 192' ' ' ILE . . . -53.65 -29.21 37.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.928 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -24.64 48.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.997 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.42 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.8 mt-30 -81.35 -53.75 6.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.021 0.438 . . . . 0.0 110.452 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.887 HD13 HG22 ' A' ' 169' ' ' VAL . 16.9 mt -55.64 -28.9 24.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.66 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.595 ' HB2' HD11 ' A' ' 192' ' ' ILE . 86.4 t60 -71.67 -43.0 66.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.843 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.12 -18.76 29.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.002 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.769 ' CD1' HD11 ' A' ' 166' ' ' ILE . 27.2 t80 -58.05 -60.88 3.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.228 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.688 ' CE2' ' O ' ' A' ' 207' ' ' ILE . 13.5 p90 -73.92 -8.4 55.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.139 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 93.1 m -65.11 -38.28 90.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.486 -0.485 . . . . 0.0 109.81 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.14 97.56 50.58 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.813 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -64.69 115.85 3.46 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.222 1.948 . . . . 0.0 111.911 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.495 -179.965 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.772 0.32 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.45 147.11 34.64 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.464 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -66.14 104.91 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.754 2.302 . . . . 0.0 111.959 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -64.08 -25.38 68.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.653 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.65 -30.26 5.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.345 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.72 HD11 HD11 ' A' ' 184' ' ' ILE . 0.7 OUTLIER -82.76 -63.09 1.44 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.453 ' N ' HD23 ' A' ' 160' ' ' LEU . 38.2 mtp85 -56.59 -17.34 8.25 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 158' ' ' SER . 98.8 m -85.6 -25.85 26.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.893 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 166' ' ' ILE . 1.4 t -74.78 -53.06 17.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.298 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.442 ' N ' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -46.79 -18.7 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.223 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.452 ' N ' ' C ' ' A' ' 163' ' ' VAL . 7.1 mt-30 -84.46 10.89 9.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.124 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.794 HD11 ' CD1' ' A' ' 210' ' ' PHE . 7.4 mt -75.51 130.41 79.6 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.835 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.81 129.71 12.79 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.033 1.822 . . . . 0.0 111.082 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.32 -49.85 0.83 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.888 HG22 HD13 ' A' ' 207' ' ' ILE . 39.6 t -49.7 -44.35 19.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.581 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 79.8 80.91 0.78 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.6 pttt -43.13 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 170' ' ' GLY . 40.8 t -67.88 -48.68 74.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.116 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.651 ' O ' ' N ' ' A' ' 176' ' ' LEU . 4.3 tttp -77.96 -34.85 50.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.796 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.704 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -29.12 -59.98 0.24 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.41 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.704 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 18.8 Cg_endo -60.99 -32.47 92.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.36 2.04 . . . . 0.0 111.645 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.651 ' N ' ' O ' ' A' ' 173' ' ' LYS . 12.7 tp -70.42 -56.81 5.73 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.458 0.647 . . . . 0.0 109.829 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.706 ' CD2' HD13 ' A' ' 187' ' ' LEU . 0.8 OUTLIER -70.53 -18.34 62.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.204 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 181' ' ' PHE . 5.8 tp -55.85 -43.55 77.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.256 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -56.39 -20.64 20.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.382 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.5 mtpt -99.17 -17.57 18.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.692 ' O ' HD12 ' A' ' 178' ' ' LEU . 68.0 m-85 -136.79 150.4 69.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.88 0.371 . . . . 0.0 110.786 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.623 ' O ' ' CD1' ' A' ' 178' ' ' LEU . 88.1 Cg_exo -37.34 -79.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.044 2.496 . . . . 0.0 112.814 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.3 OUTLIER -163.29 171.58 15.95 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.672 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.72 HD11 HD11 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -38.91 -17.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.899 0.38 . . . . 0.0 110.103 -179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.671 ' N ' ' O ' ' A' ' 183' ' ' SER . 1.5 tm0? -67.35 -62.04 1.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.55 HE21 HD22 ' A' ' 189' ' ' ASN . 21.5 tp60 -88.22 -34.85 17.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.24 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.2 OUTLIER -45.36 -56.96 4.4 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.553 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.483 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 38.9 m -59.88 -4.72 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.498 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.55 HD22 HE21 ' A' ' 186' ' ' GLN . 25.9 t30 -113.95 2.03 14.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.683 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -47.57 154.37 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.521 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -46.81 154.18 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.548 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 29.4 mm -65.49 -50.83 69.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.557 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -48.96 -47.23 32.21 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.709 ' O ' HG23 ' A' ' 198' ' ' VAL . 2.8 mm-40 -64.29 -62.9 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 0.0 110.859 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.683 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 1.3 mt -57.1 -21.7 34.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.583 ' C ' ' H ' ' A' ' 198' ' ' VAL . 9.0 tt0 -79.5 -61.59 1.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.043 0.449 . . . . 0.0 110.823 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -67.76 7.52 0.5 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 194' ' ' GLU . 14.7 t -106.64 -37.43 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.131 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -144.19 -38.95 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.33 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.444 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.15 138.39 3.71 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.36 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -66.55 -38.76 87.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -78.34 -28.55 47.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.468 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 206' ' ' GLN . 13.6 t -70.01 -61.29 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.17 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -48.81 -39.35 25.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.57 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -70.37 -25.4 63.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.663 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.503 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.13 -36.37 22.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.525 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.888 HD13 HG22 ' A' ' 169' ' ' VAL . 66.4 mt -65.79 -43.16 93.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.966 0.412 . . . . 0.0 110.203 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.474 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 8.9 t60 -63.68 -42.26 98.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.039 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.8 -18.4 37.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.814 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.794 ' CD1' HD11 ' A' ' 166' ' ' ILE . 42.6 t80 -56.12 -60.05 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.873 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 208' ' ' HIS . 25.7 p90 -78.29 -5.51 52.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.053 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 41.1 m -65.11 -37.59 87.96 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -118.53 97.66 50.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.636 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 215' ' ' ARG . 8.2 Cg_exo -65.0 117.48 4.58 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.221 1.947 . . . . 0.0 111.996 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 214' ' ' PRO . 37.4 mtm180 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.67 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.713 0.292 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.02 159.41 30.08 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.507 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.02 140.69 25.69 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.866 2.377 . . . . 0.0 112.367 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.659 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -68.92 -39.74 79.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.553 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.721 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -35.58 -23.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.464 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.771 HD11 HD11 ' A' ' 184' ' ' ILE . 0.7 OUTLIER -82.74 -63.39 1.38 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.52 ' N ' HD23 ' A' ' 160' ' ' LEU . 8.2 ttt-85 -55.73 -21.73 20.23 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.5 m -85.78 -33.63 21.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.213 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 159' ' ' LEU . 2.1 t -64.64 -46.46 92.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.45 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -54.83 -21.44 11.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.47 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -83.14 0.35 45.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.448 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.57 HG22 HG23 ' A' ' 169' ' ' VAL . 4.4 mt -59.56 131.42 88.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.473 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -72.61 129.12 14.21 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.907 1.738 . . . . 0.0 110.884 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.514 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 119.64 -50.77 0.8 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.868 HG22 HD13 ' A' ' 207' ' ' ILE . 15.7 t -49.51 -59.48 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.095 0.474 . . . . 0.0 110.123 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 93.56 84.81 1.59 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 170' ' ' GLY . 28.7 pttt -42.75 -18.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 170' ' ' GLY . 26.1 t -68.17 -43.28 85.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.3 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 170' ' ' GLY . 18.5 tttt -91.9 -7.79 48.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.654 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -45.79 -59.73 4.29 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.62 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 33.3 Cg_endo -66.64 -32.6 37.98 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.581 2.187 . . . . 0.0 111.836 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 25.5 tp -66.84 -57.85 6.2 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 121.608 0.718 . . . . 0.0 110.71 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.954 HD22 HD13 ' A' ' 187' ' ' LEU . 5.6 tt -67.27 -30.11 69.91 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.847 HD23 ' C ' ' A' ' 178' ' ' LEU . 2.1 tt -57.83 -42.37 84.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.969 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.641 ' N ' HD23 ' A' ' 178' ' ' LEU . 10.5 pt20 -38.75 -32.87 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.157 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 178' ' ' LEU . 7.4 mtpt -92.85 -34.92 13.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.203 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.608 ' O ' ' O ' ' A' ' 178' ' ' LEU . 8.2 m-85 -112.76 149.21 40.85 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.925 0.393 . . . . 0.0 110.892 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -35.3 -77.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.866 2.377 . . . . 0.0 112.496 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 57.0 p -162.71 173.5 13.76 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.813 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.771 HD11 HD11 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -39.73 -14.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.917 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 9.5 tt0 -69.53 -62.66 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 189' ' ' ASN . 20.4 tt0 -87.89 -34.46 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.955 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.954 HD13 HD22 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -45.32 -56.56 4.79 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.376 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.457 ' O ' HG22 ' A' ' 207' ' ' ILE . 3.8 m -59.27 -13.09 6.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.012 0.434 . . . . 0.0 110.256 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.676 ' ND2' ' O ' ' A' ' 189' ' ' ASN . 1.1 t-20 -103.97 2.65 32.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.651 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -51.01 157.21 0.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.53 135.78 10.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.664 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.406 HD11 ' CB ' ' A' ' 208' ' ' HIS . 48.0 mm -54.54 -47.3 71.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.364 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.19 -46.56 62.57 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 198' ' ' VAL . 4.3 mt-10 -63.9 -65.26 0.7 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 0.0 110.193 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.615 HD22 HD12 ' A' ' 207' ' ' ILE . 1.8 mt -50.05 -23.42 2.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.013 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 198' ' ' VAL . 10.8 tt0 -79.37 -61.11 2.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.717 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -67.24 4.71 0.87 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 194' ' ' GLU . 71.4 t -108.99 -35.03 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.34 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.523 ' CG1' HG11 ' A' ' 203' ' ' VAL . 1.0 OUTLIER -144.14 -39.24 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.942 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -179.57 138.5 3.48 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 119.764 -1.208 . . . . 0.0 112.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -67.07 -42.09 85.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.13 -21.38 54.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.457 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.523 HG11 ' CG1' ' A' ' 199' ' ' VAL . 41.3 t -78.4 -60.76 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.057 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -47.47 -31.5 4.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.685 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -81.13 -27.5 35.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.77 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -81.48 -23.42 37.41 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.574 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.868 HD13 HG22 ' A' ' 169' ' ' VAL . 65.0 mt -78.38 -36.02 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.51 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.492 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 61.0 t-80 -80.69 -32.13 36.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.215 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.58 -18.78 30.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.228 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.564 ' CD2' HD11 ' A' ' 166' ' ' ILE . 41.7 t80 -66.11 -62.94 1.21 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.242 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.593 ' CE2' ' O ' ' A' ' 207' ' ' ILE . 13.9 p90 -75.0 -1.05 20.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.254 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 1.2 m -68.32 -37.27 80.42 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -117.87 97.63 50.92 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.707 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.45 117.54 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.321 2.014 . . . . 0.0 112.18 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.448 ' CG ' HH11 ' A' ' 215' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.481 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.471 ' O ' ' OG ' ' A' ' 155' ' ' SER . 4.2 p . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.838 0.352 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.22 157.56 52.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.532 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -76.08 33.29 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.786 2.324 . . . . 0.0 112.317 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 160' ' ' LEU . 3.2 p -65.75 -17.86 64.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.52 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 158' ' ' SER . 5.0 tp -38.43 -20.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.658 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.621 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.6 pp -83.83 -45.32 13.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.601 ' N ' HD12 ' A' ' 160' ' ' LEU . 9.2 ttt180 -75.28 -20.13 59.31 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 45.7 m -85.92 -34.81 20.82 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.307 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.461 HG21 ' CE2' ' A' ' 211' ' ' PHE . 2.3 t -72.26 -52.9 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.505 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.52 ' C ' ' H ' ' A' ' 166' ' ' ILE . 8.3 pt20 -49.33 -31.69 9.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.105 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.04 12.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.097 0.475 . . . . 0.0 110.209 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.629 HD11 ' CD1' ' A' ' 210' ' ' PHE . 4.5 mt -76.4 132.39 72.93 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.13 128.95 14.47 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.033 1.822 . . . . 0.0 110.856 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 118.49 -50.41 0.81 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.848 HG22 HD13 ' A' ' 207' ' ' ILE . 37.2 t -48.56 -49.64 13.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.103 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 173' ' ' LYS . . . 84.73 82.6 1.03 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 170' ' ' GLY . 25.1 pttt -42.96 -19.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 170' ' ' GLY . 65.8 t -70.46 -42.62 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.845 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 19.0 tttm -86.91 -12.62 47.14 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.722 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.771 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -43.97 -60.02 3.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.293 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 29.0 Cg_endo -65.66 -29.68 51.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.507 2.138 . . . . 0.0 111.788 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.49 HD23 ' HG3' ' A' ' 173' ' ' LYS . 39.9 tp -70.92 -57.92 4.1 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.587 0.708 . . . . 0.0 110.37 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.025 HD22 HD13 ' A' ' 187' ' ' LEU . 5.7 tt -67.69 -31.6 71.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.131 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.766 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -55.61 -21.35 17.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.675 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.522 ' N ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -61.94 -26.89 68.46 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.2 mttm -97.53 -18.03 19.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.042 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.61 ' O ' ' O ' ' A' ' 178' ' ' LEU . 35.2 m-85 -132.88 150.92 77.01 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.417 . . . . 0.0 111.361 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -38.56 -74.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 123.213 2.609 . . . . 0.0 112.944 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.66 ' O ' ' N ' ' A' ' 185' ' ' GLN . 1.3 t -160.51 169.33 23.2 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.066 0.46 . . . . 0.0 111.298 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.727 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.65 -15.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.731 -179.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.66 ' N ' ' O ' ' A' ' 183' ' ' SER . 5.6 tt0 -66.53 -63.59 1.04 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -89.41 -31.26 17.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.173 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 1.025 HD13 HD22 ' A' ' 177' ' ' LEU . 0.2 OUTLIER -48.09 -55.22 10.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.631 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.676 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.0 OUTLIER -62.58 -17.67 60.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.721 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -101.39 8.09 42.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.511 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.606 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -49.77 154.51 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.579 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 46.3 t -45.2 146.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.568 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 30.7 mm -59.49 -43.66 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -57.88 -50.41 66.03 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.846 ' O ' HG23 ' A' ' 198' ' ' VAL . 39.3 mt-10 -62.28 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.727 0.299 . . . . 0.0 110.598 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.606 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 3.4 mt -53.0 -21.42 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.56 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 198' ' ' VAL . 11.5 tt0 -77.84 -61.23 2.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.745 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -68.14 5.22 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 194' ' ' GLU . 71.9 t -108.59 -36.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.365 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.527 ' CG1' HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -143.34 -39.09 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.349 -0.941 . . . . 0.0 112.705 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.84 136.7 2.96 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.472 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.07 -47.75 83.27 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.469 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -72.77 -36.92 67.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.439 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.527 HG11 ' CG1' ' A' ' 199' ' ' VAL . 23.5 t -58.37 -61.49 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.219 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.444 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.92 -34.01 26.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.79 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -69.94 -27.14 64.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.76 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.469 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 1.0 OUTLIER -84.23 -55.98 3.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.422 . . . . 0.0 110.545 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.848 HD13 HG22 ' A' ' 169' ' ' VAL . 26.8 mt -48.52 -28.08 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.906 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -80.69 -32.6 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.88 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -83.45 -22.49 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.589 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.629 ' CD1' HD11 ' A' ' 166' ' ' ILE . 32.4 t80 -57.54 -47.58 81.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.825 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.461 ' CE2' HG21 ' A' ' 163' ' ' VAL . 76.4 m-85 -46.6 -51.94 14.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.636 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 19.8 m -68.46 -37.96 80.64 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.218 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -118.89 97.53 50.78 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.531 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -74.53 113.98 3.92 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.359 2.039 . . . . 0.0 111.684 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.579 -179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.837 0.351 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 158' ' ' SER . 4.0 mm-40 -110.97 95.91 26.83 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.394 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.547 ' O ' ' CD2' ' A' ' 160' ' ' LEU . 72.1 Cg_exo -46.38 81.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.427 2.085 . . . . 0.0 112.001 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 160' ' ' LEU . 22.9 p -66.46 -18.75 65.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.862 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 159' ' ' LEU . 1.0 OUTLIER -32.04 -32.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.641 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.604 ' HG ' ' H ' ' A' ' 161' ' ' ARG . 0.3 OUTLIER -84.06 -51.25 7.24 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.604 ' H ' ' HG ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -62.86 -18.04 62.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.468 ' N ' ' O ' ' A' ' 158' ' ' SER . 60.6 m -85.76 -46.08 11.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.98 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.529 HG13 HD12 ' A' ' 166' ' ' ILE . 1.8 t -53.22 -48.9 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.44 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -18.97 0.55 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.708 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -83.27 2.36 36.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.472 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.831 HD11 ' CD1' ' A' ' 210' ' ' PHE . 6.1 mt -67.11 131.2 93.67 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.491 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.433 ' O ' ' NE2' ' A' ' 206' ' ' GLN . 30.5 Cg_endo -68.14 128.66 17.94 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.52 1.48 . . . . 0.0 110.351 178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.404 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 118.89 -49.97 0.84 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.466 HG23 ' H ' ' A' ' 169' ' ' VAL . 2.0 t -49.29 -57.58 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.812 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 99.94 87.28 1.94 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 170' ' ' GLY . 2.2 pttt -43.2 -19.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 170' ' ' GLY . 58.9 t -72.27 -45.12 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.2 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.2 tttm -87.24 -17.53 32.37 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.777 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.829 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -35.53 -58.77 0.78 Allowed Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.307 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.829 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 53.5 Cg_endo -72.5 -36.26 5.36 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.686 2.258 . . . . 0.0 111.451 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 176' ' ' LEU . 15.0 tp -60.7 -57.61 11.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.247 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.893 ' O ' HD23 ' A' ' 177' ' ' LEU . 3.0 tt -65.69 -31.63 72.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.84 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.598 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -51.53 -14.39 0.31 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.167 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -79.05 -35.24 42.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.063 179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -85.13 -6.93 59.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.652 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.644 ' CZ ' ' HB1' ' A' ' 190' ' ' ALA . 38.6 m-85 -147.29 153.56 44.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.664 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -38.27 -73.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 123.097 2.531 . . . . 0.0 112.836 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -160.79 168.93 23.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.014 0.435 . . . . 0.0 111.24 -179.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.419 HG23 ' H ' ' A' ' 184' ' ' ILE . 0.6 OUTLIER -39.13 -26.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.752 -179.329 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 183' ' ' SER . 7.6 tt0 -63.19 -56.34 17.52 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.5 tp60 -87.39 -38.81 15.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.999 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.36 -50.67 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.142 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.482 ' N ' ' HG ' ' A' ' 187' ' ' LEU . 22.9 p -64.16 -17.84 63.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.526 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.512 ' O ' ' OD1' ' A' ' 189' ' ' ASN . 48.7 t-20 -106.12 1.2 26.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.726 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.644 ' HB1' ' CZ ' ' A' ' 181' ' ' PHE . . . -44.24 159.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.415 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.1 p -52.29 137.76 28.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.534 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.2 mm -54.92 -43.59 69.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.681 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -53.0 -33.87 45.14 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.885 ' O ' HG23 ' A' ' 198' ' ' VAL . 67.5 mm-40 -81.78 -65.6 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.645 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.438 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 2.4 mt -47.86 -29.53 3.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.867 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.566 ' C ' ' H ' ' A' ' 198' ' ' VAL . 2.5 tm-20 -72.54 -61.01 1.95 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.897 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.511 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 7.1 pt20 -67.76 6.76 0.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 194' ' ' GLU . 72.7 t -106.24 -38.94 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.076 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.79 -39.09 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.361 -179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.57 139.25 3.98 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.266 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.445 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 37.7 tt0 -65.27 -44.72 87.14 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.69 -31.2 64.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.465 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 206' ' ' GLN . 18.6 t -68.31 -61.35 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.884 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.438 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -46.96 -33.48 4.69 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -81.4 -23.47 37.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.992 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 203' ' ' VAL . 4.1 pt20 -83.23 -31.56 26.94 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.557 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.37 -50.04 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.102 0.477 . . . . 0.0 110.007 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.582 ' O ' ' OG1' ' A' ' 212' ' ' THR . 66.1 t60 -54.21 -35.72 62.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.894 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.5 -20.68 27.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.831 ' CD1' HD11 ' A' ' 166' ' ' ILE . 27.0 t80 -61.57 -61.51 2.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.976 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.505 ' CE2' ' HA ' ' A' ' 208' ' ' HIS . 26.8 p90 -78.75 1.36 23.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.235 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 208' ' ' HIS . 21.2 m -65.34 -38.06 88.98 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -119.16 97.84 50.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.529 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.462 ' O ' ' C ' ' A' ' 215' ' ' ARG . 12.0 Cg_exo -63.73 115.19 2.92 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.173 1.915 . . . . 0.0 112.013 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.462 ' C ' ' O ' ' A' ' 214' ' ' PRO . 9.6 mtt85 . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.614 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.802 0.334 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -112.48 95.08 30.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.676 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.27 90.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.624 2.216 . . . . 0.0 112.083 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.8 t -88.08 -17.74 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.721 ' O ' HG23 ' A' ' 163' ' ' VAL . 1.9 tp -48.79 -20.31 0.47 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.576 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.757 HD11 HD11 ' A' ' 184' ' ' ILE . 1.0 OUTLIER -83.83 -63.26 1.38 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.14 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.514 ' N ' HD23 ' A' ' 160' ' ' LEU . 34.4 ttt-85 -62.27 -21.84 65.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.533 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 29.7 m -85.92 -29.32 23.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.903 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 159' ' ' LEU . 2.4 t -73.12 -47.95 45.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -53.05 -22.58 6.12 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.827 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -80.61 13.51 2.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.879 0.371 . . . . 0.0 110.522 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.631 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.8 mt -78.15 130.44 72.32 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.869 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.74 129.2 13.26 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.897 1.732 . . . . 0.0 110.87 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.46 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 120.65 -51.45 0.78 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.819 HG22 HD13 ' A' ' 207' ' ' ILE . 63.6 t -49.39 -45.66 19.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.945 0.402 . . . . 0.0 110.112 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 82.21 81.1 0.92 Allowed Glycine 0 CA--C 1.519 0.34 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.37 -19.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 170' ' ' GLY . 46.4 t -66.91 -44.68 88.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.069 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.679 ' O ' ' N ' ' A' ' 176' ' ' LEU . 2.7 ttmm -84.06 -32.49 24.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.795 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.739 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -28.27 -62.69 0.19 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.425 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.739 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -55.51 -36.4 94.23 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.245 1.963 . . . . 0.0 111.115 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.679 ' N ' ' O ' ' A' ' 173' ' ' LYS . 19.5 tp -77.74 -57.01 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.555 0.693 . . . . 0.0 109.54 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.054 HD23 HD11 ' A' ' 187' ' ' LEU . 23.6 tp -59.98 -18.59 46.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.095 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.875 HD23 ' C ' ' A' ' 178' ' ' LEU . 1.0 OUTLIER -73.58 -38.24 65.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.16 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.683 ' N ' HD23 ' A' ' 178' ' ' LEU . 22.5 mt-30 -47.02 -20.57 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.326 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.405 ' N ' ' C ' ' A' ' 178' ' ' LEU . 6.2 mmtt -101.38 -26.5 13.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.692 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.59 ' O ' ' O ' ' A' ' 178' ' ' LEU . 21.6 m-85 -126.23 148.53 63.9 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.967 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -36.79 -76.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.199 2.6 . . . . 0.0 113.31 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.7 OUTLIER -157.17 168.18 28.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.841 -0.344 . . . . 0.0 111.021 -179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.774 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -39.52 -16.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.476 -179.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 183' ' ' SER . 1.9 tp-100 -66.33 -62.95 1.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -88.09 -32.3 18.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.034 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 1.054 HD11 HD23 ' A' ' 177' ' ' LEU . 0.3 OUTLIER -49.89 -54.03 22.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.632 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.671 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.8 OUTLIER -68.94 -12.61 61.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.937 0.399 . . . . 0.0 110.417 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -107.72 6.51 27.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.645 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 195' ' ' LEU . . . -53.87 163.26 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.557 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.1 t -43.98 159.48 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.698 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 196' ' ' GLU . 50.3 mm -76.33 -42.96 36.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.625 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.8 -37.16 92.06 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.9 ' O ' HG23 ' A' ' 198' ' ' VAL . 16.4 mt-10 -69.34 -65.18 0.74 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.771 0.32 . . . . 0.0 110.384 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.503 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 0.8 OUTLIER -57.52 -22.62 45.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.741 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 198' ' ' VAL . 3.8 tm-20 -74.11 -60.39 2.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.494 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -66.77 2.9 1.18 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.565 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 194' ' ' GLU . 45.3 t -96.94 -48.9 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.07 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 203' ' ' VAL . 0.4 OUTLIER -134.62 -39.62 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.679 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 199' ' ' VAL . . . -178.79 143.27 5.77 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.947 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 205' ' ' GLN . 12.6 tt0 -65.66 -36.36 83.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 206' ' ' GLN . . . -71.56 -43.34 66.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.563 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.649 HG11 HG11 ' A' ' 199' ' ' VAL . 46.6 t -58.44 -61.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.531 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.503 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.27 -27.3 5.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.644 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.431 ' CG ' ' O ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -80.0 -25.32 40.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.291 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 202' ' ' ALA . 3.9 mt-30 -84.48 -43.09 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.967 0.413 . . . . 0.0 110.655 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.819 HD13 HG22 ' A' ' 169' ' ' VAL . 17.3 mt -63.19 -48.99 85.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.877 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.474 ' CB ' HD11 ' A' ' 192' ' ' ILE . 60.7 t-80 -58.9 -37.03 75.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.771 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -81.82 -27.2 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.631 ' CD2' HD11 ' A' ' 166' ' ' ILE . 14.1 t80 -44.86 -53.65 7.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.523 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.58 ' CE2' HG21 ' A' ' 163' ' ' VAL . 71.4 m-85 -46.59 -36.6 7.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.303 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 9.0 m -65.33 -37.81 88.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.263 -0.426 . . . . 0.0 109.907 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 210' ' ' PHE . 29.9 mt-30 -118.47 97.35 50.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.756 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.63 119.76 6.82 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.325 2.017 . . . . 0.0 112.114 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.606 179.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.732 0.301 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -56.37 149.94 35.66 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.561 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -64.48 165.68 19.57 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.708 2.272 . . . . 0.0 112.033 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.674 ' O ' ' N ' ' A' ' 160' ' ' LEU . 11.0 p -88.2 -20.23 25.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.817 HD23 ' O ' ' A' ' 159' ' ' LEU . 1.6 tt -35.59 -22.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.502 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 158' ' ' SER . 1.9 pp -83.7 -48.24 10.36 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.579 ' O ' ' NE2' ' A' ' 164' ' ' GLN . 0.1 OUTLIER -65.17 -17.49 64.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.5 m -85.66 -25.16 26.74 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.248 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.613 ' C ' ' H ' ' A' ' 165' ' ' GLN . 14.5 t -79.72 -56.25 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.782 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.674 ' OE1' ' N ' ' A' ' 165' ' ' GLN . 0.1 OUTLIER -47.89 -6.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.74 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.674 ' N ' ' OE1' ' A' ' 164' ' ' GLN . 20.5 mt-30 -94.29 3.93 54.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.43 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.998 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.3 mt -71.81 131.14 86.1 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.546 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.86 129.12 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.794 1.663 . . . . 0.0 110.899 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.67 -49.64 0.85 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.886 HG22 HD13 ' A' ' 207' ' ' ILE . 22.6 t -53.79 -37.55 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.999 0.428 . . . . 0.0 110.205 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 75.35 82.65 0.45 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -42.83 -19.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 170' ' ' GLY . 49.9 t -68.14 -51.6 46.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.091 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.526 ' O ' ' C ' ' A' ' 174' ' ' ALA . 21.7 tttm -75.67 -29.27 59.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.785 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.765 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -29.3 -64.68 0.18 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.669 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.765 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 18.5 Cg_endo -61.28 -36.33 80.1 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.542 2.161 . . . . 0.0 111.657 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 173' ' ' LYS . 43.3 tp -64.12 -57.32 9.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.558 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.734 HD22 HD13 ' A' ' 187' ' ' LEU . 1.4 tt -68.84 -28.25 66.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.592 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.863 HD23 ' C ' ' A' ' 178' ' ' LEU . 0.8 OUTLIER -55.17 -39.03 69.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.909 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.751 ' N ' HD23 ' A' ' 178' ' ' LEU . 76.4 mt-30 -45.04 -30.29 1.03 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.993 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -100.24 -17.9 17.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.261 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.601 ' O ' ' O ' ' A' ' 178' ' ' LEU . 62.6 m-85 -124.73 149.05 61.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 111.006 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -37.57 -78.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.921 2.414 . . . . 0.0 112.686 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.677 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.56 167.03 23.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.905 0.383 . . . . 0.0 111.079 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.737 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.58 -13.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.811 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.677 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.0 OUTLIER -72.1 -60.96 1.97 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 189' ' ' ASN . 46.8 tt0 -87.91 -32.31 19.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.026 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.89 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.84 -50.17 14.53 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.397 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.53 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.8 OUTLIER -62.45 -10.79 12.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.502 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 186' ' ' GLN . 40.6 t30 -111.63 4.69 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.711 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.55 ' HB1' ' CZ ' ' A' ' 181' ' ' PHE . . . -46.45 158.11 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.372 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -47.82 131.37 15.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.458 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 30.9 mm -47.88 -50.61 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -45.63 -42.86 10.79 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 198' ' ' VAL . 5.1 mm-40 -73.02 -62.05 1.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.873 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.485 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.8 mt -53.84 -25.41 19.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.907 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.64 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 2.6 tm-20 -78.21 -60.75 2.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 110.836 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.64 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 1.6 pt20 -67.1 3.52 1.13 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 196' ' ' GLU . 3.4 t -103.74 -37.67 4.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.094 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.615 ' CG1' HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -144.07 -38.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.455 -0.898 . . . . 0.0 112.749 -178.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.433 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.48 138.25 3.59 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.578 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.452 ' NE2' ' HG3' ' A' ' 196' ' ' GLU . 3.9 tp-100 -58.79 -52.53 65.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.11 84.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.736 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.615 HG11 ' CG1' ' A' ' 199' ' ' VAL . 21.0 t -53.87 -60.99 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.276 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.485 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -52.14 -29.17 20.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.799 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -78.89 -27.61 43.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.401 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 210' ' ' PHE . 1.2 mt-30 -80.49 -51.37 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.111 0.482 . . . . 0.0 110.403 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.886 HD13 HG22 ' A' ' 169' ' ' VAL . 25.3 mt -52.75 -34.37 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.669 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.487 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 21.1 t-80 -71.56 -40.92 69.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.812 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -84.17 -18.47 36.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.998 ' CD2' HD11 ' A' ' 166' ' ' ILE . 69.6 t80 -58.36 -65.09 0.71 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.202 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.627 ' CE2' ' O ' ' A' ' 207' ' ' ILE . 27.5 p90 -72.42 -3.57 24.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.23 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 66.1 m -65.5 -38.45 89.76 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.408 -0.517 . . . . 0.0 109.821 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -119.46 97.5 50.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.904 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -64.8 116.82 4.03 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.12 1.88 . . . . 0.0 111.851 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.516 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.806 0.336 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.78 144.81 98.92 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.658 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.45 ' O ' HD23 ' A' ' 160' ' ' LEU . 58.6 Cg_endo -74.79 156.5 43.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.638 2.226 . . . . 0.0 112.198 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -71.28 -15.74 62.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.338 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.697 ' O ' HG23 ' A' ' 163' ' ' VAL . 3.8 tp -37.46 -19.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.513 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.686 ' N ' ' O ' ' A' ' 158' ' ' SER . 2.4 pp -83.81 -44.76 14.03 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.612 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -74.17 -22.42 59.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.9 m -86.0 -32.7 21.36 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.625 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.7 HG13 HD12 ' A' ' 166' ' ' ILE . 3.4 t -71.9 -51.17 33.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.847 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 165' ' ' GLN . 9.3 pt20 -46.58 -27.55 1.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.853 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.438 ' N ' ' HG3' ' A' ' 164' ' ' GLN . 10.5 mt-30 -76.37 8.5 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.424 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.781 HD11 ' CD2' ' A' ' 210' ' ' PHE . 5.1 mt -69.43 131.54 90.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.589 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.98 129.53 14.37 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.876 1.717 . . . . 0.0 110.822 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.488 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 117.91 -49.71 0.85 Allowed Glycine 0 CA--C 1.523 0.594 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.873 HG22 HD13 ' A' ' 207' ' ' ILE . 17.6 t -54.79 -45.97 74.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 109.96 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 85.68 83.89 1.06 Allowed Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.5 OUTLIER -43.03 -19.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.566 ' N ' ' O ' ' A' ' 170' ' ' GLY . 63.9 t -71.22 -55.7 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.917 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.541 ' O ' ' C ' ' A' ' 174' ' ' ALA . 0.3 OUTLIER -71.71 -29.0 64.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.439 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.795 ' HB3' ' CD ' ' A' ' 175' ' ' PRO . . . -29.32 -64.83 0.18 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.247 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.795 ' CD ' ' HB3' ' A' ' 174' ' ' ALA . 11.0 Cg_endo -57.13 -45.38 35.96 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.703 2.269 . . . . 0.0 111.495 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 173' ' ' LYS . 21.3 tp -54.27 -57.24 11.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.507 0.67 . . . . 0.0 110.399 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.795 HD22 HD13 ' A' ' 187' ' ' LEU . 1.8 tt -72.35 -17.68 61.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.679 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.593 ' O ' ' O ' ' A' ' 181' ' ' PHE . 6.2 tt -59.47 -30.74 68.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.32 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -62.28 -21.79 65.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.214 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -96.86 -22.29 16.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.122 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.593 ' O ' ' O ' ' A' ' 178' ' ' LEU . 48.1 m-85 -132.32 150.21 75.33 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -36.77 -76.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.997 2.464 . . . . 0.0 112.65 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.678 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.9 OUTLIER -162.59 171.26 17.22 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.015 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.565 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.38 -15.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.493 -179.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.678 ' N ' ' O ' ' A' ' 183' ' ' SER . 24.0 tt0 -70.78 -60.21 2.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 189' ' ' ASN . 1.3 tt0 -87.99 -34.46 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.025 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.909 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -45.33 -51.02 11.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.25 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 207' ' ' ILE . 54.5 m -61.68 -15.02 36.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.301 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 186' ' ' GLN . 5.3 t-20 -105.51 12.22 31.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.083 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -53.71 149.55 8.29 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.31 128.7 4.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.653 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 5.2 mm -48.26 -49.17 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -50.72 -35.94 31.6 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 198' ' ' VAL . 18.4 mt-10 -77.8 -64.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.697 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 1.7 mt -51.4 -23.91 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.606 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.629 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 3.2 tm-20 -79.73 -60.98 2.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.854 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.629 ' N ' ' CD ' ' A' ' 196' ' ' GLU . 0.8 OUTLIER -66.44 3.67 0.91 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 196' ' ' GLU . 13.4 t -104.06 -37.54 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.131 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 203' ' ' VAL . 0.7 OUTLIER -143.67 -39.03 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 119.486 -0.886 . . . . 0.0 112.436 -179.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.432 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.89 139.08 3.83 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 119.763 -1.208 . . . . 0.0 112.413 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.437 ' HA ' ' CG ' ' A' ' 196' ' ' GLU . 6.5 tp-100 -63.71 -40.63 97.23 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.35 68.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.872 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 199' ' ' VAL . 29.8 t -63.83 -61.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.209 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.524 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -50.07 -33.37 18.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.734 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -78.46 -26.37 46.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.927 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.498 ' C ' ' CD ' ' A' ' 206' ' ' GLN . 0.0 OUTLIER -84.69 -36.18 22.05 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.649 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.873 HD13 HG22 ' A' ' 169' ' ' VAL . 72.3 mt -65.34 -43.35 94.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.088 0.47 . . . . 0.0 109.959 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.447 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 3.8 t60 -66.99 -35.41 79.9 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.703 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -87.2 -18.42 30.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.781 ' CD2' HD11 ' A' ' 166' ' ' ILE . 45.1 t80 -64.65 -65.4 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.491 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 207' ' ' ILE . 40.2 p90 -75.03 1.19 13.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.041 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -66.02 -38.35 88.21 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.67 97.41 49.86 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.036 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -65.92 120.5 7.67 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.262 1.974 . . . . 0.0 111.885 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.545 179.892 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.845 0.355 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.98 165.14 25.55 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.523 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.644 ' O ' ' CD2' ' A' ' 160' ' ' LEU . 29.0 Cg_endo -66.73 158.51 55.75 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.786 2.324 . . . . 0.0 112.078 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 161' ' ' ARG . 26.1 t -88.41 -15.84 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.793 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 158' ' ' SER . 0.5 OUTLIER -35.93 -28.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.268 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.777 HD23 ' H ' ' A' ' 160' ' ' LEU . 2.7 pt? -83.36 -40.32 19.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.605 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -74.15 -18.02 60.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.5 m -85.97 -40.01 16.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.135 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.821 HG13 HD12 ' A' ' 166' ' ' ILE . 2.9 t -66.22 -53.28 38.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.676 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.56 -22.82 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.628 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -84.94 10.32 12.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.299 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.821 HD12 HG13 ' A' ' 163' ' ' VAL . 4.5 mt -70.21 132.01 88.34 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.817 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.04 129.17 16.85 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.021 1.814 . . . . 0.0 111.247 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.64 -47.86 1.0 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.839 HG22 HD13 ' A' ' 207' ' ' ILE . 93.9 t -50.64 -46.31 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.043 0.449 . . . . 0.0 110.232 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 81.2 82.12 0.82 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.522 ' CB ' ' NZ ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -42.75 -18.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' A' ' 170' ' ' GLY . 43.8 t -66.9 -42.04 88.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.013 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.567 ' N ' ' O ' ' A' ' 170' ' ' GLY . 23.8 tttt -87.6 -22.25 24.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.672 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.793 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -33.93 -61.83 0.39 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.597 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.793 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 24.4 Cg_endo -63.69 -37.42 46.48 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.603 2.202 . . . . 0.0 111.707 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.473 HD23 ' HG3' ' A' ' 173' ' ' LYS . 22.0 tp -59.26 -56.68 19.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.562 0.696 . . . . 0.0 110.562 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.051 HD22 HD13 ' A' ' 187' ' ' LEU . 5.9 tt -74.47 -28.2 60.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.722 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.564 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.8 tt -50.32 -17.87 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.847 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 179' ' ' GLN . 9.2 mm100 -78.04 -36.55 48.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.826 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -82.39 -18.62 41.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.564 ' O ' ' O ' ' A' ' 178' ' ' LEU . 20.9 m-85 -131.82 154.34 81.74 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.194 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -36.62 -76.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.841 2.361 . . . . 0.0 112.462 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.691 ' O ' ' N ' ' A' ' 185' ' ' GLN . 68.8 m -162.8 169.4 19.95 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.789 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.712 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.54 -14.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.481 -179.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.691 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.1 OUTLIER -73.26 -60.91 2.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -87.7 -26.66 22.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.088 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 1.051 HD13 HD22 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -55.11 -53.93 49.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.51 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.495 ' O ' HG22 ' A' ' 207' ' ' ILE . 1.4 t -64.32 -19.99 65.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.086 0.469 . . . . 0.0 110.13 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.571 ' O ' ' OD1' ' A' ' 189' ' ' ASN . 22.8 t-20 -104.05 11.09 35.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.927 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.504 ' HB1' ' CE2' ' A' ' 181' ' ' PHE . . . -57.87 163.59 2.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.635 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.1 p -51.25 131.86 28.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.703 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.4 mm -49.46 -49.82 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.791 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -47.48 -46.93 23.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.896 ' O ' HG23 ' A' ' 198' ' ' VAL . 64.1 mm-40 -66.68 -66.12 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.647 0.261 . . . . 0.0 110.56 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.458 ' C ' ' HB2' ' A' ' 204' ' ' ALA . 3.7 mt -49.4 -25.53 2.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.686 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 198' ' ' VAL . 4.3 tt0 -73.29 -60.93 2.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -69.03 6.21 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.926 HG11 HD12 ' A' ' 177' ' ' LEU . 89.7 t -108.71 -36.4 3.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.505 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 200' ' ' GLY . 0.5 OUTLIER -142.82 -38.98 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 119.422 -0.911 . . . . 0.0 112.606 -179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -178.53 137.48 3.29 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.263 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -63.73 -45.89 87.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.48 -29.29 59.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.58 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' A' ' 206' ' ' GLN . 19.7 t -68.08 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.094 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' A' ' 195' ' ' LEU . . . -47.68 -31.05 4.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.852 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.62 -26.48 41.16 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.765 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 203' ' ' VAL . 0.0 OUTLIER -84.76 -32.98 23.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.73 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.839 HD13 HG22 ' A' ' 169' ' ' VAL . 63.3 mt -68.46 -34.02 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.685 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -71.99 -41.58 67.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.137 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' A' ' 212' ' ' THR . . . -76.11 -29.71 57.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.882 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.708 ' CD1' HD11 ' A' ' 166' ' ' ILE . 9.2 t80 -50.77 -41.55 56.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.917 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.434 ' CZ ' ' OG ' ' A' ' 188' ' ' SER . 73.5 m-85 -46.32 -19.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.625 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 209' ' ' ALA . 0.2 OUTLIER -76.53 -36.8 57.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.667 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -117.65 97.44 50.76 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.426 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -76.54 114.6 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.402 2.068 . . . . 0.0 111.841 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.584 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 85.8 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.772 0.32 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.453 ' OE1' ' N ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -51.8 143.9 20.74 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.53 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.601 ' O ' HD21 ' A' ' 160' ' ' LEU . 57.4 Cg_endo -73.78 64.09 4.86 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.569 2.179 . . . . 0.0 112.008 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 160' ' ' LEU . 15.7 t -84.64 -20.63 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.641 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.48 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -34.12 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.601 HD21 ' O ' ' A' ' 157' ' ' PRO . 0.4 OUTLIER -83.92 -46.94 11.56 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.548 ' H ' ' HG ' ' A' ' 160' ' ' LEU . 14.2 mtp180 -70.12 -18.21 63.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 158' ' ' SER . 7.5 m -85.7 -25.85 26.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.059 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 166' ' ' ILE . 2.7 t -80.17 -46.0 22.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.581 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.48 -12.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.533 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -96.12 4.39 52.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.522 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.805 HD11 ' CD1' ' A' ' 210' ' ' PHE . 3.6 mt -56.52 115.76 10.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.556 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -51.28 129.57 29.36 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.788 1.658 . . . . 0.0 111.288 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.491 ' HA3' HG13 ' A' ' 203' ' ' VAL . . . 110.72 -46.26 1.2 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 207' ' ' ILE . 4.1 t -48.86 -55.2 3.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.333 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.574 ' O ' ' N ' ' A' ' 172' ' ' VAL . . . 83.83 82.33 0.98 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -42.83 -19.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 170' ' ' GLY . 48.6 t -64.14 -41.81 93.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.945 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 176' ' ' LEU . 0.2 OUTLIER -85.86 -31.12 22.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.888 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' A' ' 175' ' ' PRO . . . -29.07 -65.13 0.17 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.696 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 174' ' ' ALA . 18.7 Cg_endo -60.77 -33.42 93.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.561 2.174 . . . . 0.0 111.691 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 173' ' ' LYS . 53.9 tp -67.9 -56.47 8.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.605 0.717 . . . . 0.0 109.734 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.668 ' CD2' HD13 ' A' ' 187' ' ' LEU . 0.5 OUTLIER -72.47 -17.06 61.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.233 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.624 ' O ' ' O ' ' A' ' 181' ' ' PHE . 4.7 tt -52.59 -54.16 36.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.435 ' N ' HD23 ' A' ' 178' ' ' LEU . 0.0 OUTLIER -48.48 -23.91 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.533 -179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 179' ' ' GLN . 49.2 mttp -88.91 -16.15 32.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.869 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.624 ' O ' ' O ' ' A' ' 178' ' ' LEU . 95.3 m-85 -148.6 145.73 20.75 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 121.003 0.43 . . . . 0.0 110.922 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 181' ' ' PHE . 80.8 Cg_exo -31.82 -78.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 123.17 2.58 . . . . 0.0 112.87 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 185' ' ' GLN . 0.2 OUTLIER -163.11 175.8 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.857 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.597 ' N ' HD13 ' A' ' 184' ' ' ILE . 0.1 OUTLIER -39.78 -14.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.516 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.685 ' N ' ' O ' ' A' ' 183' ' ' SER . 0.5 OUTLIER -69.29 -62.92 1.18 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' A' ' 189' ' ' ASN . 6.1 tt0 -88.37 -33.26 18.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.033 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.877 ' O ' HD12 ' A' ' 187' ' ' LEU . 0.1 OUTLIER -46.06 -52.07 12.61 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.234 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.824 ' O ' HG22 ' A' ' 207' ' ' ILE . 0.4 OUTLIER -65.63 -3.69 5.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.51 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 186' ' ' GLN . 49.1 t-20 -121.98 3.98 9.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.773 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.63 ' HB3' ' CD1' ' A' ' 195' ' ' LEU . . . -48.71 161.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.487 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.43 140.7 4.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.729 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -62.51 -47.54 92.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.528 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -52.41 -28.53 28.41 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 198' ' ' VAL . 4.2 mm-40 -81.87 -64.9 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.786 0.327 . . . . 0.0 110.782 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.63 ' CD1' ' HB3' ' A' ' 190' ' ' ALA . 0.7 OUTLIER -52.58 -30.21 29.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.807 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 198' ' ' VAL . 15.1 tt0 -72.39 -61.09 1.92 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.156 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -67.49 4.25 1.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 194' ' ' GLU . 25.4 t -108.78 -35.58 2.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 203' ' ' VAL . 0.8 OUTLIER -143.01 -39.34 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 119.256 -0.978 . . . . 0.0 112.551 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.447 ' N ' HG12 ' A' ' 199' ' ' VAL . . . -179.69 138.03 3.29 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 119.724 -1.227 . . . . 0.0 112.445 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -63.79 -43.5 96.13 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.97 -32.88 69.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.545 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.602 HG11 HG11 ' A' ' 199' ' ' VAL . 48.6 t -66.3 -61.68 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.849 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.473 ' HB2' ' N ' ' A' ' 196' ' ' GLU . . . -50.69 -29.97 12.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.491 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -81.09 -28.01 35.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.813 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 210' ' ' PHE . 3.4 pt20 -84.44 -42.77 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.599 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 188' ' ' SER . 65.4 mt -58.62 -42.5 85.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.654 ' O ' ' CZ ' ' A' ' 211' ' ' PHE . 58.4 t-80 -66.72 -42.63 86.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.862 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -86.0 -18.57 32.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.038 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.805 ' CD1' HD11 ' A' ' 166' ' ' ILE . 6.5 t80 -51.91 -56.93 11.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.035 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.654 ' CZ ' ' O ' ' A' ' 208' ' ' HIS . 8.4 p90 -74.74 18.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.451 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 210' ' ' PHE . 41.8 m -71.58 -37.87 70.96 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.975 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -118.95 97.3 50.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.291 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.43 114.13 3.91 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.296 1.997 . . . . 0.0 112.08 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.65 179.925 . . . . . . . . 0 0 . 1 stop_ save_